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Abstract and Layout of Thesis 
Sequence-specific synthesis is essential to life. In nature, information-rich polymers such as 
polynucleotides, polypeptides and polysaccharides are responsible for virtually all vital 
processes. As opposed to nature’s optimised approach towards sequence control employing 
sophisticated molecular machines such as ribosomes and nucleotide polymerases, the 
synthetic chemist’s toolbox for the generation of highly ordered monomeric sequences is 
limited in scope.  
In this thesis, the realisation of the first artificial small-molecule machines capable of 
synthesising peptides, translating information that is encoded in a molecular strand, is 
described. The chemical structure of such machines is based on a rotaxane architecture: a 
molecular ring threaded onto a molecular axle. The ring carries a reactive arm, a thiolate 
group that iteratively removes amino acids from the strand that block the path of the 
macrocycle. The acyl monomers are transferred to a peptide-elongation site through native 
chemical ligation, thereby translating the information encoded in the track into a growing 
peptide strand. The synthesis is demonstrated with ~1018 molecular machines acting in 
parallel; this process generates milligram quantities of a peptide with a single sequence as 
confirmed by tandem mass spectrometry.   
 
Chapter I describes previous strategies that have been employed to realise sequence specific 
synthesis and gives an overview about relevant literature in the field.  
Chapter II describes the concept, previous work and model studies which lay the ground 
work for the more advanced machines. The first generation design of a molecular machine 
based on transacylation catalysis as well as the second generation design based on native 
chemical ligation are discussed. The successful operation of a single-barrier rotaxane capable 
of elongating its reactive arm by a single amide bond formation and subsequent 
self-immolation is described. 
Chapter III describes the first small-molecule molecular machine capable of sequence-
specific assembly of a tripeptide. The sequence-integrity of the operation product is 
determined by tandem mass spectrometry and comparison with an authentic sample. 
Chapter IV describes a novel synthetic approach towards highly complex molecular 
machines. Using this rotaxane elongation strategy, a molecular machine with four aminoacyl 
monomers on the strand is reported. The successful operation afforded the expected product 
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2 Chapter I 
1.1 Synopsis 
Sequence-specific synthesis is essential to life. In nature, information-rich polymers such as 
DNA, RNA, peptides, and carbohydrates are responsible for information storage and 
replication, translation of information, catalysis of essential reactions, energy storage, and 
are employed as structural components. As opposed to nature’s approach towards sequence-
control using sophisticated molecular machines such as ribosomes and nucleotide 
polymerases, the chemists’ synthetic toolbox for the generation of highly information-rich 
monomeric sequences is limited in scope, but has developed considerably in recent years. 
The efficient and selective synthesis of sequence-specific polymers holds the promise for the 
development of new materials with unprecedented micro- and macroscopic properties. In 
this first chapter, the ribosome as gold standard for sequence-specific catalysis is analysed 
and assessed, and the various synthetic strategies developed, ranging from the solid-phase 
synthesis of oligomers to the synthesis of information-rich synthetic polymers over DNA-
templated synthesis that finally lead to the development of small-molecule ribosome 
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1.2 Introduction 
Sequence defined polymers are essential to life and are found in every single living 
organism. Nature’s solution for the chemical challenges all organisms are exposed to is the 
incorporation of sequence-defined polymers in all processes of life.
1
 In order to cope with 
fundamental problems such as information storage and replication, translation of 
information, catalysis of essential reactions, energy storage and structure three major classes 
of information-rich biopolymers have evolved: polynucleotides, polypeptides and 
polysaccharides. 
The individual properties of the incorporated monomers and their sequence in the primary 
structure of the single-chain polymer strand allow the formation of kinetically stable three-
dimensional structures under physiological conditions. Only the ability to form well-defined 
architectures with the possibility of precise positioning of active groups in space enables the 
unique catalytic properties found in enzymes. 
In nature, sequence control of polymers is realised through the operation of complex 
molecular machines consisting of sequence-defined polymers themselves.
2
 In case of DNA, 
the synthesis of a new strand is achieved through the action of DNA polymerases, enzymes 
that transcribe the information contained in a parental DNA strand by connecting the four 
nucleotide building blocks in the complementary order (DNA replication). Similarly, the 
sequence-specific synthesis of RNA is realised by RNA polymerases, like the DNA 
polymerases molecular machines capable of transcribing a single DNA strand to a 
complementary RNA strand incorporating uracil in all instances where thymine would have 
occurred (transcription). Polypeptides on the other hand are most commonly synthesised by 
the action of ribosomes, extraordinary molecular devices that translate the genetic code into 
a sequence-defined polypeptide by moving directionally along an mRNA strand 
(translation). In contrast to polypeptides and polynucleotides, the sequence and structure of 
polysaccharides is commonly less well-controlled.
3
 Their structure can range from linear to 
highly branched, and the monomeric sequence can vary, sometimes containing only a single 
monomeric repeating unit, in other instances consisting of a variety of monosaccharides with 
different linkages and substitution patterns. Their moderately sequence-controlled synthesis 
is achieved in vivo by the complex interplay of several cooperatively interacting enzymes but 
is only partly understood.
4
 
In sharp contrast to nature’s ability to generate information-rich monodisperse polymers, 
most approaches used by chemists today are limited in scope. Solution phase synthesis 
requires elaborate protection/deprotection sequences in order to built up sequence-specific 
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chains and in case of classical step and chain growth polymerisation a precise positional 
control of co-monomers in the growing polymer chain is not possible and usually a statistical 
distribution of monomers is found in synthetic copolymers.
5
 Although polymers with narrow 
molecular weight distributions
6
 and well-defined tacticities
7
 and macromolecular 
architectures
8
 have been realised, the field of sequence-controlled synthesis of polymers 
remains largely unexplored. It is obvious that the construction of single polymer chains with 
well-defined primary structure would allow the synthesis of materials with novel micro- and 
macromolecular properties as found in nature. New techniques using oligonucleotide 
templates or molecular machines based on synthetic small-molecules are emerging in order 
to overcome those difficulties but remain thus far limited to short oligomeric products. 
This introductory chapter aims to provide an overview of the different approaches that have 
been applied for sequence control in chemical synthesis. The function of the ribosome as the 
prime example and benchmark for a sequence-control in polymerisation is assessed and 
discussed from a synthetic chemist’s perspective. Approaches towards sequence control that 
have appeared in literature, ranging from the use of a solid support over DNA templates to 
sophisticated ribosome mimetics, are described with a focus on the underlying concepts. 
1.2.1 The Gold Standard of Sequence Control: the Ribosome 
In all living cells, the translation of information from the genetic code into sequence-specific 
polypeptides is achieved through the action of the ribosome, a highly complex molecular 
machine.
2
 Initially discovered in the 1940s, ribosome research took off at the end of the 
1970s with extensive biochemical studies on function and components.
9
 Since the 
publication of the first atomic resolution crystal structure of ribosomal subunits in 2000
10
 the 
understanding of the function and structure of the ribosome has made remarkable progress 




Structural studies revealed that the ribosome is composed of two subunits of unequal size 
(Figure 1.1, A).
12
 In bacteria the 70S
13
 ribosome consists of a large 50S and a small 30S 
subunit (Figure 1, A and C respectively), which together form a 2.3 MDa protein-RNA 
assembly. In their eukaryotic counterparts, the 80S ribosome is considerably larger and is 
composed of subunits with sedimentation coefficients of 60S and 40S and a total weight of 
4.2 MDa. The surfaces of the two subunits responsible for the self-assembly and most parts 
of the core architecture consist mainly of RNA whereas in peripheral parts of the ribosome 
proteins are incorporated. 
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Figure 1.1. Crystal structures of the ribosome. (A) 70S ribosome complexed with tRNA and mRNA. 
(B) Exploded view of the 50S subunit, and (C) exploded view of the 30S subunit; tRNA shown in red 
(A-site), green (P-site) and range (E-site). Adapted with permission from Elsevier. 
For the ribosomal translation of the genetic code two RNA components are essential: (i) a 
messenger RNA (mRNA) which is a transcript of a DNA strand and carries the actual 
information that is translated by the ribosome and (ii) a transfer RNA (tRNA), the building 
block that carries an activated aminoacyl residue and a three-nucleotide recognition site 
referred to as a codon that enables the interaction with the mRNA in the translation cycle. 
The mRNA that is read-out during translation fits neatly into a cleft of the smaller subunit, 
which mediates the codon/anti-codon interactions of the incoming tRNA. The peptidyl 
transferase centre (PTC) responsible for the actual catalysis of the peptide chain transfer is 
located in the large subunit (Figure 1.1, B) in close proximity to the three binding sites for 
the tRNA found in the ribosome (red, green, orange structure respectively, Figure 1.1, C): (i) 
the A-site that interacts with the incoming aminoacyl tRNA, (ii) the P-site that is occupied 
by the tRNA loaded with the emerging peptide strand, and (iii) the E-site (exit) where the 
deacylated, “spent” tRNA is transferred to from the P-site after peptide chain elongation.  
The process of translation is commonly divided into three stages: initiation, elongation and 
termination.
12a
 During initiation the actual ribosome mRNA complex is assembled from its 
subunits around the start codon of the mRNA through the action of several protein initiation 
factors.
14
 In the elongation cycle, the assembled ribosome then initiates the translation and 
consequently the synthesis of the polypeptide (Figure 1.2). At the start of this sequence 
(Figure 1.2, A), both E- and P-sites are occupied with tRNA exhibiting codon-anticodon 
binding, whereas the A-site remains empty. The P-site tRNA is carrying the nascent 
polypeptide chain and the deacylated tRNA remains in the E-position. 
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Figure 1.2. Schematic overview of the ribosomal elongation pathway. For simplicity, not all 
intermediate steps deduced from kinetic experiments are shown. 
For a successful translation, elongation factors (EF), comparatively small proteins that 
facilitate the translation and mediate interactions between the tRNA, mRNA and the 
ribosome, are essential. The EFs responsible for the translation cycle (EF-Tu and EF-G) both 
have a GTP hydrolysis site that allows the conversion to GDP. Upon correct 
codon/anticodon recognition at the A-site with the corresponding ternary EF-Tu-GTP-tRNA 
complex (Figure. 2, B), GTP is hydrolysed to give the corresponding EF-Tu-GDP fragment. 
This fragment can now dissociate from the ribosome, while the tRNA building block 
carrying the amino acid is delivered to the A-position.
15
 Now a series of interconnected 
events happen: the deacylated, “spent” tRNA in the E-site dissociates and triggers the 
accommodation of the aminoacyl-end of the “loaded” A-site mRNA in the PTC (Figure. 2, 
D). The nascent peptide chain is transferred from the middle P-site tRNA to the A-site tRNA 
(Figure.2, E) and the new amide bond is formed.
16
  
In order to achieve a reset of the machine, the spent tRNA blocking the P-site has to be 
transferred to the E-site. This is achieved through the action of the EF-G-GTP complex and 
subsequent GTP hydrolysis (Figure. 2, F).
17
 Accordingly, the peptidyl-carrying A-site tRNA 
is moved to the P-site, and the whole ribosome moves along the mRNA in the 3’ direction, 
leaving the A-site empty for the next EF-Tu-GTP-tRNA binding event. The elongation 
continues until the ribosome encounters a stop codon. Aided by ribosome release factors the 




Looking at the schematic description of the ribosomal translation from a chemist’s 
perspective attempting to learn about sequence-specific synthesis from nature, two 
(interconnected) key questions remain unanswered: 
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(i) How exactly does the ribosome achieve its near-perfect sequence-specificity even for 
very similar codons and/or aminoacyl residues?  
(ii) What mechanism is responsible for uni-directional movement of the ribosome along the 
mRNA strand? 
The most obvious answer to the correct decoding of the mRNA strand is the free energy 
difference of a matching codon-anticodon pair of mRNA and tRNA compared to the 
mismatched case. However, with respect to the remarkably high fidelity of decoding leading 
to error rates in the order of 10
-4
, the remarkably high accuracy of tRNA selection cannot be 
solely accounted for by the favourable Watson-Crick base pairing binding energies of a 
cognate codon.
19
 A free energy difference of 18-24 kJ/mol would be required to explain the 
error rates which are observed both in vitro and in vivo but the energy differences of cognate 
(two complementary trinucleotide sequences) versus near-cognate (one out of three 
nucleotide pairs mismatching) base pairs are estimated to be the order of only 2 to 6 
kJ/mol.
20
 So if not realised through energetically favourable recognition (alone) how is the 
remarkably low error rate achieved? 
One process that supports the selection of the cognate RNA is the so-called kinetic 
proofreading
21
 which happens after the codon-independent recognition of the ternary EF-Tu-
GTP-tRNA complex by the ribosome. In most cases, mismatching tRNA is expelled before 
GTP hydrolysis by EF-Tu but in case near-cognate RNA is bound and GTP hydrolysis as 
well as EF-Tu dissociation are triggered, incorrect tRNA can be expelled before the 




A second process aiding the differentiation between similar codon-anticodon pairs is the 
induced-fit mechanism
19a,23
, which accelerates the accommodation of the cognate tRNA over 
the near-cognate tRNA in the PTC, and therefore does not only make use of the differences 
in rates of dissociation but also in rates of association of tRNA to mRNA.
24
 By interaction of 
ribonucleotide bases of the ribosome with the minor groove of the first two base pairs of the 
codon-anticodon pairs in the A-site, a domain closure in the 30S subunit is induced and the 
incorporation of cognate versus non-cognate tRNA in the PTC is accelerated.
25
 
This multiplicative exploitation of differences enhances the sequence fidelity significantly 
compared to a hypothetical mechanism based solely on Watson-Crick base pairing of codon 
and anticodon.
26
 Nature makes use of several processes that are mutually supportive in order 
to generate an optimal result. 
One sometimes overlooked essential requirement for the remarkably small error rates in the 
translation process is the synthesis of tRNA loaded with the correct aminoacyl residue, 
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which is carried out independently from the action of the ribosome. If tRNA with a specific 
codon was loaded with a mixture of several amino acyl residues, even the most efficient 
ribosome would fail to deliver a peptide with a single sequence. 
The aminoacyl-tRNA synthetases that realise the loading of the tRNA can select even from 
structurally very closely related aliphatic amino acids such a valine, leucine and isoleucine 
specifically.
27
 For example, in case of isoleucyl-tRNA synthetases, it has been found that a 
double sieve mechanism is in operation.
28
 In the first step, both valine and isoleucine are 
activated and loaded on the corresponding isoleucyl-tRNA, but the slightly larger leucine is 
excluded (“coarse” sieve). In a second editing step, the enzyme selectively hydrolyses all 
valylated products (“fine” sieve). As in the case of the selection process of the ribosome, the 
realisation of sequence fidelity achieved by the complex interplay of different mechanisms 






Finally, the directional movement of the individual ribosomal components is essential for the 
successful translation of the mRNA strand. But how is directional movement of the ribosome 
achieved? 
Interestingly, movement of the ribosome is possible in both directions in the absence of 
elongation factor EF-G and GTP.
30
 Both translocation and retro-translocation are observed, 
albeit at relatively low reaction rates; tRNAs can move through the ribosome at 
physiological temperature in order to find the energetically most favourable position (tRNAs 
have, depending on their nature, a preferred site of occupation, i.e. E, P or A). The 




In order to “pay” the thermodynamic penalty of directional movement a fuel needs to be 
consumed by the ribosome. This input of energy could be the formation of the energetically 
more favourable peptide bond or one of the two GTP hydrolysis events during the elongation 
cycle (or a combination of both). 
In reality, the directional movement occurs after EF-G-GTP binding (the second GTP 
hydrolysis) and seems to be independent from the amide bond formation.
17b,32
 The rate-
limiting step during the translocation reaction is believed to be the movement of the tRNA 
anticodon stem-loops on the 30S subunit.
17b
 Binding of EF-G-GTP lowers the energy barrier 
of this transition probably through stabilisation of an otherwise unfavourable transition 
state.
33
 It is not entirely clear whether the decisive translocation step that follows is a power-
stroke mechanism, i.e. that the chemical energy from GTP hydrolysis is converted to 
mechanical energy and therefore biases the forward movement or whether GTP hydrolysis is 
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just triggered by the forward movement of the ribosome and prevents the reverse reaction 
from happening.
34
 Further experiments will have to indicate which mechanism is in 
operation. 
1.3 Strategies for Sequence Control 
Nature’s capability to control complex monomer sequences remains unrivalled by modern 
polymer chemistry standards. Consequently, the most straightforward approach towards the 
synthesis of information-rich polymers is the exploitation of ribosomes and polymerases in 
vitro. Advanced techniques have been developed in recent years ranging from the 
amplification of DNA (polymerase chain reaction [PCR]) to the incorporation of unnatural 
amino acids or even the creation of new polymer linkages such as polyesters using nature’s 
machinery.
1,35
 But although the use of enzymes in vitro for the synthesis of sequence-defined 
polymers represents a fascinating (and powerful) strategy, the ultimate aim is the synthesis 
of sequence-defined polymers of any set of co-monomers–natural or synthetic–in order to 
generate novel functional materials not limited by reaction conditions and a narrow substrate 
scope.
5c
 In the following paragraphs several strategies towards the synthesis of sequence 
controlled oligomers and polymers will be highlighted and discussed.  
1.3.1 Solid Phase Synthesis 
Today, the most powerful and most often applied method for the synthesis of sequence-
specific biomolecules is the solid-phase synthesis (SPS) introduced in 1963 by Merrifield,
36
 




In the literature, a vast number of reviews on SPS have appeared, dealing with peptide 
synthesis specifically
38
 or covering other aspects and reactions on solid support
39
. The 
following paragraph will therefore only highlight selected approaches that focus on 
sequence-specificity aided by polymer matrix support. 
Typically for solid-phase peptide synthesis
40
 an N-protected amino acid (Scheme 1.1, A) is 
connected via a cleavable linker to a poly(styrene) resin. After deprotection, a second N-
protected amino acid can be attached. This deprotection/chain-extension cycle is then 
repeated until the desired peptide sequence is obtained and the target molecule is cleaved 
from the solid support.  
This process allows the facile synthesis of peptides up to 50 amino acids and has been used 
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Scheme 1.1. Polymer matrix assisted synthesis of sequence-defined oligomers. (A) Solid phase 
peptide synthesis originally developed by Merrifield.
42
 (B) Sequence-specific synthesis of 
oligophenylacetylenes introduced by Moore.
43
 
The main advantages that lead to the widespread use of SPS
40
 are the ease of procedure and 
especially the rapid purification by filtrating and washing off by-products from the matrix-
bound polypeptide. Additionally, the high yield compared to the solution phase approach for 
multiple peptide couplings and the possibility for automation of the process are major 
advantages. Using peptide-synthesising machines, large libraries of peptides are accessible 
with ease. 
In principle, SPS can be applied to all step growth polymerisations as long as a suitable, high 
yielding and clean protection/deprotection strategy is available. Advanced approaches have 





The well-established peptide bond formation methodology together with 
fluorenylmethoxycarbonyl (Fmoc)- or tert-butyloxycarbonyl (Boc)-protecting groups for the 

















11 Chapter I 
Because of the interest in synthetic foldamers with their potential biological applications
53
, 





 have been developed as well.  
In addition, C-C bond forming reactions have been employed to synthesise polymers via the 
solid phase approach. The use of SPS for the synthesis of conjugated sequence-specific 
oligomers was demonstrated in 1994 (Scheme 1.1, B).
52c,56
 Employing TMS-protected 3-iodo 
phenylacetylenes, the synthesis starts with a resin bound TMS-protected phenylacetylene 
derivative. Liberation of the alkyne moiety using TBAF and subsequent addition of a TMS-
protected 3-iodo phenylacetylene under Sonogashira coupling conditions allows the stepwise 
built-up of sequence-defined oligomers. Cleavage from the resin with methyl iodide, ipso-
substitution the triazene group for iodine, delivers the target molecule. 
Subsequently the SPS approach has been extended to the synthesis of a large range of 
oligomers incorporating different reactions and substrates. Oligothiophenes can be obtained 
by alternating bromination and Stille coupling
57







 and nucleophilic substitution
61
 have also been 
employed. 
Despite the evident advantages of SPS, certain limitations remain. In contrast to the 
biopolymers synthesised by nature, all monomers have to be added sequentially and the 
sequence selectivity is achieved by step-wise deprotection and elongation which requires 
individual work-up and purification after each monomer addition. Furthermore, to obtain 
sequence selectivity, yield or the bond forming reaction, subsequent deprotection and final 
purification are crucial. 
1.3.2 Liquid-Phase Step- and Chain Growth Polymerisations 
In order to generate high molecular weight polymers with sequence control, bulk 
polymerisation techniques are desirable especially considering the limitation of iterative 
synthesis approaches to generate oligomers with more than a few monomeric units. Chain 
and step growth polymerisations of co-monomers have been used for the synthesis of 
copolymers in many instances, but sequence-specificity rather than a random incorporation 
of different units is problematic to realise in practice. In the last years numerous approaches 
towards the sequence-control of polymers have been developed in order to overcome those 
inherent problems and sequence-controlled polymerisations have been an emerging field of 
scientific interest.
5b
 For further information, the excellent reviews and perspectives from 
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Scheme 1.2. Different approaches towards sequence-controlled polymers. (A) Step-growth Passerini 
polymerisation of terminal functionalised biscarboxylic acids, bisisonitriles and an aldehyde from 
Li.
62
 (B) Sequential addition of N-functionalised maleimide co-monomers to a living radical styrene 
polymerisation introduced by Lutz.
63
 (C) Sequence-regulated radical polymerisation using a 
Pd-templated monomer from Ouchi and Sawamoto. (D) Nucleobase-templated Sonogashira 
polymerisation pioneered by Sleiman.
64
 
Step-growth polymerisation represents the most straightforward strategy for the synthesis of 
alternating copolymers, the simplest case of a defined monomer sequence. Sequence control 
is possible using monomers of the A-A and B-B or A-B type.
65
 On the other hand, more 
complex sequences are difficult to realise. 
Representing a notable exception, employing the Passerini reaction, a step-growth ABAC-
type polymer was synthesised by Li and co-workers (Scheme 1.2, A).
66
 The classical three-
component Passerini reaction allows the synthesis of an depsipeptide from an isocyanide, an 
aldehyde (or ketone), and a carboxylic acid.
67
 By employing a dicarboxylic acid, an 
aldehyde, and a diisocyanide it was possible to incorporate the sequential information into 
the structure of the polymer chain affording a sequence-regulated 
poly(ester−ester−amide−amide) in an one-pot process. 
In the case of chain growth polymerisation, where the chain propagation is achieved by the 
reaction of highly reactive active centres, i.e. radicals or ions, monomer sequence control is 
inherently more problematic and in most cases as a result a statistical copolymer is obtained. 
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One general strategy that allows the synthesis of sequence-defined polymers using chain 
growth polymerisations exploits reactivity differences of co-monomers. For example, the 
metal-catalysed copolymerisation of carbon monoxide with epoxides leads to the formation 
of poly(-hydroxyalkanoate)s since neither carbon monoxide nor epoxides have a tendency 
to homopropagate under the reaction conditions.
68
 Catalyst control is another method for the 
selective alternating incorporation of monomers and suppression of homopropagation in the 
growing polymer chain. This method was used by Thomas and co-workers in a very elegant 
synthesis of syndiospecific alternating polyesters.
69
 In the reaction mixture, enantiomerically 
pure but differently functionalised -lactone monomers were polymerised using an yttrium 
complex as initiator and delivering a highly alternating polyester. 
But also chain-growth polymerisations of non-metal catalysed reactions can be employed for 
the generation of alternating polymers. Because of its high tendency for cross-propagation 
over homopropagation, maleic anhydride or N-substituted maleimides have been used for the 
synthesis of A-B type polymers.
70
 The controlled radical copolymerisation of maleic 
anhydride or N-substituted maleimide derivatives and styrene gives highly alternating 
copolymers, since the electron-poor maleic anhydride is preferentially incorporated into the 
living polymer chain over styrene, even if a large excess of styrene is present, but has a low 
tendency to homopropagate.  
In a particular example by Kamigaito and co-workers another aspect of maleimide reactivity 
was exploited for the generation of an AAB-type polymer. In case of the radical 
copolymerisation of phenylmaleimide (A) and D-limonene (B), it was observed that the 
intermediate adduct AA of two phenylmaleimide units strongly favours the incorporation of 
monomer B over A, whereas an AB terminus exclusively reacts with another maleimide 
monomer A.
71
 The solvent choice is critical for the outcome of this polymerisation, as 
fluorinated alcohols like PhC(CF3)2OH favour the incorporation of another maleimide 
monomer to an AB·unit, supposedly through hydrogen bonding to the maleimide’s carbonyl 
groups. 
A different approach towards sequence-defined polymers that makes use of the sequential 
addition of monomers to a growing polymer chain was introduced by Lutz and co-workers in 
2007 and subsequently extended in the following years allowing the incorporation of 
individually functionalised maleimide monomers in a polystyrene chain with high precision 
(Scheme 1.2, B).
72
 The position and order of differently functionalised monomers is 
achieved by addition of differently N-substituted maleimides during the living chain growth 
at different conversions of the styrene co-monomer. Adding exactly one equivalent of 
maleimide with respect to the number of the living polystyrene chains, precisely one of the 
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more reactive co-monomer units is incorporated in the growing polystyrene chains due to the 
fact that maleimides have no tendency to homopropagate. Since a living polymerisation is 
employed, the length of the simultaneously growing chains is very similar and therefore the 
positional control of the insertion is relatively accurate. Tuning the reaction conditions and 
adding the maleimide co-monomers at high styrene conversions, the incorporation in a zone 
of uncertainty of only 1 or 2 styrene units in average has been achieved.
72a
 This sequential 
addition of co-monomers to a growing polymer chain in order to generate sequence-
regulated polymers can be applied, if (i) in the reaction mixture all polymer chains grow 
simultaneously, (ii) the added co-monomer is more reactive than the co-monomer present in 
the reaction mixture and therefore incorporated shortly after addition, and (iii) cross-
propagation of the added monomer is disfavoured. Unfortunately, with the exception of the 
styrene/maleimide pair introduced by Lutz no other examples for the sequential addition 
approach have been reported to date.  
Finally, chain-growth sequence-regulated polymers have been synthesised through the use of 
templates that arrange the co-monomers in a certain sequence. Pioneered by Ouchi and 
Sawamoto it was possible to obtain AB alternating sequences by controlled radical 
cyclopolymerisation of methylmethacrylate and a methacrylate held in position by ester 
linkages onto a naphthalene scaffold.
73
 After hydrolysis, an alternating methylmethacrylate-
acrylate polymer was obtained. 
This strategy was extended to ABA-alternating copolymers (Scheme 1.2, C) exploiting π-π-
stacking interactions between two aromatic side groups (A) and a pyridine ligand (B) held in 
place by a palladium atom.
74
 Demetallation of the polymer and cleavage of the amide bonds 
to remove the template lead to an ABA-sequence regulated copolymer.  
Ideally, monomers held in place by supramolecular interactions would allow the translation 
of templates without the need of covalent linkage and post-polymerisation cleavage of the 
templated polymer strand. First studies towards the template-assisted radical polymerisation 
relying on supramolecular interactions with the ultimate aim of sequence control have been 
reported by Ouchi and Sawamoto, but the successful implementation into a sequence-
controlled polymerisation has yet to be demonstrated.
75
 
Sleiman and co-workers reported an interesting nucleobase-templated polymerisation that 
allowed to inherit the chain length and polydispersity of a parental template strand with 
narrow molecular weight distribution to the daughter strand, although no sequence control 
was possible (Scheme 1.2, D).
76
 Usually, step-growth polymerisations suffer from poor 
molecular weight control, but the preassembly of nucleobase-functionalised monomers on a 
template through Watson-Crick base pairing enabled the synthesis of daughter strands 
 
15 Chapter I 
through Sonogashira polymerisation with narrow molecular weight distribution. Without 
template, short conjugated oligomers with a significantly higher polydispersity index and 
lower average molecular weight are formed. 
Similarly, Luh and co-workers demonstrated the possibility of polynorbornene replication. 
Norbornene monomers were assembled on a polynorbornene strand through ester linkages. 
After ring opening metathesis polymerisation, the daughter strand was removed by 




1.3.3 Introduction to DNA-Templated Methods 
Although step- and chain growth polymerisation allow the synthesis of high molecular 
weight polymers with narrow weight distributions, to date the sequence-specificity of the 
polymer chains is limited to small repetitive segments. One reason for the limitation of 
synthetic polymer chemistry to simple repetitive sequences of monomers is the use of 
statistical reactions and the lack of information-rich templates that feature selective 
interactions between monomers and the template strand. 
The use of information-rich biopolymers as templates for the generation of synthetic 
sequence-specific polymers seems therefore a promising approach towards the ultimate goal 
of precise monomer positioning. Self-evidently, early on DNA has been identified as 
potential template for polymerisations. Introduced more than 40 years ago by Naylor
78
, a 
focus of research has been laid upon DNA templated synthesis (DTS) over the last 15 years 
and the field has been subject to several reviews.
79
 DTS relies on the sequence-specific 
hybridisation of longer oligonucleotide strands; the most commonly used DTS approaches 
are shown in Figure. 3. Typically, a DTS reagent consists of a DNA oligonucleotide with the 
sole function of mediating the interactions with the template and a linker that connects the 
reactive group selected for the templated reaction with the DNA strand (Figure 1.3, A).
79a
 
The tethered oligonucleotide template itself only interacts with the DNA strands connected 
to the reactive groups but does not participate in the reaction. Alternatively, an 
oligonucleotide strand linked to a reactive group can be hybridised directly with a 
complementary DNA-linked reagent without the need of an additional template strand 
(Figure 1.3, B). 
Due to the high affinity of the DNA oligonucleotides to the template a high effective 
molarity of reactants is realised, which results in an enhanced reaction rate between the 
substrates. Accordingly, with DTS it is possible to direct reactions between reactants which 
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Figure 1.3. General strategies utilised in DNA templated synthesis. (A) Two reactive groups A and B 
tethered to a DNA-oligonucleotide strand brought together mediated by a DNA-template strand. (B) 
Reactive groups A and B held together by mutual interactions of their DNA tethers; matching colours 
indicate complementary sequences between strands; lines indicating base pairing do not represent a 
particular number of bases. 
Furthermore, libraries of DTS reagents can be exposed to in vitro selection and PCR 
amplification. The powerful approach of DTS for controlling the effective molarity of 
different reactants in solution represents an ideal tool for the realisation of sequence-specific 
synthesis of either complementary DNA strands or for the translation of information into 
chemically unrelated synthetic sequences. 
1.3.4 DNA-Templated Transcription 
Initially, DTS was mainly investigated with view on in vitro transcription. In the search for 
ways to non-enzymatic molecular replication–a prerequisite for the emergence of life
81
–
DNA templated coupling of activated oligonucleotides has been attempted as early as 1966 
by Naylor and Gilham.
82
 Seminal work from Orgel and co-workers showed the possibility to 




Even more intriguing, an autocatalytic full replication cycle of an RNA-hexamer in the 
presence of two activated trinucleotides, generating the original (+)-RNA strand has been 
realised by von Kiedrowski in 1986.
84
 But although impressive examples of DNA-templated 
synthesis have been realised, the use DNA-templated polymerisation of nucleotides has 
faced two substantial limitations. 
First, all non-enzymatic replication reactions using mononucleotide interactions have been 
low-yielding with respect to the generated oligomers. One reason for the low yield of the 
desired strands is the efficiency of the coupling steps. Even for relatively high-yielding 
reactions a low overall yield is obtained if many connections have to be formed. For 
example, assuming a coupling efficiency of 75% for each individual step and 10 coupling 
steps in total, the theoretical yield of the resulting 11-mer would be only 5.6%. Accordingly, 
in the quite impressive synthesis of an RNA 14-mer by transcribing a DNA strand with 
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Second, the sequence accuracy of the strands synthesised was generally not determined in 
the early work by Orgel and von Kiedrowski.
79a
 Later studies carried out by Rojas, Stütz, and 
Richard showed that error rates of DNA-templated mononucleotide coupling reactions can 
be greater than 50% for A:T and around 30% for G:C pairs, indicating that sequence-
specificity is difficult to achieve with individual mononucleotide interactions.
85
 Attempts to 
overcome problems with yield and sequence fidelity have been undertaken, e.g. by replacing 
the problematic phosphodiester formation step by using a phosphoramidate backbone,
86
 or 
the use of modified nucleobases that show enhanced interactions
86b,86d
, but to date no 
enzyme-free copying mechanism showing high sequence fidelity and high yield has been 
reported. 
From these limitations conclusions for the application of templated reactions for the 
synthesis of non-natural polymers can be drawn. The requirements for the successful 
templated enzyme-free sequence-specific synthesis of oligomers are: (i) a highly efficient 
reaction for the coupling of the individual monomer units, (ii) a reaction that is distance-
dependent, i.e. successful reactions are only possible with the nearest neighbour of each 
monomer, (iii) the interactions between the template and the monomers are efficiently strong 
to hold components in place, and (iv) recognition of each monomer is achieved by a 
selective interaction able to distinguish between the different monomers in solution.
87
  
Liu and co-workers realised the synthesis of peptide nucleic acid (PNA) oligomers 
containing up to 40 nucleobases (representing 10 consecutive coupling reactions) on a 5`-
NH2-terminated DNA-hairpin template employing reductive aminations of complementary 
-aldehyde -amine terminated PNA-tetranucleotides (Scheme 1.3, A). 
87
 Crucial for the 
success of this approach is the use of the high-yielding reductive amination strategy that 
guarantees the selective, i.e. distance dependent, coupling between neighbouring monomeric 
units assembled on the substrate. Additionally, the PNA-tetramers show strong and selective 
binding to their respective anticodon on the DNA-hairpin template. In their initial study the 
authors explored the synthesis of homopolymers of different length. Quite impressively, 
when mismatched codons only different in one nucleotide (e.g. ATTC instead of AGTC) 
were incorporated into the sequence of the template at a specific position, only products with 
a length up to the mismatched codon were produced. In a later study Liu and co-workers 
showed the possibility to employ side-chain-functionalised PNA tetra- and pentameric 
aldehydes
89
 and, even more remarkably, the synthesis of sequence-defined hexamers in the 
presence of 12 PNA-monomers from a DNA-hairpin template containing 6 codons (Scheme 
1.3, B).
90
 With the presented systems, Liu and co-workers successfully performed six 
iterated cycles of transcription, selection and amplification (a biotinylated, streptavidin-
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binding PNA segment was incorporated) and observed a >1,000,000-fold overall enrichment 
of the parental DNA strand, displaying the possibility of PNA evolution in vitro. 
 
Scheme 1.3. Synthesis of PNA oligomers assembled on a DNA-template by codon-anticodon 
recognition and subsequent connection by a reductive amination strategy introduced by Liu.
88
 (A) 
Polymerisation of a PNA-40mer by ten consecutive coupling reactions between oligonucleotide 
tetramers. (B) Sequence-specific synthesis of a PNA-30mer from six different PNA-pentanucleotides; 
matching colours represent complementary strands, DNA oligomers are depicted as rectangles, 
PNA-oligomers are depicted as rectangles with rounded edges. 
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1.3.5 Sequence-Specific Translation with DNA-Templated Synthesis 
The possibility to control the effective molarity of specific reactants mediating chemical 
reactions that would lead to considerable cross-reactivity under standard solution phase 
conditions by transcribing information from a DNA strand has led to the realisation of DNA 
templated multi-step sequence-specific syntheses. 
In their groundbreaking work, Liu and co-workers demonstrated the synthesis of a tripeptide 
based on information encoded in a DNA-template (Scheme 1.4).
91
 In the first step, a 
biotinylated 10-base oligonucleotide strand loaded with an amino acid (‘reagent’ strand) is 
annealed to a specific region of a 30-base DNA-oligomer (‘template’ strand), which features 
a terminal amino group, allowing the formation of a peptide bond after treatment with a 
coupling reagent. One problem the authors faced was the removal of the reagent strand after 
amide coupling. In order to allow subsequent extension of the peptide chain on the DNA-
template strand, the authors used a cleavable, base-labile carbamoylethyl sulfone linker 
connecting the amino acids to the DNA-oligonucleotide adapter. Therefore, removal of the 
waste reagent-DNA strand was possible in the second step by capturing the template-reagent 
adduct with magnetic avidin beads and basic elution, traceless cleaving the linker and 
releasing the template strand loaded with the first amino acid in solution. Repeating the 
procedure of reagent annealing, peptide bond formation, avidin capturing and linker 
cleavage/elution for another two cycles allowed the isolation of the desired sequence-specific 
tripeptide. 
Based on this work, Liu and co-workers demonstrated the translation of a library of template 
strands into the corresponding sequence-specific synthetic small-molecule macrocycles 
incorporating various functionalised amino acids.
92
 The 65-member library containing one 
known macrocycle-DNA conjugate possessing target affinity was subjected to in vitro 
selection and amplification and the positive control could be isolated and identified after one 
cycle. Similarly, the translation of DNA into synthetic N-acyloxazolidines has been reported 
by the same group.
93
 
In all three examples, reagents have to be added sequentially and purification has to be 
performed after each monomer addition. Liu and co-workers showed that a one-pot oligomer 
synthesis can be realised by simultaneous hybridisation of three reactive monomer strands 
onto a DNA-template featuring three complementary binding sites.
94
 Controlling the 
secondary structure of the template strand with temperature variations, the effective molarity 
of the annealed reagents could be fine-tuned and a sequence-ordered triene was obtained 
from three successive Wittig olefinations. 
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Scheme 1.4. DNA-templated multistep synthesis of a tripeptide reported by Liu.
95
 Sequence-control is 
achieved by sequential addition of oligonucleotide tethered N-protected amino acids, which are held in 
place by the complementary sequence on the amine-functionalised template strand. Amide coupling, 
avidin capturing, and basic elution allow the transfer of the monomer to the template and the removal 
of the spent oligonucleotide tether; matching colours indicate complementary sequences between 
strands; lines indicating base pairing do not represent a particular number of bases. 
Instead of using linear templates, Gothelf, Hansen and co-workers introduced multibranched 
DNA-junctions for the three-step synthesis of a sequence-defined pentapeptide with the aim 
to overcome limitations of linear templates, e.g. the intrinsic disadvantage of decreasing 
coupling efficiency with increasing distance between reactive centre on the template and the 
monomer attached to the reagent strand.
96
 The reactive monomeric unit is attached close to 
the three-way junction, thereby allowing the control of the effective molarity during the 
assembly of the nanoscale reactor, enabling the reaction of reactants in a confined space. 
Furthermore, the system allows target affinity screening by repeated rounds of selection, 
amplification, and translation. 
Another approach towards DNA-templated multistep synthesis that overcomes the 
disadvantages of a simple linear template exploits “toehold” displacement.
97
 In an 
asymmetric DNA duplex A`B`:B, where B is a strand complementary but shorter than A`B` 
and A` a “toehold”, i.e. a short sequence of unpaired nucleotides, B can be replaced by an 
incoming strand AB that hybridises with A`B`, after initial recognition of A:A`. 
Turberfield and co-workers were the first group to demonstrate a strand displacement 
mechanism for the sequence-specific multistep synthesis of an olefin by consecutive Wittig-
reactions.
98
 The reaction is based on the hybridisation of the DNA strand bound to the 
growing oligomer with a reagent strand. After group transfer to the reagent strand the spent 
DNA strand can be displaced by addition of a fully complementary remover strand.  
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This cycle of reagent addition and strand removal can be continued – in theory- infinitely, 
making it the first example of multistep DTS where the length of the target oligomer is only 
limited by the intrinsic yield of the coupling reaction, but not by the length and information 
content of the template strand. Building on these initial results, Turberfield and co-workers 
demonstrated the synthesis of a sequence-defined 10-mer, showing the possibility to realise 
relatively long sequences with DTS.
99
 
Using a similar approach, Liu developed the DNA-templated synthesis of a heptamer, 
featuring six elongation reactions.
97
 Instead of adding remover strands, a linear template 
bearing six different binding sites is employed and displacement of the spent adapters is 
achieved by addition of a reagent strand that substitutes the former strand through 
increasingly stronger interactions with the template. The reaction proceeded in 35% overall 
yield, corresponding to ∼83% average yield per step, much higher than for other comparable 
DNA-templated multi-step syntheses. 
Combining the use of branched DNA-junctions and the strand displacement strategy, 
Turberfield and co-workers recently reported the first example of a templated oligomer 
synthesis in which all reactive monomers are present in solution simultaneously (Scheme 
1.5). 
The adapters used for the synthesis consist of oligomers which feature reactive monomer 
groups at either the 5` or the 3` end. The DNA sequence consists of one individual adapter-
specific (Scheme 1.5, coloured lines) and one of two mutually complementary universal 
domains (Scheme 1.5, grey lines). The universal domain enables the interaction with all 
complementary adapters and allows the reactive units to be aligned in an end-of-helix 
configuration during the transient T-way junction that is formed when two adapters interact 
with a template strand. The template strand itself features two toeholds at either end, 
allowing its displacement by addition of a fully complementary remover strand. The 
sequence of the oligomer can therefore be controlled by the alternating addition of a DNA-
template strand and subsequent addition of a remover strand. During each Wittig reaction the 
growing oligomer is transferred to the incoming adapter, making it possible to synthesise 
products not limited by the information content of a linear template. Additionally, the 
approach from Turberfield allows the parallel synthesis of different sections, allowing access 
to highly complex product libraries and short synthetic sequences. 
Extending their DNA-PNA oligomer transcription approach, Liu and co-workers 
demonstrated in a remarkable example the possibility to translate the information encoded in 
the DNA-parental strand into structurally unrelated synthetic polymers. 
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Scheme 1.5. Mechanism for the DNA-templated sequence-controlled oligomer synthesis reported by 
Turberfield.
100
 (A) Reactive monomers A to F are tethered to nucleotide sequences featuring 
individual (coloured) and general sub-sequences (grey) that allow interaction with the complementary 
template strand (coloured) and complementary adapters (grey), respectively. Addition of a template 
strand brings two adapters together and enables the Wittig reaction and transfer of the growing 
oligomer strand. Sequential addition of template and removal strands allows sequence-control of the 
growing oligomer; matching colours indicate complementary sequences between strands; lines 
indicating base pairing do not represent a particular number of bases. (B) Hexameric reaction product 
successfully isolated by Turberfield and co-workers (tethered oligonucleotide not shown). 
Therefore, the authors employed PNA-pentamers to which oligomer fragments such as 
polyethylene glycol, -(D)-peptides or -peptides were connected via two disulfide linkages. 
The macrocyclic tRNA analogues functionalised with either two terminal azides or two 
terminal alkynes were then assembled on the DNA template and coupled using the CuAAC 
reaction in an AA-BB manner. Cleaving the disulfide bonds with the reducing agent 
dithiothreitol liberated the synthetic polymer products. In their most impressive example, the 
authors reported a polymer with a molecular weight of 26 kDa arising from 16 consecutive 
substrate couplings and containing 90 -amino acid building blocks. 
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1.3.6 Artificial Molecular Machines for Sequence-Specific Synthesis 
All highly sequence-controlled polymerisations in nature are realised with the help of 
molecular machines. Designing synthetic molecular machines for the sequence-defined 
assembly of monomeric units therefore holds the promise to eventually achieve sequence 
control similar to that of DNA-polymerases and ribosomes. 
The dynamic behaviour of molecular devices capable of synthesising sequence-specific 
polymers based on the movement along a template strand, e.g. the ribosome or DNA-
polymerase, can be described by fundamental characteristics exhibited by the system similar 
to that of molecular walkers
101
: 
(i) Processivity: the ability of the machine to remain attached to the template during the 
operation. 
(ii) Directionality: the tendency of the device to preferentially or exclusively migrate in a 
given direction, i.e. towards the end of a molecular template. 
(iii) Iterative operation: the capability of the molecular machine to be reset after a complete 
cycle of operation, e.g. to repeat the synthesis of a given oligomer using the same template. 
(iv) Repetitive operation: the ability of the molecular machine to be reset at the end of each 
synthetic step without undoing the task i.e. bond formation that was originally performed. 
(v) Autonomous operation: the ability of the molecular motor to continually function as long 
as an energy input is present, i.e. no external intervention such as the application of a 
sequence of stimuli is required.  
Those characteristics are typically fulfilled for nature’s machinery and are generally 
desirable, but not necessarily required for the successful realisation of a multistep synthesis 
aided by an artificial molecular machine. A subset of characteristics, e.g. a machine that 
processively moves along a template destroying the information encoded in the strand with 
each monomer addition shows processivity, repetitive operation and directionality through 
the burnt bridges mechanism
101
 it follows but is not capable of iterative operation. Also it 
does not necessarily have to be autonomous. Similarly, other molecular machines exhibiting 
a subset of characteristics can be successful in the synthesis of sequence-specific polymers. 
Three molecular machines which feature some of the aforementioned characteristics will be 
presented in detail in the following section. 
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1.3.7 DNA-Based Molecular Walkers for Sequence Control 
Inspired by motor proteins like kinesin, dynein and certain myosin motor proteins that 
transport cargoes within the cell by “walking” along polymeric filaments,
101-102
 several 
artificial molecular transport systems based on DNA
103
 or small molecules
104
 have been 
successfully synthesised and operated. 
Generally, a molecular walker consists of multiple binding points (`feet`) that can associate 
with corresponding `footholds` on the track. Movement along a track is achieved by 
sequential detachment and reattachment of feet that–if biased–result in directionality. 
The first example of a sequence-specific synthesis performed by a molecular machine was 
reported by Seeman and co-workers (Figure 1.4).
103i
 In their seminal work, the authors 
employed a sequentially fuelled DNA-based molecular walker capable of picking up 
differently sized gold nanoparticles along its path (Figure 1.4, A). The triangular walker 
moiety itself is constructed from seven oligonucleotide strands that form a tensegrity 
architecture (Figure 1.4, B). The walker features seven single stranded DNA-sequences: four 
feet, responsible for the directional motion, and three hands, capable of binding to the cargo. 
As track a large (ca. 300 nm wide) two-dimensional DNA-origami tile assembled from a 
total of 202 DNA oligonucleotides and featuring 18 single-stranded protruding footholds was 
used. Additionally, three cassettes containing three independently controlled two-state DNA 
machines donating the cargo to the walker in its “on” state and holding it back in the “off” 
state, were attached to the origami framework. 
The walker unit performs a 120° rotation during each step (Figure 1.4, C). Movement is 
achieved upon addition of complementary fuel strands that trigger branch-migration of the 
targeted feet by toehold-binding and substitution. The fourth foot is only used for ensuring 
the proper orientation of the triangle towards the cargo-donating devices and is therefore 
only bound to the track when cargo is to be transferred. Two steps are needed to move the 
walker from one cargo-donating station to the next. Reaching a station in its “on” state, the 
cargo can be transferred to the hand of the walker via strand displacement; the decoding 
strand attached to the cargo features a toehold therefore allowing preferential binding to the 
hand of the walking moiety (Figure 1.4, D). During its linear trajectory, the DNA-walker 
encounters three delivery devices, either in an “on” or “off” state, resulting in 8 
distinguishable cargo combinations. 
The comparatively large size of the system allowed the analysis of product formation by 
atomic force microscopy (AFM) and scanning electron microscopy (SEM) which was also 
used for the statistical analysis of the yield of the process.  
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Figure 1.4. Nanoscale assembly line published by Seeman and co-workers.
105
 (A) Schematic 
illustration of the walker moiety featuring seven single-stranded domains: four feet (F1 to F4) and 
three hands (H1 to H3). (B) Schematic illustration of the cargo transfer from the DNA-adapter to the 
walker moiety. (C) Handover of DNA-bound cargo (C1) from the DNA machine to the walker. (D) 
One ‘stride’ of the walker moiety, requiring the sequential addition of two fuel strands and one anchor 
strand (walker rotated by 120°). Figure adapted with permission from Urszula Lewandowska. 
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Scheme 1.6. Sequence-defined synthesis of a tripeptide performed by an autonomous molecular 
walker capable of performing three consecutive intramolecular acylation reactions.
106
 The light-blue 
lines indicate the DNAzyme sequence incorporated in the walker unit, which catalyses the hydrolysis 
of the ribonucleotide linkage in the three adapters. The amino acids are connected to their 
oligonucleotide strands via reactive succinimidyl ester linkages (not shown). Matching colours 
indicate complementary sequences between strands; lines indicating base pairing do not represent a 
particular number of bases. 
 
The yield depends directly on the number of cargo additions to the walker, incorporation of 
nanoparticles from the “off”-state was practically not detected. For the triple addition, a yield 
of 43% was observed: programmed single products can be obtained in 90% yield with 
negligible formation of incorrect products.  
A second example of a sequence-specific synthesis aided by a DNA-based molecular walker 
was reported shortly after Seeman’s work by Liu and co-workers (Scheme 1.6).
103j
 The 
sequence-specific synthesis of a tripeptide was successfully realised with an autonomous 
DNA walker that performs a series of peptide bond formations through its station to station 
movement along its track. The translocation mechanism is similar to a previous reported 
walker by Mao and co-workers.
103c,d
 Liu’s device consists of a DNA-track featuring four 
distinct binding sites that can coordinate to three corresponding footholds (label 2,3,4 in 
Scheme 1.6) functionalised with activated esters of three different non-natural amino acids 
and a fourth foothold (1) called the initiator that hybridises with the walker unit during the 
self-assembly of the machine, resulting in the starting state A depicted in Scheme 1.5. The 
use of rigid spacers between the N-hydroxysuccinimidyl (NHS) ester and the amine 
functionality in the amino acids was necessary in order to prevent intramolecular cyclisation. 
The single-stranded part of the walker can now hybridise with toehold 2 and–via a 
competitive strand displacement–move to the second station. Resulting from the high 
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effective molarity of the amine-functionalised walker and the activated ester an amine 
transfer is triggered. In order to allow translocation to the third foothold, a cleavage of the 
ribonucleotide linkage built in foothold 2 occurs triggered by the DNAzyme moiety present 
in the walker. After dissociation of the short DNA fragment, the now single stranded DNA-
part of the walker can hybridise with foothold 3, repeating the series of events and 
elongating the growing chain by one monomeric unit. After a final cycle of walker 
migration, acylation and DNAzyme catalysed foothold cleavage, the walker remains 
attached to foothold 4 together with the assembled tripeptide on its N-terminus. 
The reaction mixture was analysed by high-resolution mass spectrometry and by comparison 
with mass spectra of authentic samples with known composition. The estimated yield of the 
targeted product was 45%, accompanied by walker-monoamide and walker-diamide side-
products. If RNA cleavage of the footholds occurs before the acyl transfer takes place, 
truncated products result. Therefore, in an ideal system the rate of peptide bond formation 
should be significantly higher than the DNAzyme catalysed cleavage of the footholds. In 
order to assess the sequence-specificity of the synthesised peptide, Liu and co-workers 
introduced an N-protected amino acyl residue in the position of foothold 2. As a result, only 
monoamide product was detected, suggesting the system works processively and the 
products are synthesised with sequence-specificity.  
Liu showed, in contrast to Seeman’s triangular walker, that it is possible to design systems 
that operate not only directionally and processively, but also autonomously although lacking 
the ability of repetitive operation. 
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1.4 Conclusion 
Although all examples using enzyme-free sequence-specific reactions with the various 
methods demonstrated to date have shown various possibilities for achieving sequence-
control in synthesis, the ability of nature to generate peptides with a length of over 30,000 
monomeric units
107
 in a defined order remains unmatched. Albeit considerable progress 
towards the realisation of sequence-specific synthesis has been made, there is still a long way 
to go until the capability of nature to generate information-rich monodisperse polymers can 
be achieved with the tools of synthetic chemistry. With sequential synthesis on solid phase, 
polymerisations that exploit reactivity differences of monomers and 
(mainly DNA-)templated polymerisation capable of assembling monomers in order, it 
remains to be seen which technique will allow the most versatile and practical control of 
sequence-specificity. From the author’s point of view, the use of complex artificial 
molecular machines – associated with new designs – offers possibilities that might enable the 
total synthesis of proteins or polymers with unprecedented micro- and macromolecular 
properties in the future. The design, synthesis and operation of such novel molecular 
machines will be discussed in the following chapter. 
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2.1 Synopsis 
In biological systems, molecular machines are employed to perform a variety of complex 
tasks essential for the functioning of living organisms and have always been an intriguing 
inspiration for scientists. The realisation of artificial molecular analogues that mimic the 
function of nature’s nanomachinery would ultimately allow access to complex task 
performance and new ways to control chemical reactions on a molecular level. 
In order to achieve such an ambitious goal, model studies and extensive tests are required 
before the synthesis of a more complex machineultimately a synthetic ribosome 
analoguecan be undertaken. Initial model studies were conducted in order to explore the 
possibility to synthesise a molecular machine capable of sequence-specific peptide synthesis 
employing an operation mechanism based on native chemical ligation. A rotaxane containing 
a macrocycle bearing a reactive arm and stoppered by a leucine phenolic ester derived 
barrier was successfully synthesised. Pick-up of the aminoacyl residue and subsequent 
transfer onto the terminal amine functionality of the growing peptide chain attached to the 
macrocycle through native chemical ligation allowed the self-immolation of the macrocycle 
with the newly grown peptide attached. The operation product was identified by comparison 
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2.2 Introduction  
Sequence-specific synthesis aided by molecular machines is found in every living cell–
ribosomes, DNA- and RNA-polymerases are essential for all biological processes.
1
 Without 
the capability of synthesising biopolymers with high sequence-specificity life would not 
exist. Despite the abundance of information-rich polymers in nature with translation and 
transcription aided by molecular machines as examples for ultimate sequence control, 
approaches towards the goal of synthesising defined monomer sequences without repetitive 




The aim of this work is the development of a molecular machine capable of controlling 
monomer order in an oligomer chain. Using a synthetic organic approach would allow for 
the preparation of significant amounts of material, the possibility to translate information for 
the synthesis of a range of oligomers of different chemical nature and the operation of the 
machine in a variety of non-physiological conditions, e.g. in organic solvents or at a wide 
temperature range. Sequence-specific synthesis with artificial machines would give organic 
chemists a new tool formerly reserved to biological systems: the possibility to translate a 
given template into a new strand with a chemically distinct nature. 
The ribosome and nucleotide polymerases can be seen as ideal and their characteristics 
represent a benchmark for any primitive first generation organic system. Both types of 
machines assemble monomers extremely fast and in a highly sequence-specific manner. 
They do not detach from their substrates, i.e. operate with high processivity and at the same 
time read out the template strand non-destructively. Furthermore, the enzyme-assisted 
biopolymerisation works autonomous and the machines are able to be recycled after 
completed synthesis. Fully repetitive and progressive operation is therefore achieved by 
natural systems. Certainly not all of these features are essential for an initial proof of concept 
in a synthetic system but they are of course desirable for the development of more advanced 
artificial molecular machines.  
The initial idea to synthesise a molecular system capable of translation of a molecular 
template was introduced to the Leigh group in 2007 by Stephen Goldup (Figure 2.1).
3
 The 
general concept involves a rotaxane architecture consisting of a macrocycle bearing a 
catalytic moiety interlocked on a relatively rigid track. The monomeric units to be assembled 
in a sequence are attached to the track by cleavable linkages allowing for reaction with the 
catalyst. The interlocked nature of the molecular machine ensures processivity of the system 
since the macrocycle cannot detach from the track without breakage of covalent bonds and 
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the rigidity of the system prevents folding and ensures that a reaction can only take place 
between catalyst and monomers that are in close proximity. The mechanically interlocked 
architecture with a macrocycle that can diffuse along a molecular strand is essential for 
another reason. In order to enable the sequence-specific synthesis the size of the macrocyclic 
cavity has to be small enough to prevent the macrocycle to move over the monomeric 
attachment points when a monomeric unit is connected to it which therefore functions as a 
“barrier” for the catalyst. On the other hand the macrocycle is designed in such a way that 
diffusion over the attachment point is possible after the pick up of the monomers. Different 
operation mechanisms can be imagined for such a molecular machine. The initial design 
involved a nucleophilic catalyst that can attack the first monomeric unit (Figure 2.1, 
Mechanism A). After cleavage of the bond between the track and monomeric unit, the 
activated monomer on the macrocycle is deposition onto a reactive group on the next barrier 
the macrocycle encounters. Transfer of the dimer to the third monomeric unit allows a 
specific sequence to be built up. Possible side reactions include the transfer of the activated 
monomer on a barrier that is not in proximity of the macrocycle. Carefully designing the 
track to prevent folding and utilising a catalytic unit that ensures the exclusive pick-up of the 
next monomer in sequence, scrambling can be avoided. After translation is complete, the 
macrocycle can slip off from the track and the operation product can be obtained. 
Different from the initially proposed design, a second operation mechanism can be 
envisioned, where instead of the activated growing strand being transferred onto the next 
monomer, a reaction occurs with a second functional group on the macrocycle itself, thereby 
extending the oligomeric chain in a sequence-specific manner (Figure 2.1, Mechanism B). 
This pick-up and chain-elongation is then continued until the macrocycle can slip off the 
thread, similarly to operation mechanism A.  
A molecular machine based on either mechanism would allow the sequence-specific 
synthesis of molecules through its processive operation. No stimuli or mechanisms for the 
directional movement of the macrocycle are required. The purely diffusive motion of the 
catalyst bearing macrocycle on the thread is sufficient to enable the reaction with the next 
monomeric unit that is encountered. An autonomous as well as a non-autonomous operation 
could be realised with such a system depending on the chemical nature of the transformation 
carried-out by the machine. The speed of the translation depends solely on the reactivity of 
the molecular machine under the operation conditions.  
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Figure 2.1. Schematic illustration of two possible operation mechanisms of a rotaxane-based 
molecular machine capable of sequence-specific assembly of three monomeric units based on their 
order on a track. Mechanism A: a nucleophilic catalyst (grey) attached to a macrocycle (blue) picks up 
monomer A. After cleaving monomer from the thread, the macrocycle can diffuse over the attachment 
point and deposit A on the next monomeric unit B it encounters. Continuation of this process leads to 
the sequence CBA. Mechanism B: a bifunctual catalyst (grey) is attached to a macrocycle (blue). 
Monomer A is cleaved from the track and deposited on a second nucleophilic site on the catalytic unit. 
Continuation of this process allows the built-up of the sequence ABC. 
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Such artificial molecular machines are based on several elements that have analogues in 
ribosomal protein synthesis: reactive building blocks (the role played by tRNA-bound amino 
acids) are delivered in a sequence determined by a molecular strand (the role played by 
mRNA). The macrocycle ensures processivity during the machine’s operation (reminiscent 
of the way that subunits of the ribosome clamp the mRNA strand) and bears a catalyst that 
detaches the building blocks from the strand and passes them on to another site. Therefore, 
even these primitive molecular machines can be seen as a ribosome mimics. However, one 
major drawback compared to biological systems remains: the destruction of the information 
incorporated in the strand during the operation of the system. 
 
2.2.1 First Generation Design of a Molecular Machine for Sequence-
Specific Synthesis 
The realisation of a first generation design of a molecular machine capable of sequence-
specific synthesis was attempted by Dr. Daniel M. D’Souza, Dr. Anthony Fernandes, 
Dr. Stephen Goldup, and Dr. Dominik Heckmann in the Leigh group in 2007 and 2008.
3
 
Based on operation mechanism A (Figure 2.1) the synthesis of an oligopeptide was 
envisaged using aminoacyl groups attached to the track via cleavable ester linkages and a 
transacylation catalyst connected to the macrocycle via a reversibly cleavable attachment 
(Scheme 2.1). The nucleophilic attack and pick-up of the first amino acyl moiety allows the 
macrocycle to proceed to the second amino acyl-loaded ester and after amide bond formation 
with the free amino group of the second amino acyl moiety. Subsequent cleavage of the 
dipeptide allows the macrocycle to repeat the procedure until it picks up the terminal amino-
acyl residue and slips off the thread. The proposed chemical structure of the first-generation 
molecular machine 1 is shown in Figure 2.2. Rotaxane 1 features a track with a moderately 
rigid N-methylated 4-(aminomethyl)benzoic acid-based spacer unit and the aminoacyl 
residues are connected to the track through labile tyrosine-derived ester linkages. The 
pyrrolidinopyridine-derived transacylation catalyst is connected via an oxime linkage to the 
aldehyde-functionality of an endotopic pyridine group that directs the threading of the half-
threads during the active-metal template assembly of the rotaxane. A sterically demanding 
stopper unit ensures that the diffusion of the mechanically interlocked macrocycle along the 
strand results in a net movement in the direction of the aminoacyl residues and enables the 
translation of the sequence information in the track to the corresponding peptide. 
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Scheme 2.1. Proposed mechanism for sequence-specific peptide synthesis by a molecular machine 
based on transacylation catalysis. After activation of the machine, successive acyl transfer reactions 
allow the coupling of the activated amino acid building blocks to the next amino acid the macrocycle 
encounters. Thereby a built up of the sequence irreversibly transcribed from the template strand is 
possible. Once the final amino acid is cleaved, the macrocycle bearing the synthesised oligopeptide 
detaches from the strand. Hydrolysis delivers the desired tripeptide. 
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Figure 2.2. First generation design of a molecular machine capable of sequence-specific synthesis. 
 
The retrosynthetic analysis of the molecular machine 1 is shown in Scheme 2.2. For such a 
complex molecule a fast access to all building blocks and a relatively modular design are 
paramount for the success of the whole project. The functional group tolerating and 
relatively high yielding Cu(I)-catalysed azide-alkyne (CuAAC) active-metal template 
reaction
4
 was chosen as rotaxane forming reaction. Since the pyrrolidinopyridine-motif could 
act as a competing ligand for the Cu(I)-ions in solution, incorporation of the catalytic unit 2 
after the rotaxane formation step would largely avoid detrimental non-interlocked product 
formation outside the cavity of the macrocycle. Choosing a suitable deprotection/elongation 
strategy, the aminoacyl-bearing alkyne 3 could be built up in an efficient convergent fashion 
through usually high-yielding amide couplings. A backbone containing N-methyl amide 
linkages offers good solubility and the facile interconversion between cis and trans-amides 
offers moderate flexibility allowing that the catalytic unit to react with all amino acyl 
residues. 
In order to test the feasibility of the proposed operation principle of the molecular machine, 
rotaxane 4 with a phenylalanine phenolic ester as acyl-donor was synthesised and after 
successful rotaxane formation, the catalytic unit 2 was introduced through the proposed 
oxime ligation strategy (Scheme 2.3). Unfortunately the intramolecular pyrrolidinopyridine 
catalyst did not cleave the phenolic ester under the reaction conditions and no dethreading of 
the macrocycle could be observed (Scheme 2.4).  
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Scheme 2.2. Retrosythetic analysis of molecular machine 1. 
 
Also, the addition of an external nucleophile (benzylamine) in high concentration did not 
allow for the interception of the acyl-pyridinium intermediate and the formation of 2-amino-
N-benzyl-3-phenylpropanamide 6. Addition of potassium hydroxide led to the saponification 
of the ester bond of 4 and the dethreading of the macrocycle. The most likely reason for 
failure of the system was assumed to be the unfavourable equilibrium between the acyl 
intermediate and the phenolic ester, which lies on the side of the ester. In addition, the 
peptide bond formation via the pyridinium intermediate is too slow to occur on a reasonable 
time scale.
3
 Other disadvantages of the first generation design were problems with the 
purification even for the relatively small single-barrier model due to the incorporation of a 
relatively large number of polar groups (four amide linkages, one triazole), broadening of the 
1
H-NMR-spectra due to the cis-trans-isomerisation of the N-methyl amides, and the inability 
to find a more reactive transacylation catalyst. 
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Scheme 2.3. Synthesis of rotaxane test substrate 4. Reaction conditions: a) Cu(CH3CN)4PF6, CH2Cl2, 





Scheme 2.4. Operation attempt of model rotaxane 4. Reaction conditions: a) benzyl amine, CDCl3, 






47 Chapter II 
2.2.2 Native Chemical Ligation as Operation Mechanism for a Second 
Generation Machine 
Opposed to the first design based on a classical DMAP-derived transacylation catalyst 
(corresponding to Mechanism A, Figure 2.1), a second generation machine could be 
envisioned to work with a cysteine derivative as a catalytic unit–the sequence-specific 
peptide synthesis in such a machine would be achieved through native chemical ligation 
(NCL, the final machine would operate according to Mechanism B, Figure 2.1).
5
 Initially 
developed for the condensation of unprotected peptide fragments, typically in a classical 
NCL reaction, the thiol-functionality of cysteine moiety on the N-terminus of a peptide 






Scheme 2.5. Mechanism of native chemical ligation. 
 
Through a thiol-thioester exchange both peptide strands are linked. In the presence of 
external thiolate nucleophiles in the reaction mixture, this thiol–thioester exchange is highly 
reversible. In the presence of the free amino group on the N-terminal cysteine, an amide 
bond is formed through a rapid, irreversible 1,5-S,N-acyl shift.
7
 NCL has proven to be highly 
chemoselective (virtually no byproducts are formed), high yielding, and versatile, and 
therefore has been employed in many examples for the total synthesis of fully functional 
proteins and enzymes.
6b
 Also, the thioester moiety is relatively stable towards hydroxyl 
nucleophiles, especially if the NCL is carried out in a pH-range between 6 and 8. During 
NCL typically no racemisation of the moderately activated peptide-thioester in the ligation 
 
48 Chapter II 




The chemoselectivity in addition to mild reaction conditions and high yield make the NCL a 
very good candidate for the incorporation in a complex molecular machine capable of 
sequence-specific synthesis, but two further requirements for a successful molecular machine 
based on a cysteine-derived reactive arm have to be met: (i) the catalytic unit has to be able 
to cleave the bond between the acyl residues and the track, and (ii) the S,N-shift has to work 
also with large transition states since otherwise only one amide bond forming reaction could 
be realised and the molecular machine would stall after the initial pick-up.  
Since one major limitation of NCL was its restriction to peptide chains with an N-terminal 
cysteine, several research groups investigated the possibility of long range S,N-acyl 
migrations. While the 1,5-S,N-acyl shift is the most facile, 11- up to 29-membered transition 
states have been reported as feasible in literature.
9
 On the contrary, the 8-membered 
transition state for the S,N-acyl shift is unfavoured.
9a,10
 Instead of the expected ligation 
product 7 (Scheme 2.6), Katritzky and co-workers showed that disproportionation product 8 
resulting from an intermolecular reaction was mainly produced during an attempted 1,8-S,N-
acyl shift. A similar outcome was observed for cyclic 9- and 10-membered transition states, 
which are energetically disfavoured compared to larger transitition states.
10
 However, both 
NCL-products 9 resulting from a 11-membered S,N-shift and 10 resulting from an 
14-membered S,N-transfer are formed in 67% and 61% yield, respectively.  
This observation has implications for the design of a molecular machine incorporating 
several successive S,N-transfers. In order to avoid an 8-membered transition state during the 
course of operation, the incorporation of a tripeptide with cysteine on the C-terminus 
circumvents the necessity of 8, 9 or 10-membered S,N-acyl transfers during the operation.  
In principle, the aminoacyl moeties could be attached via thioester bonds to the molecular 
scaffold, which would favour the attack of the catalytic unit and would lead to a fast and 
efficient reaction. But phenolic esters are in general more synthetically accessible and more 
stable towards hydro- and aminolysis. Indeed, NCL has been reported to proceed with 




Essential information for constructing a molecular machine capable of sequence-specific 
peptide synthesis based on NCL can be acquired through the synthesis and operation of a 
rotaxane featuring a single aminoacyl residue and a macrocycle bearing a cysteine-
containing tripeptide as catalytic unit. The chemical structure of the proposed test-system is 
shown in Figure 2.3.  
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Scheme 2.6. Intramolecular S,N-acyl shift through cyclic transition states of different sizes. (A) 
8-membered transition state, (B) 11-membered transition state, and (C) 14-membered transition state. 
Reaction conditions: a) phosphate buffer (NaH2PO4/ Na2HPO4, pH 7.8)/MeCN (4:1 v/v), μw, 50 °C. 
Crude yield given based on 
1
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Figure 2.3. Rotaxane design of a test substrate for the development of a second generation molecular 
machine capable of sequence-specific synthesis. 
 
Similar to the first generation design, the strand of rotaxane 11 bears an amino acyl residue 
attached to the track by weak phenolic ester linkage. In the second generation design, instead 
of using 4-(aminomethyl)benzoic acid-based spacers, a more rigid diphenylpropane unit is 
incorporated. In the final machine, the rigidity of such spacer groups would minimise the 
possibility of the reactive arm of the machine coming into contact and reacting with a 
building block out of sequence while still maintaining solubility of the whole system. The 
macrocycle in 11 is closely related to macrocycle 5 of the first generation design featuring an 
endotopic pyridine moiety needed for the rotaxane forming step. The attachment point for 
the catalytic unit was chosen to be on the opposite hemisphere of the macrocycle, since 
electron-withdrawing groups on the pyridine moiety lower the yield of the active metal 
template reaction required for the assembly of the machine. 
Instead of employing an oxime connection for the catalytic unit, a hydrazone linkage was 
chosen since it performed well in other systems developed by our group.
12
 As a catalytic unit 
a cysteine-hydrazide derivative with an attached glycylglycine chain seemed to be the most 
promising candidate in order to circumvent the unfavourable 8-membered transition state 
and realise a 11-membered transition state for the S,N-tranfer after the pick-up of the first 
aminoacyl residue. 
The proposed mechanism for the NCL-based operation is shown in Scheme 2.7. The design 
of the machine is such that once the thiol residue of the cysteine group is deprotected (A), it 
is poised to undergo a transacylation reaction with the first amino acid phenolic ester that 
blocks the macrocycle’s path on the track (B).  
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Scheme 2.7. Proposed mechanism for the peptide synthesis with a single-barrier model rotaxane. 
After activation of the machine (A) the thiol functionality is deprotonated (B) and the resulting 
thiolate cleaves the ester bond (C). The thioester formed undergoes a 1,11-S,N-shift (D) and extends 
the peptide chain by the leucine moiety. The macrocycle then detaches from the thread.  
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The subsequently formed aminoacyl thioester (C) reacts further, transferring the amino acid 
by native chemical ligation to the glycylglycine amine group by an 11-membered cyclic 
transition state (D). Now that the blocking group is removed, the macrocycle can slip off the 
thread with the loaded tetrapeptide attached. The information gained from the synthesis of a 
rotaxane containing a catalytic unit attached to a macrocycle are therefore: 
(i) Suitable sterics of the system: is the size of the macrocycle small enough to be 
mechanically interlocked before the amono acyl residue is picked up and large 
enough to diffuse over the attachment point after cleavage? 
(ii) Suitable reactivity: is the Cys-Gly-Gly derivative reactive enough to cleave the 
phenolic ester attachment and at the same time, does the S,N-transfer happen on 
a reasonable time scale? Do side reactions interfere? 
(iii) Synthesis and stability: are all components mutually compatible? Is the 
protecting group-strategy suitable for the assembly of the system? 
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2.2.3 Retrosynthetic Analysis of a Single-Barrier Model Rotaxane  
The proposed retrosynthesis of molecular machine 11 is shown in Scheme 2.8. The crucial 
interlocking of the components can be achieved by the active metal template Cu(I)-catalysed 
cycloaddition of the terminal alkyne loaded with the leucine residue 12 with the azide- 
bearing stopper group 13 mediated by macrocycle 14. 
 
 
Scheme 2.8. Retrosynthetic analysis of rotaxane 11. 
 
The reactive unit containing a Cys-Gly-Gly motiv is incompatible with the active-metal 
template reaction and therefore should be ideally incorporated after the rotaxane formation. 
An exchange reaction with anisaldehyde-derived hydrazone such as 15 as reported by 
Greaney and co-workers is particularly mild and tolerates ester functionalities.
13
  
The individual building blocks can be synthesised in a relatively straight-forward manner 
(Scheme 2.9). Azide functionalised stopper 13 can be derived from the literature known 
phenol 16 using two Williamson reactions (Scheme 2.9, A).
14
 Pivaloyl-protected barrier 12 is 
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derived from tyrosine methyl ester by subsequent amide coupling, hydrolysis and coupling 
with aniline 17 (Scheme 2.9, B). Macrocycle 14 can be synthesised by a double Williamson 
macrocyclisation of terminal dibromide 18 and diphenol U-shape 19. The northern 
hemisphere is built up from Sonogashira-couplings of 3,5-dibromobenzonitrile with 
homopropargyl alcohol, subsequent hydrogenation and Appel-reaction of the alcohol 
functionalities. The southern hemisphere can be disconnected into 2,6-dibromopyridine and 
readily accessible zincate 20 (Scheme 2.9, C). Hydrazone exchange reagent 15 can be 
synthesised by amide coupling of Boc-protected glycyl-glycine with cysteine hydrazone 21 
(Scheme 2.9, D). 
 
 
Scheme 2.9. Retrosynthetic analysis of the building blocks required for rotaxane 11. (A) Azide-alkyl 
stopper 13. (B) N-Boc-leucine-loaded barrier 12. (C) Aldehyde macrocycle 14. (D) Hydrazone 
exchange reagent 15. 
  
 
55 Chapter II 
2.3 Results and Discussion 
2.3.1 Intermolecular Model Studies 
As a first step we decided to conduct test reactions determining suitable conditions for NCL 
with phenolic ester derivatives. Essential information obtained from those test reactions is: 
(i) identification of suitable amino acids, (ii) investigation of stability of the phenolic ester 
and catalytic unit under the reaction conditions, and (iii) general information on reaction 
conditions of NCL in non-aqueous solvents. The choice of amino acids that can be coupled 
to cysteine is limited to sterically non-demanding substrates and generally β-branching is not 
tolerated in the acyl donor-component of the NCL (e.g. valine and proline thioesters give 
low conversion under standard NCL conditions).
8
 Amino acids with charged side-chains 
might be problematic for synthetic reasons and it is known that strongly ligating groups such 
as amines or nitrogen-containing heterocycles lower the yield of the active metal template 
reaction significantly, leaving the aliphatic amino acids leucine and alanine (the steric 
demand of glycine is too low for incorporation into the molecular machine as CPK-models 
suggest that the macrocycle could pass over the amino acid attachment point without 
cleavage) as well as phenylalanine as most promising substrates for a molecular machine. 
Therefore, cysteine methyl ester was reacted with three p-cresol amino acid esters derived 
from phenylalanine, leucine, and alanine (Scheme 2.10). It was realised that a reducing agent 
was needed for successful reactions since disulfide formation, that readily occurs when trace 
amounts of oxygen are present, renders the cysteine ethyl ester inactive.  
 
 
Scheme 2.10. Investigation of the suitability of phenolic esters in native chemical ligation. Reaction 
conditions: a) TCEP∙HCl, DIPEA, CH3CN, 60 °C, µw, 24h. 
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A commonly used additive for this purpose in NCL-chemistry is 
tris(2-carboxyethyl)phosphine (TCEP).
15
 Since the final molecular machine was envisioned 
to be relatively hydrophobic, reaction conditions in organic solvents instead of aqueous 
buffers typically used for NCL-chemistry seemed most promising. Good results were 
obtained in acetonitrile and microwave irradiation. Heating cysteine ethylester with excess 
DIPEA at 60 °C for 24 h resulted in the complete consumption of all p-cresol aminoacyl 
esters 22, 23, and 24 as monitored by TLC, with the concomitant appearance of a new peak 
in the mass spectrum corresponding to the respective dipeptide. Therefore, phenylalanine 
derivative 22, leucine derivative 23, and alanine derivative 24 seemed to be suitable for 
NCL. Since chromatographic isolation of the resulting peptides proved to be low yielding, 
somewhat irreproducible and did not seem to reflect the actual amount of successful peptide 
formation that occurred in the reaction mixture, a second stability test submitting the p-cresol 
esters to the reaction conditions in the absence of cysteine ethyl ester to check for possible 
hydrolysis or other decomposition pathways was necessary. In all cases, after 24 h heating at 
60 °C in the microwave no decomposition could be observed by TLC or mass spectrometry 
analysis. 
 
2.3.2 Synthesis of a N-Boc-Leucine Containing Single-Barrier Rotaxane  
Intermolecular tests can only be a starting point for the exploration of reaction conditions for 
a molecular machine. Since the effective concentration and conformation of the catalytic unit 
are very different in the final architecture compared to the situation in intermolecular test 
systems, the first aim of the project was the synthesis of a rotaxane loaded with a single 
aminoacyl residue. This model system should give information on whether (i) the 
macrocycle is interlocked on the thread when the amino acyl residue is loaded as well as 
passes over the attachment point after deacylation and (ii) whether the envisioned NCL-
mechanism is in operation or if side reactions (e.g. hydrolysis of the ester) predominate. The 
key intermediates for the synthesis of such a system are azide stopper 13, aldehyde 
macrocycle 14, hydrazone exchange reagent 15 and N-Boc-leucine containing alkyne 12 
(Scheme 2.9). 
Bulky azide stopper 13 was synthesised following a literature procedure.
14
 The key step for 
the synthesis of the macrocycle 14 is the double Williamson macrocyclisation to give 25 
(Scheme 2.11). The synthesis of the upper hemisphere of macrocycle 14 was started by 
Sonogashira-coupling of 3,5-dibromobenzonitrile with homopropargyl alcohol to deliver 
alcohol 26. Hydrogenation of the alkyne bonds and subsequent Appel reaction gave desired 
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bromide 18 in good yield. The union of dibromide 18 with literature known diphenol 19
4a
 
under high dilution conditions afforded nitrile macrocycle 25. A final reduction of the nitrile 
to reveal the aldehyde functionality gave access to target macrocycle 14 in good yield. 
 
 
Scheme 2.11. Synthesis of aldehyde macrocycle 3. Reaction conditions: a) but-3-yn-1-ol, Pd(PPh3)4, 
CuI, THF/Et3N (2.5:1 v/v), 80 °C, 12 h, 65%; b) Pd/C, H2, THF, 12 h, 98%; c) PPh3, CBr4, CH2Cl2, 
RT, 12 h, 52%; d) Cs2CO3, DMF, 50 °C, 72 h, 40%; e) DIBAL-H, CH2Cl2, 0 °C, 12 h, 72%. 
 
 
Scheme 2.12. Synthesis of alkyne barrier 12. Reaction conditions: 
a) 4-[(trimethylsilyl)ethynyl]benzoic acid, HOBt, EDCI∙HCl, THF/CHCl3 (2:1 v/v), RT, 12 h, 62%; b) 
LiOH, THF/H2O (4:1 v/v), 12 h, 99%; c) pivaloyl chloride, DMAP, Et3N, CH2Cl2, RT, 12 h, 55%; d) 
HOBt, EDCI∙HCl, THF/CHCl3 (2:1 v/v), RT, 12 h, 74%; e) L-N-Boc-leucine, EDCI∙HCl, DCC, 
DMAP, CH2Cl2, RT, 48 h, 52%. 
 
The amino acyl loaded tyrosine barriers can be synthesised through a variety of different 
approaches. Using four steps for the longest linear sequence and avoiding amine protecting 
groups, monofunctionalistation of diamine 27 with pivaloyl chloride to give pivaloyl-
derivative 17 was chosen as initial step (Scheme 2.12). For the left half of the molecule, 
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tyrosine methyl ester was selectively coupled to 4-([trimethylsilyl]ethynyl)benzoic acid in 
presence of the phenol functionality using hydroxybenzotriazole as additive. Hydrolysis with 
LiOH removed the trimethylsilane group as well as cleaving the methyl ester to deliver 
carboxylic acid 28. Amide coupling to unite 17 and 28 gave phenol 29. N-Boc-leucine was 




Scheme 2.13. Synthesis of hydrazone exchange reagent 15. Reaction conditions: a) NH2NH2, MeOH, 
RT, 2 h, then 4-methoxybenzaldehyde, AcOH (cat.), MeOH, RT, 12 h, then piperidine, DMF,RT, 2 h, 
75% over three steps; b) N-Boc-Gly-Gly-OH, 1,1’-carbonyldiimidazole, THF, RT, 12 h, 47%. 
 
The synthesis of hydrazone exchange reagent 15 required for loading the catalytic unit onto 
the rotaxane was started from commercially available pentafluorophenyl cysteine ester 30 
(Scheme 2.13). Addition of hydrazine at room temperature yielded hydrazide 31 and left the 
Fmoc-group untouched. Direct hydrazone formation on the crude material to give 32 went 
smoothly, but isolation of amine derivative 21 proved problematic as it hydrolysed on silica. 
Best results were obtained by submitting the crude reaction mixture after deprotection 
directly to the coupling with N-Boc-Gly-Gly-OH to deliver hydrazone 15.  
For the rotaxane formation step, it is essential to stir aldehyde macrocycle 14 with 
tetrakis(acetonitrile)copper(I) hexafluorophosphate in CH2Cl2 for 30 minutes before addition 
of azide stopper 13 and aminoacyl-loaded alkyne 12 in a mixture of CH2Cl2 and tBuOH 
(Scheme 2.14). Purification by preparative thin layer chromatography delivered rotaxane 33 
in 30% yield. The stacked plot of rotaxane 33 can be seen in Figure 2.4.  
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Scheme 2.14. Synthesis of rotaxane 33. Reaction conditions: a) Cu(MeCN)4PF6, CH2Cl2/tBuOH 
(4:1 v/v), RT, 48 h, 30%. The italicised letters indicate signals in the 
1





H NMR spectrum of (A) aldehyde macrocycle 14, (B) rotaxane 33, and (C) 
corresponding free thread 36, in acetone-d6 (600 MHz, 298 K). The assignments correspond to the 
lettering shown in Scheme 2.14.  
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The interlocked nature of rotaxane 33 becomes apparent from the significant upfield shift of 
all proton signals in proximity to the central triazole moiety as well as moderate upfield 
shifts for characteristic macrocyclic proton signals. Such shielding is typical for interlocked 
architectures in which the aromatic rings of one component (the para-substiuted phenyl rings 
of macrocycle 14) are face-on to another component (here the triazole of the thread). The 
most significant upfield shifts shifts can therefore be observed for HH and HI of macrocycle 
as well as signals Hf to Hk of the thread. However, signals corresponding to the tyrosine 
moeity and the leucine residue remain largely unaffected. The limitation of the upfield shifts 
to certain proton signals of the thread implies that the macrocycle is largely confined 
between the sterically demanding tyrosine barrier and the bulky stopper on the other side as 
expected from this rotaxane. 
The loading of the catalytic moiety was achieved by using hydrazone exchange conditions 
devolped by Greaney and co-workers.
13
 The main concern was the stability of the acid labile 
protecting groups at low pH. Stirring aldehyde rotaxane 33 with hydrazone exchange reagent 
15 in DMSO/2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH 6.0) for 72 h at 60 °C 
with aniline as nucleophilic catalyst delivered target rotaxane 34 in moderate yield 
(Scheme 2.15) and left the ester and N-Boc-functionalities unaffected. 
 
 
Scheme 2.15. Synthesis of hydrazone rotaxane 34. Reaction conditions: a) aniline, DMSO/MES 
buffer (3:1 v/v, pH 6.0), 60 °C, 72 h, 45%. 
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2.3.3 Operation of Model Rotaxane 11 
For the operation of the rotaxane in the first step the acid labile Boc- and trityl-protecting 
groups were removed with CH2Cl2/TFA (5:1 v/v, Scheme 2.16). Since the purification of the 
unprotected rotaxane proved difficult, the crude reaction mixture was submitted to the 
previously established operation conditions obtained from the intermolecular model studies 
directly. For reasons of solubility, the solvent was altered from acetonitrile as used for the 
intermolecular test reactions to a mixture of MeCN/DMF (3:1 v/v). After 24 h heating in the 
microwave under a protective atmosphere, the thiol-containing macrocyclic operation 
product was oxidised by stirring the reaction mixture in air to ease purification. The resulting 
disulfide was purified by preparative thin layer column chromatography. Even with this 
optimised purification conditions only trace amounts of the expected macrocyclic product 35 
(or the corresponding disulfide dimer) could be obtained as opposed to 81% yield for the free 
thread 36. This discrepancy in yield between 35 and 36 is most likely due to hydrolysis and 
loss of the hydrazone operation product 35 on silica. The isolated macrocycle could be 
identified by mass spectrometry and comparison to reference material prepared through 
conventional synthesis.  
This result indicates that the macrocycle is interlocked on the thread when the amino acyl 
residue is loaded and can dissociate from the thread after amino acyl pick-up. The 
Cys-Gly-Gly unit seems to be a suitable catalytic unit for the cleavage of the phenolic esters 
and subsequent S,N-transfer to form the amide bond occurs under the reaction conditions.  
The operation under high dilution conditions (the concentration of the molecular machine 
under the operation conditions is  smaller than 2 mmol/l) make intermolecular reactions 
highly unlikely as compared to the intramolecular reaction of the moleular machine as is 
envisioned by the design. The effective molarity of the catalytic unit can be assumed to be 
much higher than the concentration of molecular machines in solution. 
This result therefore suggests that the synthesis and operation of a larger molecular machine 
capable of the sequence-specific synthesis of peptides is in reach. 
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Scheme 2.16. Operation of molecular machine 34. Reaction conditions: a) CH2Cl2/TFA (5:1 v/v), RT, 
2 h 52%; b) DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), 60 °C μw, 24 h. 
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2.4 Conclusion 
First model studies were conducted to explore the possibility to synthesise a molecular 
machine capable of the sequence-specific peptide synthesis. The envisioned operation 
mechanism is based on NCL. The macrocycle bearing a Cys-Gly-Gly-containing catalytic 
unit is envisioned to pick-up the aminoacyl residues it encounters and deposits them through 
an S,N-transfer on the terminal amine functionality on the growing peptide strand. In order to 
investigate suitable operation conditions for such a machine, several test reactions were 
conducted, showing that phenolic esters are suitable acyl donors for the in-situ formation of 
the thioester intermediate. As amino acids, phenyl alanine, leucine and pivaloyl protected 
alanine were identified as promising substrates. In order to show an initial proof of concept 
of such an molecular machine, a rotaxane containing the aminoacyl residue leucine and the 
catalytic unit Cys-Gly-Gly attached to the macrocycle by a reversible hydrazone formation 
was successfully synthesised. The expected operation product could be isolated and was 
identified by comparison with reference material that was prepared by conventional 
synthesis. These promising results indicate that the synthesis of the full molecular machine 
bearing three different aminoacyl residues is indeed possible with an extended system based 
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2.5 Experimental Section 
2.5.1 General Methods and Abbreviations 
Unless stated otherwise, all reagents and solvents were purchased from Aldrich Chemicals 




 were prepared according to 
literature procedures. Compound E3 was prepared by Dr. Bartosz Lewandowski. All 
reactions requiring microwave heating were carried out in a Biotage Initiator 2.5.3. Dry 
DMF, CH2Cl2, CHCl3 and THF was obtained by passing the solvent (HPLC grade) through 
an activated alumina column on a PureSolv™ solvent purification system 
(InnovativeTechnologies Inc., MA). Flash column chromatography was carried out using 
Geduran® Si 60 (particle size 40-63 μm, Merck, Germany) as the stationary phase, and 
analytical TLC was performed on precoated silica gel plates (0.25 mm thickness, 60 F254, 
Merck, Germany) and observed under UV light or stained with a phosphomolybdic acid 
solution in ethanol. Preparative TLC was performed on precoated silica gel plates (2 mm, 
UNIPLATE GF, Analtech Inc., DE or 2 mm, Tapered plate, UNIPLATE-T, Analtech Inc., 
DE). NMR spectra were recorded on Bruker AV 300 MHz, Bruker AV 400 MHz, Bruker 
AV 500 MHz (equipped with a cryoprobe) or Bruker Avance III (equipped with a 
cryoprobe) with an Oxford AS 600 MHz magnet. Chemical shifts are reported in parts per 
million (ppm) from high to low frequency and referenced to the residual solvent resonance. 
Coupling constants (J) are reported in hertz (Hz). Standard abbreviations indicating 
multiplicity were used as follows: s = singlet, d = doublet, t = triplet, q = quartet, 
quin = quintuplet, m = multiplet, br = broad. 
1
H-NMR assignments were made using 
2D NMR methods (COSY, HSQC, HMBC). Melting points (m.p.) were determined using a 
Sanyo Gallenkamp apparatus and are reported uncorrected. Low resolution ESI mass 
spectrometry was performed with a Finnigan LCQ-MS mass spectrometer. High resolution 
ESI (electrospray ionisation) and APCI (atmospheric-pressure chemical ionisation) mass 
spectrometry was carried out by the mass spectrometry services at the EPSRC National Mass 
Spectrometry Service Centre, Swansea, UK or the Mass Spectrometry Service of the 
University of Manchester, UK. Optical rotations were recorded using a Bellingham and 
Stanley ADP 220 Polarimeter using a 1 dm cell. 
 
65 Chapter II 
2.5.2 Test reactions 
2.5.2.1 General Procedure for the Initial NCL Test-Reactions 
 
Scheme 2.17. Reaction conditions: a) TCEP·HCl, DIPEA, CH3CN, 60 °C, µw, 24 h. 
A phenolic aminoacyl ester (0.11 mmol, 1.00 equiv.), L-cysteine methyl ester hydrochloride 
(28 mg, 0.11 mmol, 1.00 equiv.) and TCEP∙HCl (62 mg, 0.22 mmol, 2.00 equiv.) were 
added to a flame dried microwave vial. The vial was evacuated and refilled with nitrogen 
three times. A separately prepared, degassed solution of 1M DIPEA in MeCN (1.00 mmol, 
1.00 ml, 9.10 equiv.) was added and the reaction mixture was heated at 60 °C in the 
microwave for 24 h. TLC analysis revealed the complete disappearance of phenolic ester 
(petroleum ether/EtOAc, 7:3 v/v). Mass spectrometric analysis revealed peaks corresponding 
to the expected dipeptide. LRESI(+)-MS (MeOH) of 37: m/z 419.3 [M+ Na]
+
; LRESI(+)-MS 
(MeOH) of 38: m/z 385.3 [M+ Na]
+
; LRESI(+)-MS (MeOH) of 39: m/z 327.4 [M+ Na]
+
. 
2.5.2.2 Stability Tests of Phenolic Esters 
A phenolic ester aminoacyl ester (0.11 mmol, 1.00 equiv.) and TCEP∙HCl(62 mg, 
0.22 mmol, 2.00 equiv.) were added to a flame dried microwave vial. The vial was evacuated 
and refilled with nitrogen three times. A separately prepared degassed solution of 
1M DIPEA in MeCN (1.00 mmol, 1.00 ml, 9.10 equiv.) was added and the reaction mixture 
was heated at 60 °C in the microwave for 24 h. TLC analysis revealed a visible spot 
corresponding to phenolic ester in the reaction mixture (petroleum ether/EtOAc, 7:3 v/v) and 
no visible spot corresponding to p-cresol. Mass spectrometric analysis revealed peaks 
corresponding to the phenolic esters starting materials. LRESI(+)-MS (MeOH) of 22: 
m/z 378.3 [M+ Na]
+
; LRESI(+)-MS (MeOH) of 23: m/z 322.2 [M+ Na]
+
; LRESI(+)-MS 
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2.5.3 Operation of Molecular Machine 34 
 
Scheme 2.18. Operation of molecular machine. Reaction conditions: a) CH2Cl2/TFA (5:1 v/v), RT, 
2 h, then DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), µw, 60 °C, 48 h. 
Molecular machine 1 (20 mg, 7.8 μmol) was stirred at room temperature in a mixture of 
CH2Cl2/TFA (5:1 v/v, 2 ml) for 2 h. Toluene (5 ml) was added and the solvent removed 
under reduced pressure. The crude mixture was then dissolved in degassed MeCN/DMF 
(3:1 v/v, 4 ml) and both N,N-diisopropylethylamine (100 µl, 0.58 mmol, 74 equiv.) and 
TCEP∙HCl (3.0 mg, 11 μmol, 1.4 equiv.) were added and the reaction mixture was stirred 
under microwave heating at 60 °C for 24 h. The reaction mixture was allowed to stir on air 
for 5 h. Preparative TLC (SiO2 [UNIPLATE-T], CH2Cl2/MeOH 5%) of the crude residue 
afforded 35 (1.0 mg) as a colourless film. The residue was analysed by LRESI-MS (MeOH): 
m/z 906.6 [M+H]
+
; m/z 952.6 [M+COOH+H]
+
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Title compound 36 was isolated as a side product from the reaction mixture for operation of 
34 as a colourless film (7.5 mg, 81%). 
1
H NMR (600 MHz, CDCl3) δ = 8.65 (s, 1H, Hr), 7.83 (s, 1H, Hi), 7.76 (s, 4H, Hj+k), 7.46 (s, 
1H, Hx), 7.44 (d, J = 7.8 Hz, 1H, Hl), 7.36 (d, J = 8.7 Hz, 2H, Hs), 7.27 (d, J = 8.6 Hz, 2H, 
Hw), 7.24 (d, J = 8.5 Hz, 6H, Hb), 7.14 – 7.08 (m, 8H, Ht+c), 7.07 (d, J = 8.5 Hz, 2H, Hv), 
7.04 (d, J = 8.2 Hz, 2H, Ho), 6.77 (d, J = 8.8 Hz, 2H, He), 6.68 (d, J = 8.0 Hz, 2H, Hp), 4.62 
(t, J = 7.0 Hz, 2H, Hh), 4.00 (t, J = 5.6 Hz, 2H, Hf), 3.23 – 3.09 (m, 2H, Hn), 2.42 (p, 
J =6.4 Hz, 2H, Hg), 1.59 (s, 6H, Hu), 1.31 (s, 27H, Ha), 1.28 (s, 9H, Hy); 
13
C NMR 
(150 MHz, CDCl3) δ = 177.2, 169.9, 167.3, 156.3, 155.6, 148.5, 147.1, 147.0, 146.7, 144.2, 
140.3, 135.4, 135.0, 133.9, 133.0, 132.5, 130.8, 130.6, 128.0, 127.4, 127.3, 125.8, 124.2, 
121.1, 120.5, 120.3, 120.2, 115.9, 113.1, 67.5, 64.1, 63.2, 56.3, 47.6, 42.4, 37.8, 34.4, 31.5, 
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2.5.4 Synthetic Schemes 
2.5.4.1 Synthesis of Aldehyde-Functionalised Pyridyl-Macrocycle 14 
 
Scheme 2.19. Reaction conditions: a) but-3-yn-1-ol, Pd(PPh3)4, CuI, THF/Et3N (2.5:1 v/v), 80 °C, 
12 h, 65%; b) Pd/C, H2, THF, 12 h, 98%; c) PPh3, CBr4, CH2Cl2, RT, 12 h, 52%; d) Cs2CO3, DMF, 
50 °C, 72 h, 40%; e) DIBAL-H, CH2Cl2, 0 °C, 12 h, 72%. 
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2.5.4.2 Synthesis of N-Boc-Protected Leucine-Barrier 12 
 
 
Scheme 2.20. Reaction conditions: a) 4-[(trimethylsilyl)ethynyl]benzoic acid, HOBt, EDCI∙HCl, 
THF/CHCl3 (2:1 v/v), RT, 12 h, 62%; b) LiOH, THF/H2O (4:1 v/v) 12 h, 99%; c) pivaloyl chloride, 
DMAP, Et3N, CH2Cl2, RT, 12 h, 55%; d) HOBt, EDCI∙HCl, THF/CHCl3 (2:1 v/v), RT, 12 h, 74%; e) 
L-N-Boc-leucine, EDCI∙HCl, DCC, DMAP, CH2Cl2, RT, 48 h, 52%. 
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2.5.4.3 Synthesis of Hydrazone Exchange Reagent 15 
 
Scheme 2.21. Reaction conditions: a) NH2NH2, MeOH, RT, 2 h, then 4-methoxybenzaldehyde, AcOH 
(cat.), MeOH, RT, 12 h, then piperidine, DMF, RT, 2 h, 75% over three steps; b) N-Boc-Gly-Gly-OH, 
1,1’-carbonyldiimidazole, THF, RT, 12 h, 47%. 
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2.5.4.4 Synthesis of Single-Barrier Rotaxane 33 and 34 
 
Scheme 2.22. Reaction conditions: a) Cu(MeCN)4PF6, CH2Cl2/tBuOH (4:1 v/v), RT, 48 h, 45%; b) 
aniline, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 72 h, 52%. 
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2.5.4.5 Synthesis of Phenolic Esters 22, 23, and 24 
 
Scheme 2.23. Reaction conditions: a) L-N-Piv-alanine, 1,1'-carbonyldiimidazole, THF, 50 °C, 12 h, 
52%; b) L-N-Boc-leucine, 1,1'-carbonyldiimidazole, THF, 50 °C, 12 h, 62%; c) 
L-N-Boc-phenylalanine, 1,1'-carbonyldiimidazole , THF, 50 °C, 12 h, 58%. 
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2.5.4.6 Synthesis of Authentic Reference Macrocycle 35 
 
Scheme 2.24 Reaction conditions: a) L-N-Boc-leucine, PyBrOP, DMF, RT, 24 h, 60%; b) 13, aniline, 
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2.5.5 Synthetic Procedures and Characterisation Data 
3,5-Bis(4-hydroxybut-1-ynyl)benzonitrile 26 
 
To a stirred solution of 3,5-dibromobenzonitrile (6.00 g, 22.9 mmol, 1.00 equiv.), 
Pd(PPh3)3Cl2 (1.61 g, 2.29 mmol, 0.10 equiv.) and CuI (0.87 g, 4.59 mmol, 0.20 equiv.) in 
THF/Et3N (2.5:1 v/v, 168 ml) at room temperature was added 3-butyn-1-ol (6.96 ml, 
91.9 mmol, 4.00 equiv.). The reaction mixture was then heated at 80 °C for 12 h. The 
reaction mixture was allowed to cool to room temperature and filtered over celite. The 
filtrate was diluted with EtOAc (200 ml) and washed with aqueous saturated NH4Cl 
(2 × 200 ml). The organic layer was dried over MgSO4, filtered, and the solvent removed 
under reduced pressure. Flash column chromatography (SiO2, petroleum ether/EtOAc 2:8) of 
the residue afforded 26 (5.10 g, 93%) as an off-white solid.  
m.p. 65 °C; 
1
H NMR (400 MHz, acetone-d6) δ = 7.70 (d, J = 1.5 Hz, 2H, Hd), 7.66 (s, 1H, 
He), 4.08 – 4.01 (m, 2H,Ha), 3.74 (q, J = 6.4 Hz, 4H, Hb), 2.63 (t, J = 6.6 Hz, 4H, Hc); 
13
C NMR (100 MHz, acetone-d6) δ = 139.1, 134.5, 126.7, 118.1, 114.2, 92.3, 79.5, 61.2, 
24.4; LRESI(+)-MS (MeOH): m/z 262.1 [M+ Na]
+
; HRFT(+)-MS: m/z 240.1016 [M+H]
+
, 
240.1019 calc. for C15H14NO2. 
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3,5-Bis(4-hydroxybutyl)benzonitrile E1 
 
To a stirred solution of 26 (5.10 g, 21.3 mmol, 1.00 equiv.) in THF (100 ml) at room 
temperature was added palladium on carbon 10% wt. loading (0.50 g) in one portion and the 
reaction mixture was stirred under a hydrogen atmosphere at room temperature for 12 h. The 
reaction mixture was filtered over celite and the solvent removed under reduced pressure to 
afford E1 (5.20 g, 98%) as a colourless oil. 
1
H NMR (400 MHz, CDCl3) δ = 7.30 (d, J = 1.5 Hz, 2H, Hf), 7.25 (s, 1H, Hg), 3.65 (t, 
J = 6.4 Hz, 4H, Hb), 2.65 (t, J = 7.5 Hz, 4H, He), 2.05 (s, 2H, Ha), 1.75 – 1.65 (m, 4H, Hc), 
1.63 - 1.54 (m, 4H, Hd); 
13
C NMR (100 MHz, CDCl3) δ = 143.7, 133.4, 129.5, 119.3, 112.1, 





, 248.1645 calc. for C15H22NO2. 
  
 
76 Chapter II 
3,5-Bis(4-bromobutyl)benzonitrile 18 
 
To a stirred solution of E1 (5.20 g, 21.0 mmol, 1.00 equiv.) and tetrabromomethane (27.9 g, 
84.2 mmol, 4.00 equiv.) in CH2Cl2 (500 ml) at 0 °C was added triphenylphosphine (16.6 g, 
63.2 mmol, 3.00 equiv.) in small portions and then the reaction mixture was allowed to warm 
to room temperature. The reaction mixture was stirred at room temperature for 12 h and the 
solvent was removed under reduced pressure. Flash column chromatography (SiO2, 
petroleum ether/EtOAc 95:5) of the residue afforded 18 (4.11 g, 52%) as a colourless oil.  
1
H NMR (400 MHz, CDCl3) δ = 7.30 (d, J = 1.4 Hz, 2H, He), 7.22 (br s, 1H, Hf), 3.42 (t, 
J = 6.5 Hz, 4H, Ha), 2.64 (t, J = 7.6 Hz, 4H, Hd), 1.84 – 1.80 (m, 4H, Hb), 1.82 – 1.72 (m, 
4H, Hc); 
13
C NMR (100 MHz, CDCl3) δ = 143.3, 133.2, 129.6, 119.1, 112.4, 34.5, 33.3, 32.0, 
29.5; LRESI(+)-MS (MeOH): m/z 371.0 [M+H]
+
; HRFT(+)-MS: m/z 370.9870 [M+H]
+
, 
370.9878 calc. for C15H19NBr2. 
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Nitrile-Functionalised Pyridylmacrocycle 25 
 
To a stirred solution of Cs2CO3 (17.9 g, 55.1 mmol, 5.00 equiv.) in DMF (2.50 L) at 50 °C 
was added a solution of 18 (4.11 g, 11.0 mmol, 1.00 equiv.) in DMF (50 ml) and diphenol 19 
(3.82 g, 11.0 mmol, 1.00 equiv.) in DMF (50 ml) at a rate of 2.5 ml/h over a period of 20 h 
with the aid of two syringe pumps. After completed addition, the reaction mixture was 
stirred at this temperature for a further 48 h and then the solvent was removed under reduced 
pressure. Flash column chromatography (SiO2, petroleum ether/EtOAc 7:3) of the residue 
afforded 25 (2.46 g, 40%) as a white solid.  
m.p. 108 °C; 
1
H NMR (500 MHz, CDCl3) δ = 7.49 (t, J = 7.6 Hz, 1H, Hm), 7.30 (br s, 3H, 
Ha+b), 7.05 (d, J = 8.6 Hz, 4H, Hh), 6.96 (d, J = 7.6 Hz, 2H, Hl), 6.78 (d, J = 8.6 Hz, 4H, Hg), 
3.94 (t, J = 5.5 Hz, 4H, Hf), 2.81 (t, J = 7.3 Hz, 4H, Hk), 2.67 (t, J = 7.2 Hz, 4H, Hc), 
2.60 - 2.53 (m, 4H, Hi), 2.06 – 1.96 (m, 4H, Hj), 1.84 – 1.73 (m, 8H, He+d); 
13
C NMR 
(125 MHz, CDCl3) δ = 161.5, 157.2, 143.8, 136.6, 134.7, 133.1, 129.8, 129.4, 120.2, 119.4, 
114.4, 112.2, 67.5, 38.0, 35.0, 34.8, 32.5, 28.6, 28.1; LRESI(+)-MS (MeOH): m/z 559.9 
[M+H]
+
; HRFT(+)-MS: m/z 559.3323 [M+H]
+
, 559.3319 calc. for C38H43N2O2. 
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Aldehyde-Functionalised Pyridylmacrocycle 14 
 
To a stirred solution of 25 (0.50 g, 0.90 mmol, 1.00 equiv.) in CH2Cl2 (8 ml) at 0 °C was 
added a 1.0 M solution of diisobutylaluminum hydride in hexanes (1.80 ml, 1.80 mmol, 
2.00 equiv.) dropwise. The reaction mixture was allowed to warm to room temperature and 
stirred at room temperature for 12 h. Methanol (2 ml) was added to quench the reaction and 
the reaction mixture was diluted with CH2Cl2 (10 ml). The organic layer was washed with 
H2O (20 ml). The layers were separated and the aqueous layer was extracted with CH2Cl2 
(2 × 10 ml). The combined organic layers were dried over MgSO4, filtered, and the solvent 
removed under reduced pressure. Flash column chromatography (SiO2, 
petroleum ether/EtOAc 7:3) of the residue afforded 14 (0.36 g, 72%) as a white solid.  
m.p. 99-100 °C; 
1
H NMR (500 MHz, CDCl3) δ = 9.97 (s, 1H, Ha), 7.52 (d, J = 1.5 Hz, 2H, 
Hb), 7.48 (t, J = 7.6 Hz, 1H, Hn), 7.34 (br s, 1H, Hc), 7.05 (d, J = 8.6 Hz, 4H, Hi), 6.96 (d, 
J = 7.6 Hz, 2H, Hm), 6.75 (d, J = 8.6 Hz ,4H, Hh), 3.94 (t, J = 5.7 Hz, 4H, Hg), 2.80 (t, 
J = 7.4 Hz, 4H, Hl), 2.73 (t, J = 7.4 Hz, 4H, Hd), 2.59 (t, J = 8.0 Hz, 4H, Hj), 2.07 – 1.97 (m, 
4H, Hk), 1.88 – 1.74 (m, 8H, He+f); 
13
C NMR (125 MHz, CDCl3) δ = 192.9, 161.5, 157.3, 
143.5, 136.9, 136.6, 134.8, 134.7, 129.5, 127.7, 120.2, 114.5, 67.6, 38.0, 35.1, 34.8, 32.5, 
28.7, 28.2; LRESI(+)-MS (MeOH): m/z 562.7 [M+H]
+
; HRFT(+)-MS: m/z 562.3310 
[M+H]
+
, 562.3316 calc. for C38H44NO3. 
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N-(4-(2-(4-Aminophenyl)propan-2-yl)phenyl)pivalamide 17 
 
To a stirred solution of 4,4'-(propane-2,2-diyl)dianiline (6.78 g, 30.0 mmol, 1.00 equiv.) and 
Et3N (1.67 ml, 12 mmol, 1.20 equiv.) in CH2Cl2 (50 ml) at 0 °C was added pivaloyl chloride 
(3.69 ml, 36.0 mmol, 1.20 equiv.) dropwise. The reaction mixture was allowed to warm to 
room temperature and stirred at room temperature for 12 h. The solvent was removed under 
reduced pressure. Flash column chromatography (SiO2, petroleum ether/EtOAc 6:4) of the 
residue afforded 17 (5.12 g, 55%) as a pale yellow solid. 
m.p. 42 °C; 
1
H NMR (400 MHz, CDCl3) δ = 7.41 (d, J = 8.7 Hz, 2H, Hf), 7.27 (s, 1H, Hg), 
7.18 (d, J = 8.7 Hz, 2H, He), 7.00 (d, J = 8.6 Hz, 2H,Hc), 6.61 (d, J = 8.6 Hz, 2H, Hb), 5.32 
(br s, 2H, Ha), 1.61 (s, 6H, Hd), 1.30 (s, 9H, Hh); 
13
C NMR (100 MHz, CDCl3) δ = 176.6, 
147.3, 143.7, 141.3, 135.6, 127.8, 127.4, 119.7, 115.1, 42.0, 39.6, 31.0, 27.8; LRESI(+)-MS 
(MeOH): m/z 311.20 [M+H]
+
; HRFT(+)-MS: m/z 311.2124 [M+H]
+








Tyrosine methylester (1.27 g, 6.49 mmol, 1.00 equiv.) and 4-[(trimethylsilyl)ethynyl]benzoic 
acid (1.70 g, 7.79 mmol, 1.20 equiv.) were dissolved in dry THF/CHCl3 (2:1 v/v, 60 ml). 
Then EDCI·HCl (1.49 g, 7.79 mmol, 1.20 equiv.) and HOBt·H2O (1.19 g, 7.79 mmol, 
1.20 equiv.) were added and the reaction mixture was stirred at room temperature for 12 h. 
The solvent was removed under reduced pressure. Flash column chromatography (SiO2, 
petroleum ether/EtOAc 7:3, then 6:4) of the residue afforded E2 (1.60g, 62%) as an 
off-white solid. 
m.p. 111 °C; [α]D = -0.19° (c 1.21, MeOH); 
1
H NMR (300 MHz, CDCl3) δ = 7.66 (d, 2H, 
J = 8.3 Hz, Hb), 7.49 (d, 2H, J = 8.3 Hz, Hc), 6.95 (d, 2H, J = 8.4 Hz, Hg), 6.71 (d, 2H, 
J = 8.4Hz, Hh), 6.64 (d, 1H, J = 7.7 Hz, Hd), 6.00 (s, 1H, Hi), 5.04 (dd, 1H, J = 13.1 Hz, 
5.6 Hz, He), 3.77 (s, 3H, Hj), 3.20 (dd, 1H, J = 14.0 Hz, 5.5 Hz, Hf), 3.20 (dd, 1H, 
J = 14.0 Hz, 5.5 Hz, Hf’), 0.26 (s, 9H, Ha); 
13
C NMR (75 MHz, CDCl3) δ = 172.2 , 166.3, 
155.2, 133.1, 132.1, 130.4, 127.2, 126.9, 126.8, 115.5, 103.9, 97.3, 53.7, 52.6, 37.1, -0.2; 
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(S)-2-(4-Ethynylbenzamido)-3-(4-hydroxyphenyl)propanoic Acid 28 
 
LiOH (120 mg, 5.00 mmol, 5.00 equiv.) was dissolved in THF/H2O (4:1 v/v, 12.5 ml). 
Methyl ester E2 (395 mg, 1.00 mmol, 1.00 equiv.) was then added and the resulting reaction 
mixture was stirred at room temperature for 12 h. The reaction mixture was diluted with 
CH2Cl2 (20 ml) and the pH was adjusted to pH 1 by addition of 1M HCl (20 ml). The 
solution was extracted with CH2Cl2 (3 × 30 ml). The combined organic layers were dried 
over Na2SO4, filtered, and the solvent was removed under reduced pressure to afford 28 
(310 mg, 99%) as a white solid. Please note: Racemisation of the chiral centre occurs during 
the reaction. 
m.p. 175 °C; 
1
H NMR (600 MHz, acetonitrile-d3) δ = 7.84 (d, J = 8.1 Hz, 2H, Hc), 7.81 (d, 
J = 8.2 Hz, 1H, Hd), 7.55 (d, J = 8.3 Hz, 2H, Hb), 7.16 (d, J = 8.3 Hz, 2H, Hg), 6.75 (d, 
J = 8.4 Hz, 2H, Hh), 4.84 (td, J = 8.6 Hz, 5.3 Hz, 1H, He), 3.82 (s, 1H, Ha), 3.24 (dd, 
J = 14.0 Hz, 4.9 Hz, 1H, Hf), 3.07 (dd, J = 14.0 Hz, 9.1 Hz, 1H, Hf`); 
13
C NMR (150 MHz, 
acetonitrile-d3) δ = 173.5, 167.8, 156.6, 134.6, 132.9, 131.3, 128.9, 128.3, 126.2, 116.1, 83.3, 
81.3, 55.3, 36.8; LRESI(+)-MS: m/z 308.3 [M-H]
-
; HRESI(+)-MS: m/z 332.0915 [M+Na]
+
, 
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Ethynyl-Tyrosine-N-Pivaloyl Derivative 29  
 
 
Tyrosine derivative 28 (309 mg, 1.00 mmol, 1.00 equiv.) and amine 17 (342 mg, 1.10 mmol, 
1.10 equiv.) were dissolved in THF/CHCl3 (2:1 v/v, 12 ml). Then, EDCI·HCl (200 mg, 
1.05 mmol, 1.05 equiv.) and HOBt·H2O (161 mg, 1.05 mmol, 1.05 equiv.) were added and 
the reaction mixture was stirred at room temperature for 12 h. The solvent was removed 
under reduced pressure. Flash column chromatography (SiO2, petroleum ether/EtOAc 6:4) of 
the residue afforded 29 (445 mg, 74%) as a colourless solid. 
m.p. 183 °C; 
1
H NMR (400 MHz, acetone-d6) δ = 9.34 (s, 1H, Hj), 8.53 (s, 1H, Hp), 
7.98 - 7.90 (m, 1H, Hd), 7.91 – 7.81 (m, 2H, Hc), 7.58 (d, J = 8.8 Hz, 2H, Hk), 7.54 (d, 
J = 8.3 Hz, 2H, Hb), 7.52 (d, J = 8.5 Hz, 2H, Ho), 7.20 – 7.11 (m, 6H, Hn+l+f), 6.73 (d, 
J = 8.5 Hz, 2H, Hg), 4.92 (td, J = 8.2 Hz, 6.0 Hz, 1H, Hi), 3.81 (s, 1H, Ha), 3.23 (dd, 
J = 13.9 Hz, 5.9 Hz, 1H, He), 3.07 (dd, J = 13.9 Hz, 8.4 Hz, 1H, He’), 1.63 (s, 6H, Hm), 1.27 
(s, 9H, Hq); 
13
C NMR (125 MHz, acetone-d6) δ = 179.9, 172.1, 169.2, 157.4, 148.2, 148.1, 
137.3, 136.8, 135.3, 133.0, 131.4, 128.9, 128.6, 128.1, 128.0, 127.1, 122.5, 121.4, 116.3, 
83.6, 81.1, 57.7, 43.3, 40.4, 38.5, 31.2, 27.8; LRESI(+)-MS (MeOH): m/z 602.3 [M+H]
+
; 
HRFT(+)-MS: m/z 602.3011 [M+H]
+
, 602.3019 calc. for C38H41N3O4. 
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Ethynyl-N-Boc-Leucine-N-Pivaloyl Barrier 12 
 
Phenol derivative 29 (100 mg, 166 μmol, 1.00 equiv.), L-N-Boc-leucine (46.3 mg, 200 μmol, 
1.20 equiv.), EDCI·HCl (38.3 mg, 192 μmol, 1.15 equiv.), DCC (41.3 mg, 206 μmol, 
1.24 equiv.) and DMAP (3 mg, 33 μmol, 0.20 equiv.) were stirred in CH2Cl2 (3 ml) at room 
temperature for 48 h. The solvent was removed under reduced pressure. Flash column 
chromatography (SiO2, petroleum ether/EtOAc 6:4) of the residue afforded 12 (70.0 mg, 
52%) as a white solid. 
m.p. 120-122 °C; 
1
H NMR (600 MHz, CDCl3) δ = 7.96 (s, 1H, Ho), 7.72 (d, J = 7.6 Hz, 2H, 
Hc), 7.55 (d, J = 8.0 Hz, 2H, Hb), 7.43 (d, J = 8.6 Hz, 2H, Hg), 7.32 (d, J = 8.0 Hz, 3H, Ht+u), 
7.26 – 7.31 (m, 2H, Hp), 7.17 (d, J = 8.5 Hz, 2H, Hh), 7.15 (d, J = 8.0 Hz, 2H, Hq), 7.09 (d, 
J = 7.3 Hz, 1H, Hd), 7.06 (d, J = 8.0 Hz, 2H, Hs), 5.05 (d, J = 8.5 Hz, 1H, Hm), 5.01 – 4.94 
(m, 1H, He), 4.57 – 4.50 (m, 1H, Hi), 3.31 (dd, J = 13.9 Hz, 6.1 Hz, 1H, Hf), 3.20 – 3.25 (m, 
2H, Ha+f’), 1.88 – 1.76 (m, 2H, Hj), 1.71 – 1.66 (m, 1H, Hk), 1.64 (s, 6H, Hr), 1.47 (s, 9H, 
Hn), 1.33 (s, 9H, Hv), 1.03 (d, J = 6.2 Hz, 6H, Hl); 
13
C NMR (150 MHz, CDCl3) δ = 176.7, 
172.4, 168.8, 166.8, 155.7, 149.8, 147.4, 146.6, 135.7, 134.7, 134.4, 133.5, 132.5, 130.6, 
127.5, 127.4, 127.2, 126.0, 122.0, 120.0, 119.8, 80.2, 80.0, 55.9, 52.5, 42.5, 41.6, 39.7, 37.9, 
30.9, 28.5, 27.8, 25.1, 23.1, 22.0; LRESI(+)-MS (MeOH): m/z 837.4 [M+Na]+; HRESI(+)-
MS: m/z 851.3913 [M+Na]+, 851.3923 calc. for C47H6 O6N1Na1Si1. 
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(R)-2-Amino-N'-(4-methoxybenzylidene)-3-(tritylthio)propanehydrazide 21 
 
To a stirred solution of Fmoc-Cys(STrt)-OPfp (1.00 g, 1.33 mmol, 1.00 equiv.) in MeOH 
(20 ml) at room temperature was added hydrazine monohydrate (47 μl, 1.46 mmol, 
1.10 equiv.). After 2 h the white precipitate that formed was filtered and dried under vacuum. 
To a suspension of this crude hydrazide (750 mg, 1.25 mmol, 1.00 equiv.) in MeOH (5 ml) 
at room temperature was added p-anisaldehyde (0.17 ml, 1.38 mmol, 1.10 equiv.) and acetic 
acid (15 μL, 0.25 mmol, 0.20 equiv.) and the resulting suspension was stirred at room 
temperature for 12 h. The solvent was removed under reduced pressure and the residue 
dissolved in CH2Cl2 (10 ml). The organic layer was washed with H2O (10 ml) and dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. The crude hydrazone 
(753 mg, 1.05 mmol) was then dissolved in a mixture of DMF/piperidine (4:1 v/v, 5 ml) and 
stirred at room temperature for 2 h before the solvent was removed under reduced pressure. 
Flash column chromatography (SiO2, petroleum ether/EtOAc 1:1) of the residue afforded 21 
(494 mg, 75% over 3 steps) as a pale yellow oil. Please Note: The compound is unstable and 
should be used within a week after preparation. 
[α]D = +127° (c 0.13, MeOH); 
1
H NMR (500 MHz, acetone-d6) δ = 9.35 (s, 1H, He), 7.70 (d, 
J = 8.8 Hz, 2H, Hc), 7.48 – 7.43 (m, 6H, Hh), 7.3 – 7.30 (m, 7H, Hd+i), 7.28 – 7.24 (m, 3H, 
Hj), 6.99 (d, J = 8.8 Hz, 2H, Hb), 3.84 (s, 3H, Ha), 3.52 (dd, J = 7.7 Hz, 3.9 Hz, 1H, Hf), 
2.80  2.73 (m, 1H, Hg), 2.56 (dd, J = 15.8 Hz, 6.1 Hz, 1H, Hg’); 
13
C NMR (125 MHz, 
acetone-d6) δ = 169.7, 162.7, 154.1, 145.8, 130.5, 130.5, 129.7, 127.7, 127.7, 115.1, 67.4, 
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N-Boc-Gly-Gly-Cys(STrt)-4-methoxybenzylidene Acyl Hydrazone 15 
 
N-Boc-Gly-Gly-OH (975 mg, 4.20 mmol, 1.50 equiv.) was suspended in anhydrous THF 
(40 ml) and 1,1’-carbodiimidazole (680 mg, 4.20 mmol, 1.50 equiv.) was added in small 
portions. The reaction mixture was allowed to stir at room temperature for 15 min and amine 
E3 (1.23 g, 2.80 mmol, 1.00 equiv.) was added. The reaction mixture was allowed to stir at 
room temperature for a further 12 h. The resulting white precipitate was filtered and washed 
with Et2O (2 × 100 ml) and dissolved in iPrOH/CHCl3 (1:3 v/v, 100 ml). The organic layer 
was washed with aqueous 1M KHSO4 (100 ml), aqueous saturated K2CO3 (100 ml) and 
brine (50 ml). The organic phase was dried over Na2SO4, filtered, and the solvent removed 
under reduced pressure to afford 15 (920 mg, 1.32 mmol, 47%) as a white powder. 
10:9 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. m.p. = 172 - 174 °C; 
[α]D = -133° (c 0.12, MeOH); 
1
H NMR (600 MHz, DMSO-d6) δ = 11.35 (s, 1H, He1), 11.31 
(s, 1H, He2), 8.38 (d, J = 8.2 Hz, 1H, Hk1), 8.33 (d, J = 8.6 Hz, 1H, Hk2), 8.19 (s, 1H, Hd2), 
8.10 (t, J = 5.7 Hz, 1H, Hm1), 7.96 (t, J = 5.7 Hz, 1H, Hm2), 7.88 (s, 1H, Hd1), 7.64 (d, 
J = 8.3 Hz, 2H, Hc2), 7.55 (d, J = 8.3 Hz, 2H, Hc1), 7.38 – 7.16 (m, 31H, Hh1+h2+i1+i2+j1+j2+o1), 
7.05 (t, J = 6.1 Hz, 1H, Ho2), 7.04 – 6.99 (m, 4H, Hb1+b2), 5.38 (td, J = 8.4 Hz, 4.8 Hz, 1H, 
Hf2), 4.46 (q, J = 7.5 Hz, 1H, Hf1), 3.83 (s, 3H, Ha1), 3.81 (s, 3H, Ha2), 3.79 – 3.69 (m, 4H, 
Hl1+l2), 3.60 - 3.56 (m, 4H, Hn1+n2), 2.48 – 2.31 (m, 4H, Hg1+g2), 1.39 (s, 9H, Hp1), 1.36 (s, 9H, 
Hp2); 
13
C NMR (150 MHz, DMSO-d6) δ = 171.1, 170.5, 170.0, 169.2, 169.0, 166.1, 161.4, 
161.2, 156.3, 156.2, 148.3, 144.6, 144.3, 129.5, 129.4, 129.3, 129.0, 128.6, 128.5, 127.3, 
127.2, 127.0, 127.0, 114.8, 66.5, 66.3, 55.8, 51.4, 48.7, 43.7, 43.6 , 42.4, 42.1, 34.1, 33.9, 
28.7, 28.6. Please Note: Due to the presence of two stereo isomers some 
13
C-signals 
coincide. LRESI(+)-MS: m/z 710.3 [M+ Na]
+
; HRFT(+)-MS: m/z 710.2990 [M+H]
+
, 
710.3012 calc. for C39H44N5O6S1. 
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Aldehyde N-Boc-Leucine Single-Barrier Rotaxane 33 
 
 
Macrocycle 14 (55 mg, 98 μmol, 2.00 equiv.) and Cu(MeCN)4PF6 (9.1 mg, 24.5 μmol, 
0.50 equiv.) were stirred in degassed CH2Cl2 (3 ml) at room temperature for 30 minutes. 
Then, a solution of alkyne 12 (40 mg, 49 μmol, 1.00 equiv.) and azide 13 (58 mg, 98 μmol, 
2.00 equiv.) in degassed CH2Cl2/tBuOH (4:1 v/v, 3 ml) was added. The reaction mixture was 
stirred at room temperature for 8 h. The reaction mixture was diluted with CH2Cl2 (20 ml) 
and the organic layer was washed with aqueous 0.1M Na4EDTA solution (3 × 20 ml). The 
organic layer was dried over Na2SO4, filtered, and the solvent removed under reduced 
pressure. Preparative TLC (SiO2 [Merck], CH2Cl2/MeOH 2%) of the crude residue afforded 
33 (43 mg, 45%) as a colourless film.  
1
H NMR (600 MHz, acetone-d6) δ = 9.96 (s, 1H, HA), 9.47 (s, 1H, Hw), 8.57 (s, 1H, Hac), 
8.03 (s, 1H, Hi), 8.00 (d, J = 8.3 Hz, 1H, Hl), 7.86 (d, J = 8.0 Hz, 2H, Hj), 7.82 (d, J = 8.0 Hz, 
2H, Hk), 7.63 – 7.53 (m, 6H, Hab+x+c), 7.43 (d, J = 8.0 Hz, 2H, Ho), 7.32 (d, J = 7.9, 6H, Hb), 
7.26 (t, J = 7.1 Hz, 1H, HN), 7.21 – 7.11 (m, 12H, Hc+y+aa+M), 7.08 – 7.02 (m, 4H, Hp+B), 
6.96 (d, 2H, Hd), 6.78 (d, J = 7.9 Hz, 4H, HI), 6.50 – 6.43 (m, 6H, He+H), 5.04 (q, J = 7.4 Hz, 
1H, Hr), 4.42 – 4.35 (m, 1H, Hm), 4.07 (t, J = 7.0 Hz, 2H, Hh), 3.84 – 3.75 (m, 4H, HG), 
3.49 (t, J = 6.1 Hz, 2H, Hf), 3.37 (dd, J = 14.0 Hz, 5.9 Hz, 1H, Hn), 3.20 (dd, J = 14.0 Hz, 8.5 
Hz, 1H, Hn’), 2.80 – 2.70 (m, 4H, HD), 2.65 – 2.59 (m, 4H, HL), 2.56 – 2.50 (m, 4H, HJ), 
1.92 - 1.71 (m, 15H, Ht+u+E+F+K), 1.65 (s, 6H, Hz), 1.42 (s, 9H, Hs), 1.32 (s, 27H, Ha), 1.29 (s, 
9H, Had), 0.99 (t, J = 7.6 Hz, 6H, Hv); 
13
C NMR (150 MHz, acetone-d6) δ = 193.1, 176.9, 
172.7, 170.30, 167.1, 162.5, 158.0, 157.2, 156.6, 150.6, 149.0, 147.0, 146.9, 146.4, 145.3, 
144.7, 140.1, 138.1, 137.9, 137.6, 137.2, 136.4, 135.6, 135.2, 134.2, 132.6, 131.4, 130.0, 
129.0, 128.7, 127.9, 127.9, 127.8, 127.5, 125.9, 125.0, 122.2, 120.6, 120.4, 120.0, 114.9, 
114.1, 79.4, 67.9, 64.8, 63.8, 53.3, 47.5, 42.7, 41.0, 40.1, 38.4, 35.7, 35.6, 34.9, 32.9, 31.7, 
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N-Boc-Leucine Thread E6 
 
Title compound E6 (14 mg, 35%) was isolated as a side product from the reaction mixture 
for the synthesis of 33 as a colourless film after preparative TLC (SiO2 [Merck], 
CH2Cl2/MeOH 2%). 
1
H NMR (600 MHz, acetone-d6) δ = 9.47 (s, 1H, Hw), 8.55 (s, 1H, Hac), 8.48 (s, 1H, Hi), 
8.04 (d, J = 8.1 Hz, 1H, Hl), 7.93 (s, 4H, Hj+k), 7.58 (d, J = 8.1 Hz, 2H, Hab), 7.54 (d, 
J = 8.2 Hz, 2H, Hx), 7.41 (d, J = 8.0 Hz, 2H, Ho), 7.31 (d, J = 7.4 Hz, 6H, Hb), 7.16 (d, 
J = 8.2 Hz, 2H, Haa), 7.14 – 7.10 (m, 8H, Hc+y), 7.08 (d, J = 7.8 Hz, 2H, Hd), 7.02 (d, 
J = 8.0 Hz, 2H, Hp), 6.84 (d, J = 8.2 Hz, 2H, He), 6.46 (d, J = 8.2 Hz, 1H, Hr), 5.02 (q, 
J = 7.6 Hz, 1H, Hm), 4.69 -(t, J = 6.9 Hz, 2H, Hh), 4.39 – 4.32 (m, 1H, Hq), 4.07 (t, 
J = 5.9 Hz, 2H, Hf), 3.36 (dd, J= 14.0 Hz, 5.7 Hz, 1H, Hn), 3.20 (dd, J = 13.9 Hz, 8.7 Hz, 1H, 
Hn’), 2.44 (p, J = 6.2 Hz, 2H, Hg), 1.88 – 1.80 (m, 1H, Hu), 1.80 – 1.69 (m, 2H, Ht), 1.39 (s, 
9H, Hs), 1.29 (s, 27H, Ha), 1.26 (s, 9H, Had), 0.97 (t, J = 7.4 Hz, 6H, Hv); 
13
C NMR (150 
MHz, acetone-d6) δ = 177.0, 172.7, 170.5, 170.4, 167.2, 167.1, 157.6, 156.7, 150.6, 149.1, 
147.0, 147.0, 146.4, 145.2, 140.5, 138.1, 137.3, 136.4, 135.2, 134.1, 132.8, 131.4, 131.2, 
128.9, 127.8, 127.5, 125.9, 125.1, 122.5, 122.2, 120.4, 120.1, 114.1, 79.4, 63.9, 56.8, 53.4, 
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N-Boc-Gly-Gly-Cys(STrt)-Acyl Hydrazone N-Boc-Leucine Single-Barrier Rotaxane 34 
 
A mixture of rotaxane 33 (20 mg, 10.8 µmol, 1.00 equiv.), 
p-CH3OC6H4CH=NNH-Cys(STrt)-Gly-Gly-N-Boc 15 (20 mg, 28.2 µmol, 2.60 equiv.) and 
aniline (50 µl) in DMSO/2-(N-morpholino)ethanesulfonic acid buffer (3:1 v/v, 1 ml, pH 6.0) 
was stirred at 60 °C for 72 h. The reaction mixture was allowed to cool to room temperature 
and then diluted with CH2Cl2 (10 ml) and the organic layer was washed with H2O (10 ml). 
The organic layer was dried over Na2SO4, filtered, and the solvent removed under reduced 
pressure. Preparative TLC (SiO2 [UNIPLATE-T], CH2Cl2/MeOH 2%, 3 elutions) of the 
residue afforded 34 (15 mg, 55%) as a colourless solid.  
1:1 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. 
1
H NMR (600 MHz, acetone-d6) 
δ = 10.58 – 10.36 (m, 2H, HL1+L2), 9.62 – 9.46 (m, 2H, Hw1+w2), 8.60 – 8.52 (m, 2H, Hac1+ac2), 
8.11 (d, J = 8.2 Hz, 1H, HD1), 8.03 – 7.98 (m, 1H, HD2), 7.95 – 7.90 (m, 2H, HM1+M2), 
7.89 - 7.82 (m, 4H, Hj1+j2), 7.80 – 7.70 (m, 6H, Hk1+k2+i1+i2), 7.62 – 7.48 (m, 12H, 
Ho1+o2+N1+N2+O1+O2+Z1+Z2), 7.45 – 7.33 (m, 16H, HK1+K2+x1+x2+ab1+ab2+F1+F2), 7.34 – 7.27 (m, 
24H, Hb1+b2+I1+I2), 7.23 – 7.11 (m, 32H, Hy1+y2+aa1+aa2+J1+J2+c1+c2), 7.05 – 6.98 (m, 6H, 
Hp1+p2+Y1+Y2), 6.99 - 6.93 (m, 4H, Hd1+d2), 6.80 – 6.73 (m, 8H, HU1+U2), 6.53 (t, J = 5.6 Hz, 
1H, HB1), 6.50 – 6.40 (m, 12H, Hr1+r2+e1+e2+T1+T2), 6.31 – 6.25 (m, 1H, HB2), 5.57 – 5.48 (m, 
1H, HG1 or G2), 5.07 – 4.97 (m, 2H, Hm1+m2), 4.57 – 4.50 (m, 1H, HG1 or G2), 4.39 – 4.32 (m, 2H, 
Hq1+q2), 4.07 – 3.96 (m, 5H, HE1 or E2, h1+h2), 3.92 (d, J = 5.4 Hz, 1H, HE1 or E2), 3.82 – 3.72 (m, 
8H, HC1+C2+S1+S2), 3.43 – 3.37 (m, 4H, Hf1+f2), 3.34 (dd, J = 14.0 Hz, 6.0 Hz, 2H, Hn1+n2), 3.19 
(dt, J = 13.6 Hz, 8.9 Hz, 2H, Hn1’+n2’), 2.80 – 2.69 (m, 4H, HH1+H2), 2.66 – 2.54 (m, 16H, 
HX1+X2+P1+P2), 2.54 – 2.49 (m, 8H, HV1+V2), 1.91 – 1.79 (m, 16H, HW1+W2+R1+R2), 1.80 – 1.75 
(m, 4H, Hg1+g2), 1.75 – 1.67 (m, 8H, HQ1+Q2), 1.62 (s, 12H, Hz1+z2), 1.40 – 1.38 (m, 36H, 
HA1+A2+s1+s2), 1.37 - 1.33 (m, 6H, Hu1+u2+t1+t2), 1.29 (s, 27H, Ha1 or a2), 1.29 (s, 27H, Ha1 or a2), 
1.26 (s, 18H, Had1+ad2), 0.97 (d, J = 6.5 Hz, 6H, Hv1+v2), 0.95 (d, J = 6.6 Hz, 6H, Hv1’+v2’); 
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13
C NMR (150 MHz, acetone-d6) δ = 177.0, 172.7, 171.4, 170.6, 170.5, 170.5, 169.8, 169.3, 
167.3, 167.3, 166.8, 162.5, 162.4, 158.0, 158.0, 157.2, 150.6, 149.6, 149.1, 149.0, 147.1, 
147.1, 146.8, 146.8, 146.4, 145.6, 145.5, 145.3, 144.1, 144.1, 144.0, 144.0, 140.1, 138.1, 
137.6, 137.5, 137.3, 136.4, 135.3, 135.1, 135.1, 135.0, 134.2, 133.8, 132.6, 131.4, 131.3, 
131.2, 130.4, 130.3, 130.0, 128.9, 128.8, 127.8, 127.8, 127.6, 127.5, 126.0, 125.1, 122.2, 
120.6, 120.6, 120.4, 120.2, 120.2, 115.0, 115.0, 114.2, 68.0, 68.0, 64.8, 64.8, 63.9, 56.9, 
56.8, 55.8, 55.7, 53.4, 53.0, 50.2, 47.6, 47.6, 45.0, 44.7, 44.1, 43.2, 42.7, 41.3, 41.0, 38.4, 
38.4, 37.9, 37.9, 36.1, 36.0, 36.0, 35.6, 35.6, 34.9, 32.9, 32.9, 31.7, 31.1, 30.3, 29.2, 28.7, 
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 (R)-p-Tolyl 2-pivalamidopropanoate 22 
 
To a solution of N-Piv-alanine (500 mg, 2.89 mmol, 2.00 equiv.) in anhydrous THF (10 ml) 
at room temperature was added N,N'-carbonyldiimidazole (469 mg, 2.89mmol, 2.00 equiv.) 
in small portions and the reaction mixture was stirred at room temperature for 1 h. To the 
reaction mixture p-cresol (156 mg, 1.45 mmol, 1.00 equiv.) was added and stirring was 
continued at 50 °C for 24 h. The reaction mixture was diluted with CH2Cl2 (50 ml) and the 
organic layer was washed with aqueous 1M NaOH (2 × 25ml), aqueous 1M KHSO4 
(2 × 25ml) and brine (25 ml). The organic layer was dried over MgSO4, filtered, and the 
solvent removed under reduced pressure to afford 22 (197 mg, 52%) as a white solid. 
m.p. 86 – 87 °C; [α]D = +6.7° (c 0.42, CH2Cl2); 
1
H NMR (600 MHz, CDCl3) δ = 7.19 (d, 
J = 7.9 Hz, 2H, Hb), 6.99 (d, J = 8.0, 2H, Hc), 6.26 (br d, J = 7.6 Hz, 1H, Hf), 4.81 (m, 1H, 
Hd), 2.36 (s, 3H, Ha), 1.59 (d, J = 7.3 Hz, 3H, He), 1.25 (s, 9H, Hg); 
13
C NMR (150 MHz, 
CDCl3) δ = 178.3, 172.4, 148.3, 135.9, 130.1, 121.0, 48.3, 38.7, 27.5, 21.0, 18.4; 
LRESI(+)-MS (MeOH): m/z 264.1 [M+H]
+
; HRESI(+)-MS: m/z 286.1407 [M+Na]
+
, 
286.1419 calc. for C15H21N1O3Na1. 
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(R)-p-Tolyl 2-([tert-butoxycarbonyl]amino)-4-methylpentanoate 23 
 
To a solution of N-Boc-leucine (2.00 g, 6.23 mmol, 2.00 equiv.) in anhydrous THF (30 ml) 
at room temperature was added N,N'-carbonyldiimidazole (1.01 g, 6.23 mmol, 2.00 equiv.) 
in small portions and the reaction mixture was stirred at room temperature for 1 h. To the 
reaction mixture was added p-cresol (337 mg, 3.12 mmol, 1.00 equiv.) and stirring was 
continued at 50 °C for 24 h. The reaction mixture was diluted with CH2Cl2 (100 ml) and the 
organic layer was washed with aqueous 1M NaOH (2 × 50 ml), aqueous 1M KHSO4 
(2 × 50 ml) and brine (50 ml). The organic layer was dried over MgSO4, filtered, and the 
solvent removed under reduced pressure to afford 23 (1.24 g, 62%) as a white solid. 
m.p. 52 °C; [α]D = -24.2° (c 0.91, CH2Cl2); 
1
H NMR (600 MHz, CDCl3) δ = 7.18 (d, 
J = 9.6 Hz, 2H, Hb), 6.99 (d, J = 9.6 Hz, 2H, Hc), 5.15 (d, J = 10.3 Hz, 1H, Hh), 4.56 (q, 
J = 9.3 Hz, 1H, Hd), 2.35 (s, 3H, Ha), 1.92-1.77 (m, 2H, He), 1.76 – 1.64 (m, 1H, Hf), 1.49 (s, 
9H, Hi), 1.03 (d, J = 7.9 Hz, 6H, Hg); 
13
C NMR (150 MHz, CDCl3) δ = 172.4, 155.5, 148.3, 
135.6, 129.91, 121.0, 52.3, 41.5, 28.3, 24.9, 22.9, 21.9, 20.8.; LRESI(+)-MS (MeOH): 
m/z 322.2 [M+H]
+
; HRESI(+)-MS: m/z 344.1832 [M+Na]
+
, 344.1832 calc. for C18H27N1Na1. 
  
 
92 Chapter II 
(R)-p-Tolyl 2-([tert-butoxycarbonyl]amino)-3-phenylpropanoate 24 
 
To a solution of N-Boc-phenylalanine (1.00 g, 3.77 mmol, 2.00 equiv.) in anhydrous THF 
(25 ml) at room temperature was added N,N'-carbonyldiimidazole (0.61 g, 3.77 mmol, 
2.00 equiv.) in small portions and the reaction mixture was stirred at room temperature for 
1 h. To the reaction mixture p-cresol (204 mg, 1.89 mmol, 1.00 equiv.) was added and 
stirring was continued at 50 °C for 24 h. The reaction mixture was diluted with CH2Cl2 
(100 ml) and the organic layer was washed with aqueous 1M NaOH (2 × 50 ml), aqueous 
1M KHSO4 (2 × 50 ml) and brine (50 ml). The organic layer was dried over MgSO4, filtered, 
and the solvent removed under reduced pressure to afford 24 (389 mg, 58%) as a white solid. 
m.p. 93-95 °C; [α]D = -8.9° (c 0.45, CH2Cl2); 
1
H NMR (600 MHz, CDCl3) δ = 7.38 (t, 
J = 7.4 Hz, 2H, Hg), 7.32 (t, J = 7.2 Hz, 1H, Hh), 7.29 (d, J = 7.3 Hz, 2H, Hf), 7.19 (d, 
J = 8.0 Hz, 2H, Hb), 6.91 (d, J = 8.0 Hz, 2H, Hc), 5.15 (d, J = 8.2 Hz, 1H, Hi), 4.89 – 4.83 
(m, 1H, Hd), 3.28 (br d, J = 6.1 Hz, 2H, He), 2.37 (s, 3H, Ha), 1.49 (s, 9H, Hj); 
13
C NMR 
(150 MHz, CDCl3) δ = 170.8, 155.2, 148.1, 135.8, 130.0, 129.5, 128.7, 127.2, 121.0, 115.2, 





, 378.1676 calc. for C21H25N1Na1. 
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N-Boc-Leu-Gly-Gly-Cys(STrt)-4-methoxybenzylidene Acyl Hydrazone E4 
 
Amine E3 (30.0 mg, 49 µmol, 1.00 equiv.) was dissolved in DMF (2 ml) and DIPEA 
(0.10 ml), and L-N-Boc-leucine (17.0 mg, 73.5 µmol, 1.50 equiv.) and PyBrop (34.0 mg, 
73.5 µmol, 2.00 equiv.) were added. The reaction mixture was allowed to stir at room 
temperature for 24 h and the reaction mixture was diluted with CH2Cl2 (20 ml). The organic 
layer was washed with H2O (20 ml), brine (20 ml) and the organic layer was dried over 
MgSO4, filtered, and the solvent removed under reduced pressure. Preparative TLC (SiO2 
[UNIPLATE-T], CH2Cl2/MeOH 3%) gave hydrazone E4 (19.5 mg, 47%) as colourless oil. 
1:1 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. m.p. decomp. over 217°; 
[α]D = +0.05° (c 0.2, MeOH); 
1
H NMR (600 MHz, DMSO-d6)  = 11.36  11.30 (br s, 2H, 
He1), 8.43 – 8.26 (m, 1H, Hk2), 8.16 (s, 1H, Hd1), 8.13 – 7.96 (m, 4H, Hm1+m2+o1+o2), 7.63 (d, 
J = 8.4 Hz, 1H, Hc1), 7.54 (d, J = 8.4 Hz, 1H, Hc2), 7.39 – 7.15 (m, 30H, Hi1+i2+j1+j2+h1+h2), 
7.04 – 6.94 (m, 4H, Hb1+b2+t1+t2), 5.38 (q, J = 7.4 Hz, 1H, Hf1), 4.44 (q, J = 7.6 Hz, 1H, Hf2), 
4.01 – 3.92 (m, 2H, Hp1+p2), 3.83 (s, 3H, Ha1 or a2), 3.83 (s, 3H, Ha1 or a2), 3.78 – 3.69 (m, 4H, 
Hl1+l2+n1+n2), 2.46 – 2.30 (m, 4H, Hg1+g2), 1.59 (q, J = 9.0 Hz, 2H, Hr1+r2), 1.47 – 1.38 (m, 2H, 
Hq1+q2), 1.37 (d, J = 5.4 Hz, 18H, Hu1+u2), 0.92 – 0.80 (m, 12H, Hs1+s2); 
13
C NMR (150 MHz, 
DMSO-d6) δ = 170.7, 169.4, 160.9, 160.8, 155.5, 147.8, 144.2, 143.8, 129.1, 128.8, 128.5, 
128.1, 128.0, 126.9, 126.7, 126.5, 114.3, 55.4, 52.8, 51.0, 48.2, 42.1, 42.0, 41.8, 41.6, 40.6, 
40.1, 39.9, 33.7, 33.4, 28.2, 24.2, 23.0, 21.5; LRESI(+)-MS (MeOH): m/z 845.4 [M+Na]
+
; 
HRESI(+)-MS: m/z 845.3668 [M+Na]
+
, 845.3672 calc. for C45H54N6O7SNa1. 
  
 
94 Chapter II 
N-Boc-Leu-Gly-Gly-Cys(STrt)-Acyl Hydrazone Macrocycle E5 
 
A mixture of macrocycle 14 (10 mg, 18 µmol, 1.0 equiv.), 
p- CH3OC6H4CH=NNH-Cys(STrt)-Gly-Gly-Leu-N-Boc (20 mg, 26 µmol, 1.5 equiv.) and 
aniline (50 μl) in DMSO/2-(N-morpholino)ethanesulfonic acid buffer (3:1 v/v, 0.5 ml, 
pH 6.0) was stirred at 60 °C for 72 h. The reaction mixture was diluted with CH2Cl2 (20 ml). 
The organic layer was washed with H2O (2 × 20 ml), dried over Na2SO4, filtered, and the 
solvent removed under reduced pressure. Preparative TLC (SiO2, CH2Cl2/MeOH 4%) of the 
crude residue afforded E5 (14 mg, 75%) as a colourless film. 
2:3 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. [α]D = +0.02° (c 0.10, MeOH); 
1
H NMR (600 MHz, acetone-d6) δ = 10.40 (s, 1H, Hq1), 10.38 (s, 1H, Hq2), 8.36 (s, 1H, Hr2), 
8.23 (t, J = 5.8 Hz, 1H, Hi1), 8.21 – 8.15 (m, 1H, Hi2), 8.03 (s, 1H, Hr1), 7.81 – 7.73 (m, 2H, 
Hg1+g2), 7.58 (t, J = 7.7 Hz, 2H, Hae1+ae2), 7.47 – 7.13 (m, 36H, Hn1+n2+o1+o2+p1+p2+s1+s2+t1+t2), 
7.10 – 7.05 (m, 12H, Hz1+z2+ad1+ad2), 6.79 – 6.73 (m, 4H, Hy1+y2), 6.35 (d, J = 6.7 Hz, 1H, 
Hb1), 6.30 (d, J = 7.3 Hz, 2H, Hb2), 5.59 – 5.53 (m, 1H, Hl1), 4.39 – 4.32 (m, 1H, Hl2), 
4.18 - 4.09 (m, 2H, Hc1+c2), 4.02 – 3.81 (m, 14H, Hx1+x2+j1+h1+h2), 3.64 – 3.59 (m, 1H, Hj2), 
2.78 (t, J = 7.4 Hz, 8H, Hac1+ac2), 2.76 – 2.70 (m, 6H, Hu1+u2+m1+m2), 2.59 – 2.55 (m, 2H, 
Hm'1+m’2), 2.06 – 2.00 (m, 8H, Hab1+ab2), 1.88 – 1.81 (m, 8H, Hv1+v2), 1.79 – 1.74 (m, 8H, 
Hw1+w2), 1.69 – 1.55 (m, 6H, Hd1+d2+e1+e2), 1.44 – 1.39 (m, 18H, Ha1+a2), 0.93 - 0.85 (m, 12H, 
Hf1+f2); 
13
C NMR (150 MHz, acetone-d6) δ = 174.7, 171.2, 168.8, 168.3, 165.7, 161.1, 161.0, 
157.4, 157.3, 148.1, 144.8, 144.7, 144.5, 143.0, 142.8, 136.4, 134.8, 134.3, 130.5, 130.3, 
129.6, 129.6, 129.5, 129.4, 129.2, 128.4, 128.0, 127.9, 127.9, 126.7, 126.7, 126.6, 125.1, 
125.1, 120.0, 120.0, 120.0, 114.1, 67.3, 53.7, 52.7, 43.6, 43.3, 42.6, 40.5, 40.5, 34.8, 34.7, 
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N-Boc-Gly-Gly-Cys(SH)-Acyl Hydrazone Macrocycle 35 
 
E5 (15 mg, 9.4 μmol, 1.0 equiv.) was dissolved in CH2Cl2/TFA (4:1 v/v, 1 ml) and 
triisopropylsilane (5.0 μl, 24 µmol, 2.6 equiv.) was added. The mixture was stirred at room 
temperature for 90 minutes. The solvent was removed under reduced pressure and the 
residue washed with Et2O (3 × 10ml) and analysed without further purification. LRESI-MS 
(MeOH): m/z 906.6 [M+H]
+
; m/z 952.6 [M+COOH+H]
+
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3.1 Synopsis 
The ribosome builds proteins by joining together amino acids in an order determined by 
messenger RNA. The design, synthesis and operation of the first molecular small-molecule 
machine that travels along a molecular strand, picking up amino acids that block its path, to 
synthesise a peptide in a sequence-specific manner is described in this Chapter. The 
chemical structure is based on a rotaxane, a molecular ring threaded onto a molecular axle. 
The ring carries a thiolate group that iteratively removes three amino acids in order from the 
strand and transfers them to a peptide elongation site through native chemical ligation. The 
synthesis is demonstrated using ~10
18
 molecular machines acting in parallel and generates 


















 have previously been used to store information
2
, to do 
mechanical work
3
, and employed in synthesis to processively epoxidise an unsaturated 
polymer
4
, switch ‘on’ and ‘off’ catalytic activity
5
 and to change the handedness of a reaction 
product
6
. Large synthetic DNA molecules have been used to guide the formation of bonds 
between unnatural building blocks
7
 and assemble gold nanoparticles in particular sequences
8
. 
The sequence-specific synthesis of a peptide consisting of naturally occurring amino acid 
building blocks has not been realised so far. 
Here, the design, synthesis and operation of a rotaxane-based small-molecule machine in 
which a functionalised macrocycle operates on a thread containing building blocks in a pre-
determined order to achieve sequence-specific peptide synthesis is reported. The design of 





 protein synthesis: reactive building blocks (the role played by 
tRNA-bound amino acids) are delivered in a sequence determined by a molecular strand (the 
role played by mRNA). A macrocycle ensures processivity during the machine’s operation 
(reminiscent of the way that subunits of the ribosome clamp the mRNA strand) and bears a 
catalyst—a tethered thiolate group—that detaches the amino acid building blocks from the 
strand and passes them on to another site at which the resulting peptide oligomer is elongated 




The operation principles and essential design features are based on the work outlined in 
Chapter 2. As iterative chemical transformation required for the assembly of three aminoacyl 
units in sequence, native chemical ligation was chosen. NCL has proven to be high yielding, 
chemoselective, can proceed through large transition states and the suitability of a cysteine-
glycylglycine reactive arm for the incorporation in a rotaxane has been established in the 
successful operation of model rotaxane 1
11
 (Figure 3.1). The chemical structure of molecular 
machine 2 featuring three amino acyl residues in sequence is shown in Figure 3.2. 
Analogous to the test-system 1, molecular machine 2 is envisioned to be built-up from a 
30-membered macrocycle incorporating a pyridyl unit required for the assembly of the 
rotaxane based on Cu(I)-catalysed azide-alkyne cycloaddition (CuAAC) active-metal 
template strategy and a reversible hydrazone attachment point for the reactive arm. The track 
features a sterically demanding stopper unit ensuring that the macrocycle can only diffuse in 
the direction of the amino acyl residues which are connected via cleavable phenolic ester 
linkages.  
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Figure 3.1. Rotaxane design of a test substrate for the development of a second generation molecular 
machine capable of sequence-specific synthesis. 
 
 
Figure 3.2. Second generation design of a molecular machine capable of sequence-specific synthesis. 
 
Relatively rigid 2,2-diphenylpropane-based spacer units prevent the reactive arm of the 
macrocycle from overreaching and reacting with monomers out of sequence. The 
mechanically interlocked nature of the machine ensures processivity and prevents the 
reactive arm from dissociation from the track. 
The suggested operation mechanism of machine 2 is shown in Scheme 3.1. After global 
deprotection of the corresponding machine in its protected form, machine 2 is allowed to 
operate in the presence of base which deprotonates the thiolate catalyst (Scheme 3.1, A). The 
in-situ formed thiolate functionality of the catalytic arm is poised to cleave the ester bond of 
the first amino acid phenolic ester that blocks the path of the macrocycle (Scheme 3.1, B). 
An S,N-acyl transfer via a 11-membered transition state transfers the amino acyl residue to 
the glycylglycine amine group (Scheme 3.1, C).   
 
102 Chapter III 
 
Scheme 3.1. Proposed mechanism for sequence-specific peptide synthesis by molecular machine 2. 
After activation of the machine by acidic cleavage of the Boc and Trt protecting groups under basic 
conditions, successive native chemical ligation reactions transfer the amino acid building blocks to the 
peptide elongation site on the macrocycle in the order that they appear on the thread. Once the final 
amino acid is cleaved, the macrocycle bearing the synthesised oligopeptide dethreads from the strand. 
  
 
103 Chapter III 
The thiolate catalyst on the reactive arm is regenerated (Scheme 3.1, D) and the macrocycle–
now able to diffuse over the first attachment point–comes in close proximity to the second 
aminoacyl residue (Scheme 3.1, E). Formation of the thioester and subsequent S,N-transfer 
via a 14-membered cyclic transition state (Scheme 3.1, F) allows the elongation of the 
peptide chain by another unit (Scheme 3.1, G). In its final step the thiolate catalyst picks up 
the third amino acyl residue (Scheme 3.1, H) and dissociates from the thread with the 
hexapeptide attached. Hydrolysis of the hydrazone linkage would allow the isolation of the 
newly formed, full length peptide. The artificial molecular machine synthesises the peptide 
from the C- to the N-terminus, the opposite direction to ribosomal translation and opposite to 
the first generation machine presented in Chapter 2.  
The features exhibited by this machine are
12
: 
(i) Processive Operation: the reactive arm covalently attached to a interlocked 
macrocycle prevents dissociation until the operation is completed. 
(ii) Directional Movement: the macrocycle, although no bias is applied and the 
motion is purely diffusional, moves along the molecular strand away from the 
bulky stopping group. 
(iii) Repetitive Elongation: after each pick-up of an amino acyl moiety the catalytic 
thiolate unit is regenerated without undoing the task that was performed. 
(iv) Autonomous Operation: once the protective groups are removed and the 
molecular machine is submitted to operation conditions, no interference is 
required and the hexapeptide is synthesised autonomously. 
Those four key characteristics underpin the similarity of the molecular machine to the 
ribosome, which features processivity
13
 (the molecular clamp made up from the 30S and 50S 
subunits does not dissociate from the mRNA strand before a stop codon is encountered), 
directional movement
14
 (the ribosome moves along the mRNA strand in the 5'-to-3' 
direction), repetitive elongation
15
 (up to 10000 amino acids are joined together through a 
single operation) and, of course, autonomous operation. The fundamental difference between 
both machines–leaving the vastly different levels of performance asideis the inability of the 
artificial system to reuse the information encoding strand the oligomer is translated from. 
The information contained is destroyed as the macrocycle moves along whereas a ribosome, 
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3.2.1 Retrosynthetic Analysis of Three-Barrier Rotaxane 2 
The importance of a fast and efficient synthetic route to a highly complex molecular machine 
cannot be overemphasised and is crucial for the success of the whole project, since often 
late-stage modifications are necessary in order to overcome unforeseen problems. Therefore, 
a short and convergent route, as well as a modular built-up that allows modification of key 
components in the end game of the synthesis (e.g. change of amino acids or the reactive 
arm), are equally important. 
The retrosynthetic analysis of molecular machine 2 is shown in Scheme 3.2. The reactive 
arm containing the tethered thiolate catalyst can be attached via a mild and selective 
hydrazone exchange reaction starting from aldehyde functionalised rotaxane 3, potentially 
allowing the screening of different catalytic units in the last step of the synthetic route. As 
protecting groups, acid labile Boc-groups for the amine-functionality and a trityl group for 
the thiolate masking allow a global deprotection in a single step. Rotaxane 3 can be derived 
from the CuAAC active metal template reaction of azide functionalised stopper 4, 
2,6-substituted pyridyl macrocycle 5 and amino acid-loaded track 6 containing a terminal 
alkyne functionality. This axle is derived from successive CuAAC “click” reactions of 
monomers featuring an azide group and a terminal trimethylsilyl (TMS)-protected alkyne 
from building blocks 7, 8 and 9. Interlocking the components at a late stage in the synthesis 
allows the change of amino acids or the length of the track with relative ease.  
Crucial for the success of this elongation/deprotection strategy required for the built-up of 
thread 6 are conditions that remove the TMS-protecting group without cleaving the loaded 
amino acyl residues. One particular attractive set of TMS-deprotection conditions makes use 




The synthesis of the remaining building blocks is straightforward. The synthesis of azide 
stopper 4 is reported in literature
17
, the syntheses of hydrazone exchange reagent 10 and 
macrocycle 5 is described in Chapter 2.
11
 External barrier 9 can be synthesised analogous to 
N-Boc-Leu-derivative outlined in the previous Chapter. Internal barrier 7 and 8 can be 
derived from phenol 11 via standard ester formation. Two amide disconnections leave 
monofuctionalised 2,2-diphenylpropane unit 12, Fmoc-tyrosine 13 and TMS-protected 
p-acetylene benzoic acid 14 as starting materials. 
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Scheme 3.2. Retrosynthetic analysis of molecular machine 2. 
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Scheme 3.3. Retrosynthetic analysis of building block 7 and 8. 
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3.3 Results and Discussion 
3.3.1 Synthesis of Molecular Machine 2 
For the synthesis of molecular machine 2 key intermediates are macrocycle 5, external 
barrier loaded with pivaloyl-protected alanine 9, internal barriers loaded with boc-protected 
phenyl alanine 7 and loaded with boc-protected leucine 8 as well as the hydrazone exchange 
reagent 10 required for loading on the reactive arm. The synthesis of internal barriers 7 and 8 
differs in one key aspect from the route to the related external barrier 9: the TMS-protecting 
group has to remain on the alkyne at the end of the synthesis. Therefore the synthesis 
commences with the amide coupling using HOBt/EDCI of Fmoc-protected tyrosine 13 with 
p-azidophenyl derivative 12 to give amide 15 (Scheme 3.4). After Fmoc-deprotection an 
amide coupling yields TMS-protected acetylene 11. Coupling with the desired amino acid 
gives access to 7 and 8. 
 
 
Scheme 3.4. Synthesis of barriers 7 and 8. Reaction conditions: a) iso-amyl nitrite, NaN3, AcOH, RT, 
2 h, 45%; b) L-N-Fmoc-tyrosine, HOBt, EDCI∙HCl, THF/CHCl3 (2:1 v/v), 12 h, 60%; 
c) DMF/piperidine (4:1 v/v), RT, 3 h, 97%; d) 4-([trimethylsilyl]ethynyl)benzoic acid, HOBt, 
EDCI∙HCl, THF/CHCl3 (2:1 v/v), RT, 12 h, 71%; e) L-N-Boc-phenylalanine, EDCI∙HCl, DCC, 
DMAP, CH2Cl2, RT, 48 h, 42%; f) L-N-Boc-leucine, EDCI∙HCl, DCC, DMAP, CH2Cl2, RT, 48 h, 
63%. 
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External Barrier 9 loaded with N-Piv-alanine is derived from an esterification of the 
corresponding carboxylic acid with phenol 16. 
The synthesis of alkyne-thread 5 starts with a CuAAC reaction and subsequent TMS-
deprotection to give 17. Polymer-bound tris([1-benzyl-1H-1,2,3-triazol-4-yl]methyl)amine 
(Tentagel TBTA) gave best results for the azide-alkyne cycloaddition since it allowed the 
removal of otherwise difficult to separate TBTA by a simple filtration (Scheme 3.5).  
 
 
Scheme 3.5. Synthesis of three-barrier alkyne 6. Reaction conditions: a) L-N-Piv-alanine, EDCI∙HCl, 
DCC, DMAP, CH2Cl2, RT, 48 h, 56%; b) Tentagel TBTA, Cu(MeCN)4PF6, CH2Cl2/tBuOH (1:1 v/v), 
RT, 48 h, then AgNO3, acetone/H2O (10:1 v/v), RT, 18 h, 43% over two steps; c) Tentagel TBTA, 
Cu(MeCN)4PF6, CH2Cl2/tBuOH (1:1 v/v), RT, 48 h, then AgNO3, acetone/H2O (10:1 v/v), RT, 18 h, 
37% over two steps. 
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Base-free deprotection conditions employing silver(I)nitrate have been chosen in order to 
circumvent saponification of the ester bonds that would be expected from basic hydrolysis 
which is commonly used for TMS-removal. Similarly, tetra-n-butylammonium fluoride 
(TBAF) as strongly nucleophilic reagent was not compatible with the substrate and cleavage 
of the esters was observed, whereas deprotection with Ag(I)NO3 in acetone delivers alkyne 
17 in good yield, which is then extended by a second CuAAC reaction. Again, a base-free 
deprotection of the terminal TMS-group allowed access to terminal alkyne 6. 
The crucial interlocking of pyridyl-macrocycle 5, azide stopper 4 and aminoacyl-loaded 
alkyne-thread 6 was successfully accomplished using 0.5 equiv. Cu(MeCN)4PF6 in a mixture 
of CH2Cl2 and tBuOH (4:1 v/v). Stirring the reaction mixture for seven days gave access to 
rotaxane 3 in 30% yield. Analogous to the simplified test-system from Chapter 2, the 
reactive arm was introduced using the mild hydrazone exchange conditions from Greaney 
and co-workers
18
 to give the fully assembled molecular machine 18 in good yield. 
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Scheme 3.6. Synthesis of rotaxane-based molecular machine 18. Reaction conditions:  
a) Cu(CH3CN)4PF6, CH2Cl2/tBuOH (2:1 v/v), RT, 4 d, 30%; b) aniline, 
N-Boc-Gly-Gly-Cys(STrt)NHN=CHC6H4OCH3, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 2 d, 
90%. The italicised letters indicate key signals in the 
1
H NMR spectrum shown in Figure 3.3.  
 
The fully assembled machine is stable in its protected form 18 and the interlocked nature of 
the molecule becomes apparent from the upfield shifts of the proton signal Hi corresponding 
to the triazole on account of shielding from the phenyl rings of the macrocycle, confirming 
that the ring is trapped in the region of the strand between the terminal stopper and the 
N-Boc-phenylalanine ester (Figure 3.3). Similarly, the signal He stemming from the two 
protons on the phenolic ring of the stopper group as well as signals Hf, Hg, and Hh connecting 
the triazole moiety with the stopping group are shifted significantly upfield in the rotaxane 
compared to the free thread. Signals further away from the shielding effects of the 
macrocycle remain largely unaffected. 
 




H NMR spectrum of (A) the non-interlocked thread and (B) rotaxane 18, in DMSO-d6 
(500 MHz, 298 K). Rotaxane 18 exists in both E- and Z-hydrazone forms. The assignments 
correspond to the lettering shown in Scheme 3.6. C′ = L-S-Trt-cysteine, G′ = L-N-Boc-glycine, 
F′ = L-N-Boc-phenylalanine, L′ = L-N-Boc-leucine, A′ = L-N-Piv-alanine. 
  
 
112 Chapter III 
3.3.2 Operation of Molecular Machine 18 
Operation conditions were chosen to be analogous to the previously established single-
barrier system: an excess of non-nucleophilic DIPEA in order to deprotonate the thiolate 
catalyst on the reactive arm as well as the amine functionalities, two equivalents reducing 
agent TCEP (tris[2-carboxyethyl]phosphine) to break-up disulfide bonds as soon as they are 
formed and acetonitrile/DMF (3:1 v/v) as polar solvent mixtures ensuring a homogeneous 
solution of all components (Scheme 3.7). After heating at 60 °C for 36 h in the microwave 
no starting material remained, as evidenced by thin layer chromatography. Two major 
products were isolated from the reaction mixture. One product was identified by 
1
H NMR 
spectroscopy and mass spectrometry as the completely deacylated thread 19. The other 
product had a 
1
H NMR spectrum and molecular weight (Figure 3.4) consistent with the 




H NMR spectra of the operation product with the correct sequence 
N-Piv-Ala-Leu-Phe-Gly-Gly-Cys(SH) 20 and the sequence-scrambled analogue 
N-Piv-Ala-Phe-Leu-Gly-Gly-Cys(SH) 21 are very similar as determined by comparison with 
an authentic sample and an isomer in which the order of the Phe and Leu residues was 
reversed, each prepared unambiguously by conventional peptide synthesis. 
Therefore, tandem mass spectrometry
19
 was chosen to elucidate the peptide sequence of the 
operation product. In an MS/MS-run based on a product ion scan commonly applied for 
sequencing of peptide chains, a precursor ion is selected in the first analyser and then 
allowed to fragment. The generation of product ions is achieved by collision induced 
disscociation
20
 through which the parental ion collides with neutral helium atoms after 
passing the first analyser. With a second analyser and a detector in line, then the fragments, 
i.e. the product ions, can be studied. Figure 3.5, A shows the MS/MS spectrum of one 
isotope of a 2+ ion of 20 formed during ionisation through the cysteine as an S,N-acetal, a 
species that gave a sufficient signal-to-noise ratio for the MS/MS experiment (the adduct is 
present in the unambiguously prepared reference substrate as well). Figure 3.5, B shows the 
superimposition of the MS/MS spectra of a similar isotope and ion from the authentic 
samples prepared unambiguously by synthesis of the macrocycle bearing the sequence 
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Scheme 3.7. Operation of molecular machine 18. Reaction conditions: a) CH2Cl2/TFA (5:1 v/v), RT, 
2 h; b) DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), 60 °C, μw, 24 h. 
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Figure 3.4. 1H NMR spectrum of molecular machine operation product 20 in DMSO-d6 
(500 MHz, 298 K). 
 
For both 20 and 21 a fragment with mass m/z 799 is observed as expected from the loss of 
the terminal pivaloyl-protected alanine (Figure 3.5, B). The difference in the fragmentation 
masses of the two sequence isomers is apparent from the loss of the next amino acid 
(m/z 726 for Leu-Gly-Gly-Cys(SH)-macrocycle; m/z 743 for Phe-Gly-Gly-Cys(SH)-
macrocycle). Since the MS/MS of operation product 20 shows only a peak m/z 743 it was 
confirmed as corresponding to the intended sequence isomer. 
No products corresponding to other peptide compositions (neither different sequences nor 
peptides with more or less than one Phe, Leu or Ala residue) were detected by preparative 
thin layer chromatography and subsequent MS analysis as well as performing an MS of the 
reaction mixture after the operation of 18, indicating that the peptide synthesis occurs 
overwhelmingly within the confines of the molecular machine.  
In contrast, a control reaction carried out under identical conditions but using the 
non-threaded strand and macrocycle gave several products, including strands with one or 
more amino acid groups cleaved, but there was no evidence for the formation of 20 under 
these conditions. Thus the threaded architecture of the molecular machine, encompassing the 
catalytic unit, elongation site and the building block strand, is essential for the sequential 
peptide synthesis and the mode of operation of the molecular machine is consistent with the 
mechanism shown in Scheme 3.1.  
The peptide 22, still bearing the Cys-Gly-Gly unit at the C-terminus, could subsequently be 
cleaved from the macrocycle by hydrolysis as evidenced by MS (Scheme 3.8).  
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Figure 3.5. (A) Tandem mass spectrum of a single isotope of the 2+ ion (m/z 876.64) of 
S,N-acetal-derivatised 20. (B) Superimposed tandem mass spectra of 2+ ions of S,N-acetal-derivatised 
macrocycles bearing the peptide sequences N-Piv-Ala-Phe-Leu-Gly-Gly-Cys(SH) (21, red; 2+ ion 
isotope selected m/z 876.73) and N-Piv-Ala-Leu-Phe-Gly-Gly-Cys(SH) (20, blue; 2+ ion isotope 
selected m/z 876.92), each prepared unambiguously by conventional peptide synthesis. Derivatisation 
occurs during the sample preparation in MeOH and HCOOH for both operation product and reference 




Scheme 3.8. Hydrolysis of operation product 20. Reaction conditions: a) CH2Cl2/TFA/H2O 
(3:1:1 v/v/v), RT, 12 h. 
  
 
116 Chapter III 
3.4 Conclusion 
The synthesis of the small peptide through autonomous multi-step synthesis by artificial 
small-molecule machine 2 was carried out on a scale of tens of milligrams, corresponding to 
parallel synthesis by ~10
18
 machines. Once its operation is initiated, the synthetic tasks 
performed by 2 proceed autonomously, requiring no further intervention. As the catalytic 
thiolate is constrained by the threaded architecture of the machine from reacting with 
building blocks out of sequence, balancing the rate of reactions with the speed that templates 
rearrange is unnecessary for a rotaxane-based machine. 
Rotaxane 2 is a (very) primitive analogue of the ribosome. Limitations of the second 
generation artificial system include slow kinetics (1 takes ~12 h to make each amide bond, 
compared to the 10 to 15 amide bonds synthesised per second by a ribosome) and loss of the 
sequence information on the strand as it is translated into the product. Furthermore, the 
length of an oligopeptide that can be produced may ultimately be restricted by the size of the 
cyclic transition states involved in S-to-N acyl transfer (although peptide ligation has been 
successfully utilised with up to 29-membered cyclic transition states
27
). Nevertheless 2 
demonstrates that relatively small, highly modular, artificial molecular machines can be 
designed to autonomously perform iterative tasks in synthesis. Potentially, the principles 
employed in the design and operation of 2 should be broadly applicable to other types of 
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3.5 Experimental Section 
3.5.1 General Methods and Abbreviations 
Unless stated otherwise, all reagents and solvents were purchased from Aldrich Chemicals 
and used without further purification. Compound 4
17
 was prepared according to the literature 
procedure. Dr. Guillaume De Bo conducted a control reaction carried out under identical 
conditions as depicted in Scheme 3.12 but using the non-threaded strand and macrocycle. 
Compounds 21, E4, E6, E9, and E10 were prepared by Dr. Bartosz Lewandowski. 
Compounds E5 and E8 were prepared using solid phase peptide synthesis by Dr. Guillaume 
De Bo. The synthesis of 1, 5, 10, 16 and E3 is described in Chapter 2.
11
 All reactions 
requiring microwave heating were carried out in a Biotage Initiator 2.5.3. Dry DMF, CH2Cl2, 
CHCl3 and THF was obtained by passing the solvent (HPLC grade) through an activated 
alumina column on a PureSolv™ solvent purification system (InnovativeTechnologies Inc., 
MA). Flash column chromatography was carried out using Geduran® Si 60 (particle size 40-
63 μm, Merck, Germany) as the stationary phase, and analytical TLC was performed on 
precoated silica gel plates (0.25 mm thickness, 60 F254, Merck, Germany) and observed 
under UV light or stained with a phosphomolybdic acid solution. Preparative TLC was 
performed on precoated silica gel plates (2 mm, UNIPLATE GF, Analtech Inc., DE or 2 
mm, Tapered plate, UNIPLATE-T, Analtech Inc., DE). NMR spectra were recorded on 
Bruker AV 400 MHz, Bruker AV 500 MHz (equipped with a cryoprobe) or Bruker Avance 
III (equipped with a cryoprobe) with an Oxford AS 600 MHz magnet. Chemical shifts are 
reported in parts per million (ppm) from high to low frequency and referenced to the residual 
solvent resonance. Coupling constants (J) are reported in hertz (Hz). Standard abbreviations 
indicating multiplicity were used as follows: s = singlet, d = doublet, t = triplet, q = quartet, 
quin = quintuplet, m = multiplet, br = broad. 
1
H-NMR assignments were made using 
2D NMR methods (COSY, HSQC, HMBC). Melting points (m.p.) were determined using a 
Sanyo Gallenkamp apparatus and are reported uncorrected. Low resolution ESI mass 
spectrometry was performed with a Finnigan LCQ-MS mass spectrometer. High resolution 
ESI (electrospray ionisation) and APCI (atmospheric-pressure chemical ionisation) mass 
spectrometry was carried out by the mass spectrometry services at the EPSRC National Mass 
Spectrometry Service Centre, Swansea, UK or the Mass Spectrometry Service of the 
University of Manchester. Optical rotations were recorded using a Bellingham and Stanley 
ADP 220 Polarimeter using a 1 dm cell. 
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3.5.1.1 Operation of Molecular Machine 18 
Scheme 3.9. Operation of molecular machine 18. Reaction conditions: a) CH2Cl2/TFA (5:1 v/v), RT, 
2 h, then DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), 60 °C, µw, 36 h. 
 
Molecular machine 18 (20 mg, 5.0 µmol) was stirred at room temperature in a mixture of 
CH2Cl2/TFA (5:1 v/v, 2 ml) for 2 h. Toluene (5 ml) was added and the solvent was removed 
under reduced pressure. The residue was then dissolved in degassed MeCN/DMF (3:1 v/v, 
4 ml) and both N,N-diisopropylethylamine (43 µl, 0.25 mmol) and 
tris(2-carboxyethyl)phosphine hydrochloride (2 mg, 8 µmol) were added and the reaction 
mixture was stirred under microwave heating at 60 °C for 36 h. Preparative TLC (SiO2 
[UNIPLATE-T], CH2Cl2/MeOH 5%) of the residue afforded 20 (2.0 mg, 30%) as a 
colourless film.  
1
H NMR (500 MHz, DMSO-d6) δ = 11.40 (m, 1H, Ho), 8.23 (m, 1H, Hn), 8.00 (m, 2H, 
Hu+w), 7.73 (m, 1H, Hac), 7.69 (m, 1H, Hak), 7.59 (t, J = 5.9 Hz, 1H, Ha), 7.48 (m, 1H, Hah), 
7.26 (m, 7H, Hm+z+aa+ab), 7.07 (d, J = 5.7 Hz, 2H, Hb), 7.03 (d, J = 8.4 Hz, 4H, Hf), 6.87 (d, 
J = 7.5 Hz, 1H, Hl), 6.74 (d, J = 8.3 Hz, 4H, Hg), 4.58 (bs, 1H, Hp), 4.47 (bs, 1H, Hx), 4.41 
(bs, 1H, Hal), 4.26 (m, 1H, Had), 3.91 (m, 2H, Ht), 3.80 (m, 4H, Hh), 3.72 (m, 2H, Hv), 3.07 
(m, 2H, Hy), 2.69 (m, 8H, Hk+c), 1.93 (m, 4H, Hd), 1.74 (m,4H, Hj), 1.67 (m, 5H, Hi+af), 1.49 




Please note: The mechanism for epimerisation of the amino acid units during the machine’s 
operation would cause significant hydrolysis of the acyl amino units from the thread leading 
to loss of sequence integrity in the product, which is not observed in the operation of 18. 
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Thus, it is very likely that the molecular machine operates with high stereochemical 
integrity.  
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3.5.1.2 Mass-spectrometric Analysis of the Operation Product 20 
 
Scheme 3.10. S,N-Acetal formation observed during sample preparation of hexapeptide macrocycle 
for mass spectrometry. Reaction conditions: HCO2H/CH2Cl2/H2O/MeOH (1:5:10:84 v/v/v/v). 
 
Analysis of the operation of molecular machine 18 obtained has a mass spectrum 
corresponding to the desired product 20 (LRESI(+)-MS [MeOH]: m/z 1208.7 [M+H]
+
). 
Upon addition of formic acid during sample preparation (0.1 mg of 20 in 1ml of 
HCO2H:CH2Cl2:H2O:MeOH [1:5:10:84 v/v/v/v]) intended for multiply-charged ion tandem 
mass spectrometry experiments (MS/MS experiments normally work better with multiply 
charged ions which are typically produced by adding acid to the sample) the rapid formation 
(within 5 min, complete conversion after1 h according to MS) of signals corresponding to 
the free aldehyde macrocycle (5, m/z 562.3 [M+H]
+
) and the formation of a derivative of 20 
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was observed. It was rationalised, that S,N-acetal formation with another molecule of 5 
occurred to give E1 (Scheme 3.10). 
Similarly, S,N-acetal could also be observed by dissolving unambiguously prepared 
macrocycle 20 or 21 upon addition of formic acid during sample preparation (0.1 mg of 7 in 
1ml of HCO2H:CH2Cl2:H2O:MeOH [1:5:10:84 v/v/v/v]). The S,N-acetal accepts multiple 
charges more readily than the underivatised counterparts and accordingly was used in the 
MS/MS peptide sequencing experiments where typically M
2+
 ions give best results.  
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3.5.1.3 Hydrolysis of 20 
 
 
Scheme 3.11. Hydrolysis of the hexapeptide macrocycle. Reaction conditions: a) CH2Cl2/TFA/H2O 
(3:1:1 v/v/v), RT, 12 h. 
 
Macrocycle 20 (2.0 mg, 1.7 μmol) was dissolved in a mixture of CH2Cl2/TFA/H2O 
(3:1:1 v/v/v, 1 ml). The reaction mixture was stirred at room temperature overnight. 
Subsequently toluene (5 ml) was added and the solvent was removed under reduced 
pressure. The residue was purified by preparative TLC (SiO2 [Analtech GF], CH2Cl2/MeOH 
5%) and analysed by LRESI-MS (MeOH): N-Piv-Ala-Leu-Phe-Gly-Gly-Cys(SH)-NHNH2 
m/z 563.25 [M+H]
+
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3.5.2 Synthetic Schemes 
3.5.2.1 Synthesis of Barriers 7, 8 and 9 
 
 
Scheme 3.12. Reaction conditions: a) iso-amyl nitrite, NaN3, AcOH, RT, 2 h, 45%;  
b) L-N-Fmoc-tyrosine, HOBt, EDCI∙HCl, THF/CHCl3 (2:1 v/v) 12 h, 60%; c) DMF/piperidine 
(4:1 v/v), RT, 3 h, 97%; d) 4-([trimethylsilyl]ethynyl)benzoic acid, HOBt, EDCI∙HCl, THF/CHCl3 
(2:1 v/v), RT, 12 h, 71%; e) L-N-Boc-leucine, EDCI∙HCl, DCC, DMAP, CH2Cl2, RT, 48 h, 42%; f) L-
N-Boc-phenylalanine, EDCI∙HCl, DCC, DMAP, CH2Cl2, RT, 48 h, 63%; g) L-N-Piv-alanine, 
EDCI∙HCl, DCC, DMAP, CH2Cl2, RT, 48 h, 56%. 
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3.5.2.2 Synthesis of Three-Barrier Alkyne 6 
 
 
Scheme 3.13. Reaction conditions: a) Tentagel TBTA, Cu(MeCN)4PF6, CH2Cl2/tBuOH (1:1 v/v), RT, 
48 h, then AgNO3, acetone/H2O (4:1 v/v), RT, 18 h, 43% over two steps; b) Tentagel TBTA, 
Cu(MeCN)4PF6, CH2Cl2/tBuOH (1:1 v/v), RT, 48 h, then AgNO3, acetone/H2O (4:1 v/v), RT, 18 h, 
37% over two steps. 
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3.5.2.3 Synthesis of Three-Barrier Rotaxane 18 
  
Scheme 3.14 Reaction conditions: a) Cu(MeCN)4PF6, CH2Cl2/tBuOH (4:1 v/v), RT, 7 d, 32%; b) 
aniline, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 72 h, 90%. 
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3.5.2.4 Synthesis of Reference Macrocycle 20 and 21 
 
Scheme 3.15. Reaction conditions: a) Fmoc-Gly-Gly-OH , DMF, PyBrop, DIPEA, RT, 12 h, 84%; b) 
DMF/piperidine (4:1 v/v), RT, 2 h, then Piv-Ala-Leu-Phe-OH, DIPEA, DMF, RT, 12 h, 88% over two 
steps; c) aniline, DMSO/MES (3:1 v/v, pH 6.0), 60 °C, 3 d, 75%; d) TIPS, CH2Cl2/TFA (4:1 v/v), RT, 
2 h, 99%; e) DMF/piperidine (4:1 v/v), RT, 2 h, then Piv-Ala-Phe-Leu-OH, DIPEA, DMF, RT, 12 h, 
70% over two steps; f) aniline, DMSO/MES (3:1 v/v, pH 6.0), 60 °C, 3 d, 75%; g) TIPS, CH2Cl2/TFA 
(4:1 v/v), RT, 2 h, 99%. 
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2.4.5 Synthetic Procedures and Characterisation Data  
4-(2-[4-Azidophenyl]propan-2-yl)aniline 12 
 
To a stirred solution of 4,4'-(propane-2,2-diyl)dianiline (1.48 g, 6.50 mmol, 1.00 equiv.) in 
acetic acid at 0 °C was added dropwise iso-amyl nitrite (674 mg, 6.50 mmol, 1.00 equiv.). 
The reaction mixture was allowed to warm to room temperature and after 30 min NaN3 (850 
mg, 13.0 mmol, 2.00 equiv.) was added in small portions. Stirring was continued at room 
temperature for 2 h. The solvent was removed under reduced pressure and the residue was 
dissolved in CH2Cl2 (250 ml). The organic layer was washed with aqueous saturated Na2CO3 
(200 ml), brine (50 ml), dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. Flash column chromatography (SiO2, petroleum ether/EtOAc 7:3) of the 
residue afforded 12 (735 mg, 45%) as a pale yellow solid.  
m.p. 47 °C;
 1
H NMR (400 MHz, CDCl3) δ = 7.23 (d, J = 8.7 Hz, 2H, Hf), 7.00 (d, J = 8.6 Hz, 
2H, Hc), 6.92 (d, J = 8.7 Hz, 2H, He), 6.61 (d, J = 8.6 Hz, 2H, Hb), 3.58 (s, 2H, Ha), 1.63 (s, 
6H, Hd); 
13
C NMR (100 MHz, CDCl3) δ = 148.4, 144.3, 140.7, 137.3, 128.4, 127.8, 118.7, 





, 253.1448 calc. for C15H17N4. 
  
 





To a stirred solution of L-N-Fmoc-tyrosine (1.10 g, 2.74 mmol, 1.00 equiv.), HOBt·H2O 
(443 mg, 2.89 mmol, 1.05 equiv.) and EDCI∙HCl (554 mg, 2.89 mmol, 1.05 equiv.) in 
THF/CHCl3 (2:1 v/v, 15 ml) at room temperature was added amine 12 (730 mg, 2.89 mmol, 
1.05 equiv.) in THF/CHCl3 (2:1 v/v, 6 ml) dropwise. The reaction mixture was stirred at 
room temperature for 12 h. The solvent was removed under reduced pressure. The residue 
dissolved in CH2Cl2 (250 ml). The organic layer was washed with H2O (200 ml), dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure. Flash column 
chromatography (SiO2, petroleum ether/EtOAc 7:3) of the residue afforded 15 (1.06 g, 60%) 
as a pale yellow solid.  
m.p. 114–116 °C; []D = 13.6° (c 1.02, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ = 7.99 (s, 1H, 
Hm), 7.72 (d, J = 7.6 Hz, 2H, Ha), 7.49 (t, J = 7.9 Hz, 2H, Hc), 7.35 (t, J = 7.5 Hz, 2H, Hb), 
7.29 – 7.19 (m, 4H, Hd+r), 7.13 (d, J = 8.6 Hz, 2H, Hn), 7.05 (d, J = 8.3 Hz, 2H, Hq), 7.03 – 
6.96 (m, 2H, Hj), 6.88 (d, J = 8.6 Hz, 2Ho), 6.66 (d, J = 8.3 Hz, 2H, Hk), 6.00 – 5.94 (m, 1H, 
Hl), 5.80 – 5.70 (m, 1H, Hg), 4.57 – 4.46 (m, 1H, Hh), 4.42 – 4.25 (m, 2H, Hf), 4.14 (t, J = 7.0 
Hz, 1H, He), 3.06 – 2.97 (m, 2H, Hi), 1.58 (s, 6H, Hp); 
13
C NMR (100 MHz, CDCl3) 
δ = 169.6, 156.5, 155.1, 147.5, 147.0, 143.7, 143.6, 141.4, 137.5, 134.8, 130.6, 129.2, 128.3, 
127.9, 127.3, 127.3, 125.1, 120.2, 118.7, 115.8, 67.5, 57.3, 47.1, 42.4, 38.1, 30.8; 
LRAPCI(+)-MS (CH2Cl2): m/z 637.7 [M+H]
+
; HRFT(+)-MS: m/z 638.2757 [M+H]
+
, 
638.2762 calc. for C39H36N5O4. 
  
 




Fmoc-derivative 15 (1.04 g, 1.64 mmol, 1.00 equiv.) was dissolved in DMF/piperidine 
(4:1 v/v, 20 ml) and the reaction mixture was stirred at room temperature for 3 h. The solvent 
was removed under reduced pressure. Flash column chromatography (SiO2, CH2Cl2/MeOH 
5%) of the residue afforded E2 (665 mg, 97%) as a pale yellow solid. 
 m.p. 102 °C; 
1
H NMR (400 MHz, CDCl3) δ = 9.35 (s, 1H, Hg), 7.48 (d, J = 8.6 Hz, 2H, Hl), 
7.23 – 7.13 (m, 4H, Hh+k), 7.10 (d, J = 8.4 Hz, 2H, Hd), 6.92 (d, J = 8.6 Hz, 2H, Hi), 6.80 (d, 
J = 8.4 Hz, 2H, He), 3.68 (dd, J = 9.2 Hz, 4.0 Hz, 1H, Hb), 3.24 (dd, J = 14.0 Hz, 4.0 Hz, 1H, 
Hc), 2.73 (dd, J = 13.9 Hz, 9.2 Hz, 1H, Hc’), 1.65 (s, 6H, Hj); 
13
C NMR (100 MHz, CDCl3) δ 
= 172.7, 154. 9, 147.7, 146.4, 137.5, 135.4, 130.6, 129.5, 128.3, 127.4, 119.5, 118.7, 115.8, 
57.0, 42.5, 39.9, 30.9; LRESI(+)-MS (MeOH): m/z 416.2 [M+H]
+
; HRFT(+)-MS: m/z 
416.2081 [M+H]
+
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TMS-Ethynyl-Tyrosine-Azide Derivative 11 
 
To a solution of amine E2 (630 mg, 1.50 mmol, 1.00 equiv.), 
4-([trimethylsilyl]ethynyl)benzoic acid (397 mg, 1.81 mmol) and EDCI∙HCl (349 mg, 
1.81 mmol, 1.20 equiv.) in THF/CHCl3 (2:1 v/v, 20 ml) was added HOBt·H2O (279 mg, 
1.81 mmol, 1.20 equiv.) and the reaction mixture was stirred at room temperature for 12 h. 
The solvent was removed under reduced pressure and the residue was dissolved in CH2Cl2 
(250 ml). The organic layer was washed with H2O (150 ml), dried over Na2SO4, filtered, and 
the solvent was removed under reduced pressure. Flash column chromatography (SiO2, 
petroleum ether/EtOAc 7:3) of the residue afforded 11 (666 mg, 71%) as a pale yellow solid.  
m.p. 132–134 °C; []D = 13.6 (c 1.03, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ = 8.48 (s, 1H, 
Hj), 7.67 (d, J = 8.5 Hz, 2H, Hb), 7.45 (d, J = 8.3 Hz, 2H, Hc), 7.34 – 7.26 (m, 3H, Hd+o), 7.15 
(d, J = 8.6 Hz, 2H, Hk), 7.12 – 7.03 (m, 4H, Hg+n), 6.89 (d, J = 8.6 Hz, 2H, Hl), 6.68 (d, 
J = 8.5 Hz, 2H, Hh+i), 5.04 (q, J = 7.2 Hz, 1H, He), 3.17 (br d, J = 6.3 Hz, 2H, Hf), 1.60 (s, 
6H, Hm), 0.26 (s, 9H, Ha); 
13
C NMR (100 MHz, CDCl3) δ = 169.7, 167.2, 155.2, 147.5, 
147.0, 137.5, 135.0, 132.9, 132.3, 130.7, 128.3 128.0, 127.3, 127.2, 120.2, 118.8, 115.9, 
110.1, 104.0, 97.7, 56.2, 42.5, 38.1, 30.8, 0.0; LRESI(+)-MS (MeOH): m/z 638.3 [M+Na]
+
; 
HRFT(+)-MS: m/z 616.2738 [M+H]
+
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TMS-Ethynyl-N-Boc-Phenylalanine-Azide Barrier 7 
 
Phenol 11 (500 mg, 0.81 mmol, 1.00 equiv.), L-N-Boc-phenylalanine (430 mg, 1.62 mmol, 
2.00 equiv.), EDCI∙HCl (171 mg, 0.90 mmol, 1.11 equiv.), DCC (184 mg, 0.90 mmol, 
1.11 equiv.) and DMAP (9 mg, 0.08 mmol, 0.10 equiv.) were stirred in CH2Cl2 (10 ml) at 
room temperature for 24 h. The solvent was removed under reduced pressure. Flash column 
chromatography (SiO2, petroleum ether/EtOAc 6:4) of the residue afforded 7 (300 mg, 42%) 
as a pale yellow solid.  
m.p. 92-95 °C; [α]D = +0.01° (c 4.10, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δ = 8.22 (s, 1H, 
Ho), 7.65 (d, J = 8.4 Hz, 2H, Hb), 7.47 (d, J = 8.4 Hz, 2H, Hc), 7.33 – 7.24 (m, 7H, Ht+p+k+m), 
7.22 (d, J = 6.8, 2H, Hm), 7.19 – 7.15 (m, 2H, Hg), 7.17 – 7.10 (m, 3H, Hd+s), 6.93 – 6.88 (m, 
4H, Hh+q), 5.09 (d, J = 8.0, 1H, Hn), 5.02 (q, J = 7.3, 1H, He), 4.83 – 4.73 (m, 1H, Hi), 
3.31 - 3.17 (m, 4H, Hf+j), 1.62 (s, 6H, Hr), 1.43 (s, 9H, Ho), 0.29 – 0.24 (m, 9H, Ha);
 
13
C NMR (125 MHz, CDCl3) δ = 170.8, 169.1, 167.1, 157.0, 155.4, 149.7, 147.6, 147.0, 
137.6, 135.9, 135.1, 134.6, 133.1, 132.4, 130.7, 129.7, 128.9, 128.4, 127.5, 127.4, 127.2, 
121.9, 120.2, 118.8, 104.1, 97.7, 80.4, 55.9, 42.6, 38.5, 38.0, 34.0, 30.9, 28.5, -0.1; 
LRESI(+)-MS (MeOH): m/z 863.6 [M+H]
+
; HRFT(+)-MS: m/z 863.3931 [M+H]
+
, 863.3946 
calc. for C50H55N6O6Si. 
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TMS-Ethynyl-N-Boc-Leucine-Azide Barrier 8 
 
 
Phenol 11 (400 mg, 0.64 mmol, 1.00 equiv.), L-N-Boc-leucine (300 mg, 1.30 mmol, 
2.00 equiv.), EDCI∙HCl (124 mg, 0.64 mmol, 1.00 equiv.), DCC (134 mg, 0.64 mmol, 
1.00 equiv.), and DMAP (16 mg, 0.12 mmol, 0.19 equiv.) were stirred in CH2Cl2 (4 ml) at 
room temperature for 24 h. The reaction mixture was diluted with CH2Cl2 (8 ml). The 
organic layer was washed with H2O (150 ml), dried over Na2SO4, filtered, and the solvent 
was removed under reduced pressure. Flash column chromatography (SiO2, 
petroleum ether/EtOAc 6:4) of the residue afforded 8 (424 mg, 63%) as a pale yellow solid.  
m.p. 111 °C; [α]D = +0.05° (c 0.50, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δ = 7.91 (s, 1H, 
Ho), 7.69 (d, J = 8.3, 2H, Hb), 7.53 (d, J = 8.4, 2H, Hc), 7.34 (d, J = 8.4, 2H, Ht), 7.32 – 7.28 
(m, 2H, Hp), 7.20 (d, J = 8.6, 2H, Hg), 7.14 (d, J = 8.6, 2H, Hq), 7.07 (d, J = 8.2, 2H, Hs), 
7.02 – 6.98 (m, 1H, Hd), 6.94 (d, J = 8.6, 2H, Hh), 5.00 – 4.90 (m, 2H, He+m), 4.54 (s, 1H, 
Hi), 3.33 (dd, J = 13.8, 6.0, 1H, Hj), 3.24 (dd, J = 13.8, 8.2, 1H, Hj’), 1.90 – 1.76 (m, 2H, Hj), 
1.73 – 1.60 (m, 7H, Hr+k), 1.48 (s, 9H, Hn), 1.04 (d, J = 6.3, 6H, Hl), 0.26 (s, 9H, Ha); 
13
C NMR (125 MHz, CDCl3) δ = 172.3, 168.8, 167.0, 155.6, 149.9, 147.6, 147.0, 137.6, 
134.9, 134.4, 133.0, 132.3, 130.6, 128.3, 127.4, 127.2, 127.1, 122.0, 120.2, 118.8, 104.0, 
97.7, 80.3, 55.9, 52.5, 41.7, 42.5, 37.9, 30.9, 28.5, 23.1, 0.0; LRESI(+)-MS (MeOH): 
m/z 852.42 [M+Na]
+
; HRFT(+)-MS: m/z 529.4103 [M+H]
+
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Ethynyl-N-Piv-Alanine-N-Pivaloyl Barrier 9 
 
Phenol 16 (300 mg, 0.50 mmol, 1.00 equiv.), L-N-piv-alanine (173 mg, 1.00 mmol, 
2.00 equiv.), EDCI∙HCl (96 mg, 0.50 mmol, 1.00 equiv.), DCC (103 mg, 0.50 mmol, 
1.00 equiv.) and DMAP (12 mg, 0.10 mmol, 0.20 equiv.) were allowed to stir in CH2Cl2 
(3 ml) at room temperature for 48 h. The solvent was removed under reduced pressure. Flash 
column chromatography (SiO2, petroleum ether/EtOAc 6:4) of the residue afforded 9 
(328 mg, 56%) as a colourless solid.  
Please Note: The title compound is a 1:1 mixture of two diastereoisomers. m.p. 104 °C; 
[α]D = +0.0° (c 0.60, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δ = 8.82 – 8.74 (m, 1H, Hs), 7.68 
(d, J = 8.4, 2H, Hc), 7.56 – 7.50 (m, 1H, Hd), 7.46 (d, J = 8.4 Hz, 2H, Hb), 7.41 (d, 
J = 8.8 Hz, 2H, Hg), 7.31 – 7.27 (m, 2H, Hn), 7.20 – 7.16 (m, 2H, Hq), 7.15 – 7.08 (m, 4H, 
Ho+h), 6.92 – 6.88 (m, 2H, Hh), 6.27 – 6.22 (m, 1H, Hk), 5.17 – 5.08 (m, 1H, He), 4.76 – 4.68 
(m, 1H, Hi), 3.24 – 3.15 (m, 3H, Ha+f), 1.60 (s, 6H, Hp), 1.51 (d, J = 7.2 Hz, 3H, Hj), 1.29 (s, 
9H, Hl), 1.21 (s, 9H, Ht); 
13
C NMR (125 MHz, CDCl3) δ = 178.3, 176.7, 172.0, 169.3, 166.8, 
149.4, 147.1, 146.4, 135.7, 135.7, 134.9, 134.4, 134.4, 133.3, 132.3, 130.5, 130.4, 127.3, 
127.2, 127.2, 125.9, 121.5, 119.9, 119.9, 82.7, 79.9, 55.7, 48.2, 42.3, 39.5, 38.6, 38.0, 30.8, 
27.6, 27.4, 18.2. LRESI(+)-MS (MeOH): m/z 779.90 [M+Na]
+
; HRFT(+)-MS: m/z 757.3964 
[M+H]
+
, 757.3959 calc. for C46H53N4O6. 
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Ethynyl- N-Boc-Leucine-N-Piv-Alanine-N-Pivaloyl Barrier 17 
 
Tentagel TBTA (750 mg) resin was loaded with Cu(MeCN)4PF6 (0.12 mmol/g, 0.20 equiv.) 
in CH2Cl2 and washed with Et2O. After drying, the resin was swollen in degassed CH2Cl2 
(2 ml) for 30 min. A degassed solution of 8 (365 mg, 0.44 mmol, 1.00 equiv.) and 9 
(333 mg, 0.44 mmol, 1.00 equiv.) in a mixture of CH2Cl2/tBuOH (1:1 v/v, 7 ml) was added 
and the reaction mixture was shaken at room temperature for 48 h, then filtered and the resin 
was washed with a mixture of CH2Cl2/MeOH (2:1 v/v, 6 ml). The combined organic filtrates 
were washed with aqueous 0.01M Na4EDTA (2 × 20 ml), dried over Na2SO4, filtered, and 
the solvent was removed under reduced pressure. The residue was dissolved in acetone 
(150 ml) and a solution of AgNO3 (85 mg, 0.50 mmol, 1.14 equiv.) in a mixture of 
acetone/H2O (4:1 v/v, 60 ml) was added. The mixture was stirred in the dark at room 
temperature for 18 h. The reaction mixture was diluted with CH2Cl2 (200 ml). The organic 
layer was washed with aqueous 1M NaCN (100 ml) and H2O (2 × 200ml), dried over 
Na2SO4, filtered, and the solvent was removed under reduced pressure. Preparative TLC 
(SiO2 [Analtech GF], CH2Cl2/MeOH 2%) of the residue afforded 17 (296 mg, 43%) as a pale 
yellow film.  
1
H NMR (500 MHz, acetone-d6) δ = 9.48 (bs, 1H, Ho), 9.43 (bs, 1H, Hag), 9.03 (bs, 1H, Hu), 
8.52 (bs, 1H, Ham), 8.08 (d, J = 8.1 Hz, 1H, Hd), 8.04 (d, J = 8.4 Hz, 3H, Hv+x), 7.98 (d, 
J = 8.4 Hz, 2H, Hw), 7.88 (d, J = 8.4 Hz, 2H, Hc), 7.86 (d, J = 8.6 Hz, 2H, Ht), 7.61 - 7.56 (m, 
4H, Hp+al), 7.56 - 7.52 (m, 4H, Hb+ai), 7.49 (d, J = 8.4 Hz, 2H, Hs), 7.24 7.41 (bd, J = 8.2 Hz, 
4H, Hg+z), 7.25-7.19 (m, 3H, Hq+ad), 7.17 (d, J = 8.6 Hz, 2H, Hai); 7.14 (d, J = 8.7 Hz, 2H, 
Hak); 7.03 (bd, 4H, Hh+aa), 6.44 (d, J = 8.1 Hz, 1H, Hm), 5.05-4.99 (m, 2H, He+af), 4.54 (p, 
J = 7.2 Hz, 1H, Hab), 4.36 (td, J = 9.1 Hz, 5.6 Hz, 1H, Hi), 3.82 (s, 1H, Ha), 3.38-3.34 (m, 
2H, Hf+y), 3.23-3.18 (m, 2H, Hf’+y’), 1.91-1.81 (m, 1H, Hk), 1.80-1.74 (m, 2H, Hj), 1.73 (s, 
6H, Hr), 1.63 (s, 6H, Hai), 1.48 (d, J = 7.3 Hz, 3H, Hac), 1.40 (s, 9H, Hn), 1.27 (s, 9H, Ham), 
1.17 (s, 9H, Hae A32), 0.97 (t, J = 6.7 Hz, 6H, Hl); 
13
C NMR (125 MHz, acetone-d6) 
δ = 178.6, 176.9, 172.7, 172.4, 170.4, 170.4, 167.2, 166.8, 156.7, 152.6, 150.8, 50.7, 147.8, 
147.1, 146.4, 146.2, 138.1, 137.7, 137.3, 136.3, 136.3, 135.8, 135.3, 134.7, 134.6, 132.7, 
131.2, 131.2, 129.0, 129.0, 128.5, 127.9, 127.8, 127.5, 126.18 2, 126.1, 122.3, 120.7, 120.4, 
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120.4, 120.3, 120.2, 83.5, 81.4, 79.4, 56.0, 53.4, 49.5, 43.3, 42.8, 41.0, 40.1, 38.9, 37.9, 31.1, 
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Ethynyl- N-Boc-Phenylalanine-N-Boc-Leucine-N-Piv-Alanine-N-Pivaloyl Barrier 6 
 
Tentagel TBTA (750 mg) resin was loaded with Cu(MeCN)4PF6 (0.12 mmol/g, 0.28 equiv.) 
in CH2Cl2 and washed with Et2O. After drying, the resin was swollen in degassed CH2Cl2 
(5 ml) for 30 min. A degassed solution of 7 (282 mg, 0.32 mmol, 1.00 equiv.) and 17 
(494 mg, 0.32 mmol, 1.00 equiv.) in a mixture of CH2Cl2/tBuOH (1:1 v/v, 7 ml) was added. 
The mixture was shaken at room temperature for 48 h, filtered, and the resin was washed 
with a mixture of CH2Cl2/MeOH (2:1 v/v, 6 ml). The combined organic filtrates were washed 
with aqueous 0.01M Na4EDTA (2 × 20 ml), dried over Na2SO4, filtered, and the solvent was 
removed under reduced pressure. The residue was dissolved in acetone (150 ml) and a 
solution of Ag(I)NO3 (66 mg, 0.39 mmol, 1.20 equiv.) in a mixture of acetone/H2O (4:1 v/v, 
60 ml) was added. The reaction mixture was stirred in the dark at room temperature for 18 h. 
The reaction mixture was diluted with CH2Cl2 (200 ml) and the organic layer was washed 
with aqueous 1M NaCN (100 ml) and H2O (2 × 200ml), dried over Na2SO4, filtered, and the 
solvent was removed under reduced pressure. Preparative TLC (SiO2 [Merck], 
CH2Cl2/MeOH 2%) of the residue afforded 6 (280 mg, 37%) as pale yellow film.  
1
H NMR (500 MHz, acetone-d6) δ = 9.53 (bs, 1H, Haj), 9.49 (bs, 1H, Hp), 9.45 (bs, 1H, 
Haab), 9.04 (s, 2H, Haah+ap), 8.55 (s, 1H, Haz), 8.12 (bs, 1H, Has), 8.10 (bs, 1H, Hd), 8.09 (bs, 
1H, Hy), 8.05 (d, J = 8.0 Hz, 4H, Hw+aq), 8.00 (d, J = 8.0 Hz, 2H, Hx), 7.99 (d, J = 8.0 Hz, 
2H, Har), 7.89 (d, J = 8.3 Hz, 2H, Hb), 7.87 (d, J = 8.5 Hz, 4H, Hu+ao), 7.67  7.55 (m, 4H, 
Hq+ak), 7.56  7.51 (m, 6H, Haac+aag+c), 7.50 (d, J = 8.3 Hz, 4H, Ht+an), 7.45 (d, J = 8.3 Hz 2H, 
Hg), 7.43  7.36 (m, 4H, Hab+av), 7.36  7.32 (m, 4H, Hk+l), 7.32  7.20 (m, 6H, Hr+m+al), 7.18 
(d, J = 8.1 Hz, 2H, Haad), 7.16 (d, J = 8.6 Hz, 2H, Haaf), 7.06 (d, J = 8.6 Hz, 2H, Hh), 7.04 (d, 
J = 8.5 Hz, 2H, Hac), 6.97 (d, J = 8.3 Hz, 2H, Haw), 6.90 (d, J = 8.4, 1H, Hah), 6.66 (d, 
J = 8.5, 1H, Hah), 5.10  5.02 (m, 3H, He+z+at), 4.62  4.51 (m, 2H, Hi+ax), 4.42  4.33 (m, 
1H, Had), 3.84 (s, 1H, Ha), 3.36  3.22 (m, 8H, Hf+j+aa+au), 1.89  1.82 (m, 1H, Haf), 
1.80 - 1.75 (m, 2H, Hae), 1.74 (s, 12H, Hs+am), 1.64 (s, 6H, Haae), 1.50 (d, J = 7.3 Hz, 3H, 
Hay), 1.41 (s, 9H, Ho or ai), 1.38 (s, 9H, Ho or ai), 1.27 (s, 9H, Haai), 1.19 (s, 9H, Haaa), 0.99 (t, 
J = 6.6 Hz, 6H, Hag); 
13
C NMR (125 MHz, acetone-d6) δ = 177.7, 176.1, 171.8, 171.5, 170.7, 
169.7, 169.6, 169.6, 166.4, 166.3, 166.0, 155.8, 155.5, 151.7, 149.8, 149.8, 149.7, 146.9, 
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146.2, 145.5, 145.4, 137.2, 137.2, 136.4, 135.6, 135.4, 135.4, 134.9, 134.4, 133.8, 133.8, 
133.7, 133.6, 133.6, 131.8, 130.4, 130.3, 129.4, 128.4, 128.1, 128.1, 127.6, 127.0, 126.9, 
126.7, 125.3, 121.4, 119.8, 119.6, 119.5, 119.3, 82.6, 80.5, 78.7, 78.5, 56.0, 55.9, 55.6, 52.6, 
48.6, 42.4, 41.9, 40.1, 39.2, 38.0, 37.2, 37.0, 37.0, 30.2, 30.1, 27.7, 27.6, 26.9, 26.8, 24.7, 
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Macrocycle 5 (89 mg, 0.16 mmol, 5.00 equiv.) and Cu(MeCN)4PF6 (5.9 mg, 16 µmol, 0.5 
equiv.) were stirred in degassed CH2Cl2 (4 ml) at room temperature for 30 minutes. Then, a 
solution of alkyne 6 (73 mg, 0.032 mmol, 1.00 equiv.) and azide 4 (37 mg, 0.063 mmol, 2.00 
equiv.) in degassed CH2Cl2/tBuOH (4:1 v/v, 38 ml) was added. The reaction mixture was 
stirred at room temperature for 7 d. The reaction mixture was diluted with CH2Cl2 
(20 ml).The organic layer was washed with 0.1M Na4EDTA (20 ml) and the aqueous layer 
was extracted with CH2Cl2 (3 × 20 ml). The combined organic layers were dried over 
Na2SO4, filtered, and the solvent was removed under reduced pressure. Preparative TLC 
(SiO2 [Merck], CH2Cl2/MeOH 2%) of the residue afforded 3 (35 mg, 32%) as a colourless 
solid.  
1
H NMR (500 MHz, acetone-d6) δ = 9.96 (s, 1H, HA); 9.54 (s, 1H, Har), 9.49 (s, 1H, Hx), 
9.47 (s, 1H, Haaj); 9.02 (s, 2H, Had+ax); 8.54 (s, 1H, Haap); 8.11 (bs, 3H, Haaa+l+ag); 8.04 (d, 
J = 7.7 Hz, 4H, Haf +az), 8.00 (d, J = 7.4 Hz, 4H, Hae+ay), 7.94  7.88 (m, 2H, Hj), 7.86 (d, 
J = 8.4 Hz, 4H, Hac+aw), 7.62 (d, J = 9.1 Hz, 2H, Has); 7.60 (d, J = 9.1 Hz, 4H, Hy+aak), 
7.61 - 7.53 (m, 7H, Haao+i+k+B), 7.49 (d, J = 7.7 Hz, 4H, Hab+av), 7.54  7.38 (m, 
7H,Ho+aj+aad+N), 7.35  7.30 (m, 3H, Hs+t), 7.34  7.28 (m, 6H, Hb); 7.24 (bd, 7H, Hz+at+r+aah), 
7.18 (d, J = 9.2 Hz, 3H, Haan+C), 7.15 (d, J = 9.2 Hz, 2H, Haal), 7.12 (m, 6H, Hc); 7.06 (d, 
J = 9.0 Hz, 2H, Hp), 7.04 (d, J = 9.0 Hz, 3H, Hak+M), 6.98 (d, J = 8.1 Hz, 2H, Haae), 
6.99 - 6.93 (m, 2H, Hd); 6.77 (d, J = 8.4 Hz, 4H, HH); 6.53  6.47 (m, 8H, Hv+ap+e+I); 5.07 
(bs, 3H, Hm+ah+aab); 4.61  4.51(m, 2H, Hu+aaf); 4.41  4.34 (m, 1H, Hal); 4.10  4.03 (m, 2H, 
Hf); 3.82  3.76 (m, 4H, HG); 3.53  3.46 (m, 2H, Hh); 3.42  3.36 (m, 3H, Hn+ai+aac); 
3.27 - 3.18 (m, 5H, Hn’+ai’+aac’+q); 2.76  2.71 (m, 4H, HD); 2.65  2.58 (m, 4H, HL); 
2.55 - 2.49 (m, 4H, HJ); 1.91  1.84 (m, 6H, Han+K); 1.74  1.84 (m, 12H, Hg+am+E+F); 1.74 (s, 
12H, Haa+au); 1.64 (s, 6H, Haam); 1.49 (d, J = 7.3 Hz, 3H, Haag); 1.41 (s, 9H, Haq or w); 1.37 (s, 
9H, Haq or w); 1.31 (s, 27H, Ha); 1.28 (s, 9H, Haaq); 1.19 (s, 9H, Haai); 0.99 (dd, J = 5.9 Hz, 
12.6 Hz, 2H, Han), 6H, Hao); 
13
C NMR (125 MHz, acetone-d6) δ = 192.3, 177.8, 176.1, 
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171.8, 171.5, 170.7, 169.7, 169.7, 169.7, 166.4, 166.4, 166.4, 157.2, 155.9, 155.5, 151.7, 
149.9, 149.8, 149.6, 148.2, 146.9, 146.2, 146.0, 145.6, 145.4, 145.3, 144.4, 143.8, 137.2, 
137.2, 137.1, 136.8, 136.4, 135.5, 135.5, 135.4, 134.9, 134.7, 133.9, 133.8, 133.6, 133.6, 
133.6, 133.3, 132.9, 131.7, 130.5, 130.4, 130.3, 130.3, 129.4, 129.1, 129.1; 128.4, 128.1, 
127.9, 127.1, 127.0, 126.9, 126.7, 126.7, 125.3, 125.0, 124.2, 121.4, 119.8, 119.6, 119.5, 
119.5, 119.3, 114.1, 113.2, 78.7, 78.5, 67.1, 64.0, 63.0, 56.0, 55.9, 55.9, 55.6, 52.6, 48.6, 
46.7, 42.4, 41.9, 40.2, 39.2, 38.0, 37.2, 37.0, 37.0, 34.9, 34.0, 32.0, 31.7, 30.8, 30.2, 30.1, 
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N-Boc-Gly-Gly-Cys(STrt)-Acyl Hydrazone N-Boc-Phenylalanine-N-Boc-Leucine-N-
Piv-Alanine Three-Barrier Rotaxane 18 
 
A mixture of rotaxane 3 (30 mg, 7.5 µmol, 1.0 equiv.), 
p CH3OC6H4CH=NNH-Cys(STrt)-Gly-Gly-N-Boc 10 (8.0 mg, 11 µmol, 1.5 equiv.) and 
aniline (50 µl) in DMSO/2-(N-morpholino)ethanesulfonic acid buffer (3:1 v/v, 1 ml, pH 6.0) 
was stirred at 60 °C for 72 h. The reaction mixture was allowed to cool to room temperature 
and then diluted with CH2Cl2 (10 ml) and the organic layer was washed with H2O (10 ml). 
The organic layer was dried over Na2SO4, filtered, and the solvent removed under reduced 
pressure. Preparative TLC (SiO2 [UNIPLATE-T], CH2Cl2/MeOH 5%) of the residue 
afforded 18 (21 mg, 90%) as a colourless solid.  
1
H NMR (500 MHz, DMSO-d6) δ = 11.45 (s, 1H, HL), 10.33 – 10.12 (m, 3H, Hx+ar+aaj), 9.35 
(s, 2H, Had+ax), 9.14 (s, 1H, Haap), 8.83 (t, 1H, J = 7.04 Hz, HD), 8.80 – 8.70 (m, 2H, Hl+aah), 
8.41 (d, J = 8.4 Hz, 1H, HFmin), 8.32 (d, J = 8.4 Hz, 1H, HFmaj), 8.18 (s, 1H, HMmin), 8.17 (s, 
1H, HMmaj), 8.05 – 7.90 (m, 12H, Hi+ae+af+ay+az+ag+aaa), 7.85 (d, J = 8.3 Hz, 8H, Hp+ak+aae +k), 
7.81 – 7.75 (m, 2H, Hj), 7.60 – 7.42 (m, 15H, HZ+N+y+ac+as+aw+aak+aao), 7.37 – 7.07 (m, 36 , 
HK+J+I+z+ab+at+av+aal+aan+b+Y+O), 7.18 – 6.96 (m, 17H, Hc+o+aj+aad+r+s+t), 6.94 – 6.88 (m, 2H, 
Haad), 6.80 – 6.74 (m, 2H, Hd), 6.73 – 6.44 (m, 4H, HU), 6.40 – 6.33 (m, 4H, HT),6.26 (d, 
J = 9.0 Hz, 2H, He), 5.40 – 5.33 (m, 1H , HGmaj), 4.92 – 4.82 (m, 3H, Hm+ah+aab), 4.83 – 4.76 
(m, 1H , HGmin), 4.43 – 4.31 (m, 2H, Hu+aaf), 4.19 – 4.12 (m, 1H, Hal), 4.06 -3.96 (m, 2H, Hh), 
3.85 – 3.48 (m, 8H, HC+E+S+h), 3.22 – 2.93 (m, 10H, Hn+ai+aac+H+q), 2.49 – 2.31 (m, 12H, 
HX+V+P), 1.83 – 1.53 (m, 32H, Haa+au+aam+R+Q+W), 1.44 – 1.19 (m, 66H, Ha+A+w+aq+aaq+an+am), 
1.11 (s, 9H, Haai), 0.90 (dd, J = 14.9 Hz, 6.3 Hz, 6H, Hao); 
13
C NMR (125 MHz, DMSO-d6) 
δ = 178.2, 176.7, 172.4, 172.1, 171.5, 170.7, 169.2, 166.5, 161.5, 156.9, 156.3, 156.1, 156.0, 
156.0, 151.8, 149.6, 149.4, 148.1, 146. 9, 146.0, 146.0, 145.6, 145.2, 144.6, 144.6, 144.4, 
144.4, 143.2, 139.1, 137.7, 137.4, 137.1, 136.8, 136.3, 134.7, 133.8, 133.5, 131.5, 130.7, 
130.7, 130.4, 129.7, 129.5, 129.4, 129.3, 128.7, 128.7, 128.6, 128.6, 128.5, 128.5, 128.4, 
127.3, 127.2, 126.8, 125.4, 125.1, 124.8, 124.6, 121.6, 121.5, 120.9, 120.3, 120.3, 120.1, 
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119.7, 119.6, 119.5, 115.4, 114.4, 113.5, 79.0, 78.9, 78.5, 67.3, 66.5, 66.1, 64.1, 62.9, 56.2, 
56.0, 52. 7, 48.7, 46.8, 43.7, 42.7, 42.1, 38.3, 37.6, 37.0, 36.7, 35.0, 34.7, 34.5, 34.5, 32.0, 
31.6, 31.0, 30.8, 29.4, 28.7, 28.7, 28.6, 28.6, 28.1, 27.7, 27.7, 26.8, 24.8, 23.3, 21.7, 16.8, 
0.6. Please Note: MS analysis (LRESI, MALDI) was unsuccessful.  
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N-Piv-Ala-Leu-Phe-Gly-Gly-Cys(STrt)-Acyl Hydrazone Macrocycle E7 
 
 
A mixture of macrocycle 5 (10 mg, 18 µmol, 1.0 equiv.), 
p- CH3OC6H4CH=NNH-Cys(STrt)-Gly-Gly-Phe-Leu-Ala-N-Piv E6 (18 mg, 18 µmol, 
1.0 equiv.) and aniline (50 μl) in DMSO/2-(N-morpholino)ethanesulfonic acid buffer 
(3:1 v/v, 4 ml, pH 6.0) was stirred at 60 °C for 2 h. The reaction mixture was diluted with 
CH2Cl2 (20 ml) and the organic layer was washed with H2O (2 × 20 ml). The organic layer 
was dried over Na2SO4, filtered, and the solvent removed under reduced pressure. 
Preparative TLC (SiO2, CH2Cl2/MeOH 4%) of the residue afforded E7 (14 mg, 75%) as a 
colourless film. 
9:10 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. [α]D = -0.26° (c 0.30, MeOH); 
1
H NMR (400 MHz, DMSO-d6) δ = 11.47 (s, 1H, Ho1), 11.45 (s, 1H, Ho2), 8.41  8.19 (m, 
6H, Hw1+w2+y1+y2+ae1+ae2), 8.18 (s, 1H, Hn1), 8.05  8.00 (m, 2H, Hu1+u2), 7.94 (s, 1H, Hn2), 7.69 
 7.65 (m, 2H, Ham1+am2), 7.60  7.55 (m, 2H, Ha1+a2), 7.42  7.38 (m, 2H, Haj1+aj2), 
7.37 - 7.29 (m, 12H, Hm1+m2+ab1+ab2+ac1+ac2+ad1+ad2), 7.28  7.19 (m, 18H, Hr1+r2+t1+t2), 
7.18 - 7.09 (m, 8H, Hl1+l2+s1+s2), 7.07 (d, J = 7.5 Hz, 4H, Hb1+b2), 7.03 (d, J = 8.7 Hz, 4H, 
Hf1), 7.01 (d, J = 8.6 Hz, 4H, Hf2), 6.74 (d, J = 8.7 Hz, 4H, Hg1), 6.69 (d, J = 8.7 Hz, 4H, 
Hg2), 5.42  5.35 (m, 1H, Hp1), 4.54  4.43 (m, 3H, Hp2+z1+z2), 4.27  4.12 (m, 4H, 
Hak1+ak2+af1+af2), 3.90 (t, J = 5.8 Hz, 4H, Hv1+v2), 3.86  3.69 (m, 8H, Hh1+h2+x1+x2), 3.08  3.00 
(m, 2H, Haa1+aa2), 2.86 2.78 (m, 2H, Haa1’+aa2’), 2.70 (t, J = 7.3 Hz, 8H, Hk1+k2), 2.67  2.61 
(m, 8H, Hc1+c2), 2.48  2.41 (m, 8H, He1+e2), 2.40  2.28 (m, 4H, Hq1+q2), 1.96  1.87 (m, 8H, 
Hd1+d2), 1.76  1.68 (m, 8H, Hj1+j2), 1.67  1.60 (m, 10H, Hi1+i2+ah1+ah2), 1.52  1.43 (m, 4H, 
Hag1+ag2), 1.37  1.31 (m, 6H, Hal1+al2), 1.09 (s, 9H, Han1), 1.08 (s, 9H, Han2), 0.84  0.75 (m, 
12H, Hai); 
13
C NMR (100 MHz, DMSO-d6) δ 161.9, 158.2, 145.7, 145.6, 143.8, 143.7, 
138.5, 137.3, 135.2, 130.5, 130.4, 130.4, 130.3, 130.3, 130.2, 130.1, 129.7, 129.1, 129.1, 
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129.0, 128.8, 128.7, 127.6, 127.5, 127.2, 126.1, 120.9, 115.0, 115.0, 68.1, 68.1, 41.3, 41.3, 
37.9, 37.9, 35.7, 35.6, 35.1, 32.6, 30.6, 28.6, 27.8, 27.7, 27.0, 27.0, 21.4; Please Note: Due to 
the presence of two stereoisomers, some 
13
C-signals coincide. LRESI(+)-MS (MeOH): 
m/z 1451.2 [M+H]
+
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N-Piv-Ala-Leu-Phe-Gly-Gly-Cys(SH)-Acyl Hydrazone Macrocycle 20 
 
 
Hexapeptide macrocycle E7 (14 mg, 9.7 μmol, 1.0 equiv.) was dissolved in CH2Cl2/TFA 
(4:1 v/v, 2 ml). Triisopropylsilane (50 µl) was added and the mixture was stirred at room 
temperature for 48 h. The reaction mixture was diluted with toluene (5 ml) and the solvent 
was removed under reduced pressure. The residue was purified by triturating with Et2O 
(2 × 5 ml) to afford authentic reference sample 20 as colourless solid (11 mg, 99%). 
m.p. 117 – 120 °C; [α]D = -1.50° (c 0.05, MeOH);
1
H NMR (400 MHz, DMSO-d6) δ =11.50 
(m, 1H, Ho), 8.27 (m, 1H, Hu), 8.20 (m, 1H, Hs), 8.06 (m, 1H, Hs), 7.97 (m, 1H, Hw), 7.69 (m, 
2H, Hak+ac), 7.42 (m, 1H, Ha), 7.36 (m, 1H, Hah), 7.21 (m, 7H, Hm+z+aa+ab), 7.10 (m, 2H, Hb), 
7.03 (d, J = 8.5 Hz, 4H, Hf), 6.88 (bs, 1H, Hl), 6.75 (d, J = 8.4 Hz, 4H, Hg), 4.53 (m, 1H,Hp), 
4.47 (m, 1H, Hx), 4.26 (m, 1H, Hai), 4.21 (m, 1H, Had), 3.90 (m, 2H, Ht), 3.80 (m, 4H, Hh), 
3.75 (m, 2H, Hv), 3.06 (m, 2H, Hy), 2.68 (m, 8H, Hk+c), 2.38 (m, 2H, Hq), 1.95 (m, 4H, Hd), 
1.72 (m, 4H, Hj), 1.68 (m, 5H, Hl+af), 1.51 (m, 2H, Hae), 1.36 (m, 3H, Haj), 1.09 (s, 9H, Hal), 
0.82 (dd, J = 18.7 Hz,.5 Hz, 6H, Hag); 
13
C NMR (100 MHz, DMSO-d6) δ 177.2, 172.5, 
171.8, 171.5, 168.9, 156.8, 142.0, 141.7, 138.0, 130.1, 129.2, 128.1, 128.0, 128.0, 126.9, 
126.9, 126.7, 126.3, 126.3, 126.2, 114.2, 113.8, 99.5, 67.1, 55.1, 54.1, 53.9, 51.1, 50.8, 50.6, 
48.6, 48.2, 45.9, 42.2, 41.9, 40.9, 40.1, 37.9, 37.5, 37.3, 31.2, 28.0, 27.6, 27.3, 24.0, 22.8, 
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Rotaxane Elongation as a New Strategy for the 
Construction of Highly Complex Molecular Machines 
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4.1 Synopsis 
The ribosome can construct polypeptides with a length up to 10000 amino acid units. 
However, artificial ribosome mimics have been limited to three individual coupling events. 
In Chapter 4, the design, synthesis and operation of a molecular machine capable of 
assembling four individual amino acid units with complete sequence-specificity is described. 
A more versatile synthetic route based on the elongation of a preformed rotaxane structure 
was crucial to the success of the project and allows in principle the incorporation of a wide 
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4.2 Introduction 
In biological systems molecular machines are employed to perform a variety of complex 
tasks essential for the functioning of living organisms (protein and nucleic acid synthesis, 
carrying cargo within cells, muscle movements, performing propelling motion etc.).
1
 These 
highly complex molecular machines have been inspiring scientists for more than twenty 
years to create synthetic analogues in order to better understand the mechanisms behind their 
operation and to mimic their function in an efficient way.
2
  
Since then, various artificial small-molecule machines have been successfully prepared and 
utilised, amongst others, to do mechanical work
3 








 tracks but 
only randomly transform the functional groups within their confines. Small-molecule 
artificial molecular machines have been prepared making use of systems exhibiting axial 
chirality and isomerisable alkene moieties or allosteric regulation of organometallic 
catalysts.
7
 Large synthetic DNA molecules have been used to guide the formation of bonds 
between unnatural building blocks
8
 and assemble gold nanoparticles sequence-specifically
9
. 
In particular, mechanically interlocked systems offer great potential for the synthesis of 
complex molecular machines and therefore have been incorporated in a large number of 
molecular devices.
10
 In Chapter 3 a rotaxane-based molecular machine capable of 
performing three peptide forming reactions in a particular order was reported. This very 
simple synthetic mimic of a ribosome operates processively due to the mechanical bond 
between the macrocycle containing the catalyst and the axle containing the amino acids and 
synthesises a single peptidic product in a sequence-specific manner.
 
In order to explore the limitations of this machine design, the construction of a molecular 
machine with more than three monomeric units would be desirable. The ultimate target for a 
system capable of sequence-specific synthesis would be the incorporation of a polymeric 
thread. Therefore, the synthesis of a molecular machine which generates oligomers with a 
higher number of monomeric units should not only point the way towards the successful 
synthesis of increasingly complex molecular machines but also demonstrate the possibility to 
construct and operate machines with an even higher number of monomeric units. Since the 
synthesis with the previously employed active metal template approach for the late stage 
interlocking is impractical for larger systems, a new strategy towards the realisation of 
machines with longer threads is described.  
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4.2.1 Rotaxane Elongation as a Novel Synthetic Tool 
The key step in the assembly of either model rotaxane 1 reported in Chapter 2 or fully 
functional molecular machine 2 reported in Chapter 3 was the interlocking of the 
macrocycle, azide half-thread and an alkyne bearing the amino acyl residues to be assembled 
through an active-metal template synthesis (Figure 4.1).
11
 In case of single-barrier rotaxane 
1, the yield of this Cu(I)-catalysed azide-alkyne cycloaddition was 45% and complete 
conversion was achieved after two days. For three-barrier rotaxane 2 the best yield obtained 
was 30% after seven days of reaction time. Target rotaxane 3 featuring four amino acyl 
groups (Figure 4.2) would pose an even bigger challenge for an active metal template 
reaction. A lower yield and significantly longer reaction times are expected. Although the 
active metal template methodology usually provides interlocked structures in good to 
excellent yields
12
, in this case the complexity of the alkyne substrate, containing multiple 
functionalities and a large number of heteroatoms, would be the most likely reason for the 
diminished efficiency. Hydrolysis of the amino acyl functional groups in the presence of 
Lewis acidic copper(I)- and the inevitably formed copper(II)-ions due to trace amounts of 
oxygen in the reaction media during the long reaction time (probably greater than 7 days) are 
likely side-reactions. The active metal template reaction as the final interlocking step 
represents therefore a bottleneck for the synthesis of more complex molecular machines.  
To circumvent these problems, an approach involving the formation of a simpler rotaxane 
containing a single blocking group on the axle that could in principle be derivatised with 
threads of any length was envisioned (Figure 4.3).
13
 This preformed rotaxane elongation 
strategy would give access to a wide range of machines that could be utilised to obtain a 
variety of oligomeric products. Also, this approach would allow the incorporation of 
functional groups in the thread that are otherwise incompatible with the active metal 
template strategy such as strongly coordinating groups or polymeric substrates. Moreover, 
the formerly difficult separation of the desired rotaxane from the corresponding un-
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Figure 4.1 Key disconnection in the synthesis of molecular machines (A) single-barrier system 1 and 
(B) three-barrier system 2. 
 
Figure 4.2. Structure of molecular machine 3. 
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Figure 4.3. Two Strategies towards the synthesis of a four barrier molecular machine: the preformed 
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4.2.2 Retrosynthetic Analysis of the Four-Barrier Rotaxane 3 
The retrosynthesis of molecular machine 3 is depicted in Scheme 4.1. The incorporation of 
the reactive arm via a hydrazone exchange reaction in the last step has proven to be 
successful previously for molecular machines 1 and 2 and leaves therefore the corresponding 
four-barrier aldehyde rotaxane as starting compound. The aldehyde rotaxane can be 
disconnected into azide functionalised single-barrier rotaxane 4 featuring only an individual 
blocking group and alkyne thread 5. Single-barrier rotaxane 4 can be derived from an active 
metal template reaction of N-Boc-phenylalanine-loaded alkyne barrier 6, macrocycle 7 and a 
large access of alkyl-azide stopper 8.  
 
Scheme 4.1. Retrosynthetic analysis of molecular machine 3. 
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4.3 Results and Discussion 
4.3.1 Synthesis of Molecular Machine 11 
The synthesis of molecular machine 3 commenced with the synthesis of rotaxane 4 
(Scheme 4.2). The CuAAC active-metal synthesis of barrier 6, derived from its 
TMS-protected analogue 9 by an Ag(I)NO3-mediated TMS-deprotection, two equivalents of 
macrocycle 7 and ten equivalents of azide stopper 8 with Cu(I)(CH3CN)4PF6 as the copper 
source gave the desired rotaxane 4 in 40% yield. Gratifyingly the excess azide stopper 8 as 
well as non-interlocked macrocycle 7 could be regenerated after column chromatography. 
 
 
Scheme 4.2. Synthesis of the azide terminated single-barrier rotaxane 4. Reaction conditions: 
a) 8 (10 equiv.), 6 (2 equiv.), 7 (1 equiv.), Cu(CH3CN)4.PF6 (0.5 equiv.), CH2Cl2/tBuOH (3:1 v/v), RT, 
24 h, 40%. 
 
Subsequently rotaxane 4 was reacted with an alkyne-terminated molecular strand containing 
three amino acids in its structure (Scheme 4.3). The reaction proceeded smoothly allowing 
the isolation of aldehyde rotaxane 10 in 40% yield. Following the previously reported 
hydrazone exchange conditions, the reactive-arm based on the Cys-Gly-Gly unit was 
attached to the rotaxane giving access to 11 in good yield. 
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Scheme 4.3. Synthesis of 4-barrier molecular machine 11. Reaction Conditions: a) Tentagel 
TBTA/Cu(CH3CN)4∙PF6, CH2Cl2/tBuOH, RT, 48 h, 40%; b) aniline, 
N-Boc-Gly-Gly-Cys(STrt)NHN=CHC6H4OCH3, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 48 h, 
90%. 
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4.3.2 Operation of Molecular Machine 11 
 
Scheme 4.4. Operation of molecular machine 11. Reaction conditions: a) CH2Cl2/TFA (5:1 v/v), RT, 
2 h; b) DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), 60 °C μw, 24 h. 
 
Molecular machine 11 was operated under the previously established conditions (see Chapter 
2 and 3, Scheme 4.4). As in this case the operation involved the formation of four peptide 
bonds the reaction time was extended by additional 12 h (studies on the original system 
suggested that this is the approximate time required to form one peptide bond). Upon 
analysis of the reaction mixture it was confirmed that the operation reached completion at 
this point and that two main products were present in the post-operation mixture. One 
product was identified as the uninterlocked thread with four ‘free’ hydroxyl groups 12 (no 
amino acids attached), the other as a macrocycle that by TLC analysis corresponded to the 
expected operation product 13. 
 
157 Chapter IV 
Figure 4.4. The 12 possible operation products of molecular machine 3. 
Considering only intra-machine reactions, 12 products can be formed during the operation 
assuming that the machine does not proceed sequence-specifically (Figure 4.4).  
In such a highly complex system side reactions can prove detrimental for the function of the 
molecular machine, since the yield of the final oligomeric operation product decreases 
exponentially with the increasing number of individual coupling steps. Even a relatively high 
yielding coupling should therefore lead to considerable byproduct formation after four 
coupling steps if the transformation is not quantitative and sequence-selective.  
Since no rotaxane products have been found after preparative TLC and 
1
H-NMR analysis, 
the sequence of the isolated operation product is reduced to three possibilities (macrocycles 
shown in Figure 4.4). The identity of the operation product with the desired macrocycle 
carrying a Phe-Phe-Leu-Ala-Piv-peptide chain was confirmed by MS analysis which 
revealed the presence of expected ions in the spectrum (m/z 1355 [M+H]
+





, D being the S,N-acetal derivative of the operation product – probably 
formed during the ionisation required for the ESI mass spectrometric analysis and observed 
in previous studies as well). Tandem mass spectrometry was then used to determine the 
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sequence of the peptide attached to the macrocycle (as reported for the original system in 
Chapter 3). Comparison of the fragmentation pattern of the isolated product with the above 
mentioned authentic sample of the macrocycle carrying a heptapeptide with identical amino-
acid sequence confirmed that the operation product was obtained with complete sequence-
specificity (Figure 4.4). This result indicates that the molecular machine operates with a high 
degree of sequence integrity and side reactions are practically not observed. 
 
Figure 4.5. Tandem mass spectra of 2+ ions of S,N-acetal–derivatised macrocycles bearing the 
peptide sequences N-Piv-Ala-Leu-Phe-Phe-Gly-Gly-Cys(SH): (A) operation product (2+ ion isotope-
selected m/z 951.42), (B) reference compound prepared unambiguously by conventional peptide 
synthesis (2+ ion isotope-selected m/z 951.58). Fragment a1 is observed as a singly-charged ion 
adduct of the aldehyde macrocycle (m/z 562) or the corresponding methanol or hydrazone adduct 
(m/z 576).  
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4.4 Conclusion 
A novel approach towards complex molecular machines designed to perform synthesis of 
oligomers from monomeric building blocks was developed. The synthetic route involves 
preparation of a simple rotaxane, functionalised with a terminal azide moiety which can then 
in principle be extended by an alkyne-terminated thread of any given length and 
functionality. Having attached an alkyne that contains three amino acids derived building 
blocks successfully, a molecular machine for tetrapeptide synthesis was obtained. The 
operation of the machine using conditions established in our previous study yielded the 
desired product with complete sequence-specificity. These results open a new path for the 
development of complex systems intended to function as sophisticated molecular devices. 
The versatility of the synthetic approach and efficiency of machine’s operation constitute 
another big step towards creating even more elaborate systems acting as molecular factories 
for preparation of useful, functional materials in the future. 
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4.5 Experimental Section 
4.5.1 General Methods and Abbreviations 
Unless stated otherwise, all reagents and solvents were purchased from Aldrich Chemicals 
and used without further purification. Compound 8
15
 was prepared according to the literature 
procedure. Compounds E5 and E6 were prepared by Dr. Bartosz Lewandowski. Compound 
E2 was prepared by Dr. Bartosz Lewandowski. The syntheses of 1 and 7 are described in 
Chapter 2.
11a
 The syntheses of 2, 5, and 9 are described in Chapter 3.
 11b
 All reactions 
requiring microwave heating were carried out in a Biotage Initiator 2.5.3. Dry DMF, CH2Cl2, 
CHCl3 and THF was obtained by passing the solvent (HPLC grade) through an activated 
alumina column on a PureSolv™ solvent purification system (InnovativeTechnologies Inc., 
MA). Flash column chromatography was carried out using Geduran® Si 60 (particle size 40-
63 μm, Merck, Germany) as the stationary phase, and analytical TLC was performed on 
precoated silica gel plates (0.25 mm thickness, 60 F254, Merck, Germany) and observed 
under UV light or stained with a phosphomolybdic acid solution. Preparative TLC was 
performed on precoated silica gel plates (2 mm, UNIPLATE GF, Analtech Inc., DE or 2 
mm, Tapered plate, UNIPLATE-T, Analtech Inc., DE). NMR spectra were recorded on 
Bruker AV 400 MHz, Bruker AV 500 MHz (equipped with a cryoprobe) or Bruker Avance 
III (equipped with a cryoprobe) with an Oxford AS 600 MHz magnet. Chemical shifts are 
reported in parts per million (ppm) from high to low frequency and referenced to the residual 
solvent resonance. Coupling constants (J) are reported in hertz (Hz). Standard abbreviations 
indicating multiplicity were used as follows: s = singlet, d = doublet, t = triplet, q = quartet, 
quin = quintuplet, m = multiplet, br = broad. 
1
H-NMR assignments were made using 2D 
NMR methods (COSY, HSQC, HMBC). Melting points (m.p.) were determined using a 
Sanyo Gallenkamp apparatus and are reported uncorrected. Low resolution ESI mass 
spectrometry was performed with a Finnigan LCQ-MS mass spectrometer. High resolution 
ESI (electrospray ionisation) and APCI (atmospheric-pressure chemical ionisation) mass 
spectrometry was carried out by the mass spectrometry services at the EPSRC National Mass 
Spectrometry Service Centre, Swansea, UK or the Mass Spectrometry Service of the 
University of Manchester. Optical rotations were recorded using a Bellingham and Stanley 
ADP 220 Polarimeter using a 1 dm cell. 
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4.5.1.1 Operation of Molecular Machine 11 
Scheme 4.5. Operation of molecular machine. Reaction conditions: a) 1. CH2Cl2/TFA (5:1 v/v), RT, 
2 h, then DIPEA, TCEP·HCl, MeCN/DMF (3:1 v/v), µw, 60 °C, 48 h. 
Molecular machine 11 (17 mg, 3.5 µmol, 1.0 equiv.) was stirred at room temperature in a 
mixture of CH2Cl2/TFA (5:1 v/v, 2 ml) for 2 h. Toluene (5 ml) was added and the solvent 
removed under reduced pressure. The residue was then dissolved in degassed MeCN/DMF 
(3:1 v/v, 4 ml) and both N,N-diisopropylethylamine (43 µl, 250 µmol 71 equiv.) and 
tris(2-carboxyethyl)phosphine hydrochloride (2.0 mg, 7.1 µmol, 2.0 equiv.) were added and 
the reaction mixture was stirred under microwave heating at 60°C for 48 h. Preparative TLC 
(SiO2 [UNIPLATE-T], CH2Cl2/MeOH 5%) of the residue afforded 13 (2.5 mg, 53%) as a 
colorless film. 
2:3 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. 
1
H NMR (600 MHz, DMSO-d6) 
δ = 11.54 (s, J = 7.7 Hz, 2H, Ho1+o2), 8.47 – 8.00 (range of signals from different isomers, 
10H, Hs1+s2+u1+u2+w1+w2+ac1+ac2+ad1+ad2), 8.20 (s, 1H, Ho1), 7.97 (s, 1H, Ho2), 7.93 – 7.60 (m, 
4H, Ham1+am2+ap1+ap2), 7.32 – 7.11 (m, 26H, Ha1+a2+l1+l2+m1+m2+z1+z2+aa1+aa2 
+ab1+ab2+af1+af2+ag1+ag2+ah1+ah2), 7.06 (d, J = 7.3 Hz, 2H, Hb1+b2), 7.03 (dd, J = 8.4 Hz, 2.2 Hz, 
8H, Hf1+f2), 6.75 (dq, J = 8.1, 2.5 Hz, 8H, Hg1+g2), 4.65 – 4.39 (m, 6H, Hp1+p2+x1+x2+ad1+ad2), 
4.24 (m, 4H, Hai1+ai2+an1+an2), 3.89 (t, J = 5.8 Hz, 8H, Hh1+h2), 3.85 – 3.73 (m, 8H, Ht1+t2+v1+v2), 
3.12 - 2.98 (m, 8H, Hy1+y2+ae1+ae2), 2.83 - 2.73 (m, 8H, Hc1+c2), 2.69 – 2.61 (m, 8H, Hk1+k2), 
2.45 – 2.39 (m, 4H, Hq1+q2), 1.94 (p, J = 7.6 Hz, 8H, Hd1+d2), 1.75 – 1.63 (m, 16H, 
Hi1+i2+j1+j2), 1.51 – 1.45 (m, 2H, Hak1+ak2), 1.35 – 1.29 (m, 4H, Haj1+aj2), 1.17 (d, J = 7.2 Hz, 
3H, Hao1), 1.14 (d, J = 7.1 Hz, 3H, Hao2), 1.11 – 1.05 (m, 18H, Haq1+aq2), 0.82  0.70 (m, 12H, 
Hal1+al2).  
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4.5.2 Synthetic Schemes 
4.5.2.1 Synthesis of Single-Barrier Rotaxane 4 
 
Scheme 4.6. Reaction conditions: a) AgNO3, acetone/H20 (4:1 v/v), RT, 77%; b) 8 (10 equiv.), 
7 (2 equiv.), 6 (1 equiv.), Cu(CH3CN)4PF6, CH2Cl2/tBuOH (3:1 v/v), RT, 24 h, 37%. 
  
 
163 Chapter IV 
4.5.2.2 Synthesis of Rotaxane 11 
 
Scheme 4.7. Reaction conditions: a) Tentagel-TBTA/Cu(MeCN)4PF6, CH2Cl2/tBuOH (4:1 v/v), RT, 
4 d, 40%; b) aniline, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 48 h, 90%. 
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4.5.2.3 Synthesis of E6 
 
Scheme 4.8. Reaction conditions: a) H2SO4, EtOH, reflux, 24 h, 94%; b) PyBroP, DIPEA, DMF, RT, 





165 Chapter IV 
4.5.2.4 Synthesis of 13 
 
Scheme 4.9. Reaction conditions: a) aniline, DMSO/MES buffer (3:1 v/v, pH 6.0), 60 °C, 72 h, 56%; 
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4.5.3 Synthetic Procedures and Characterisation Data  
Ethynyl-N-Boc-Phenylalanine-Azide Barrier 6 
 
 
N-Boc-protected phenylalanine-loaded barrier 9 (480 mg, 0.56 mmol, 1.00 equiv.) was 
dissolved in acetone (120 ml) and a solution of AgNO3 (95.0 mg, 0.56 mmol, 1.00 equiv.) in 
H2O (4 ml) was added. The reaction mixture was stirred in the dark at room temperature for 
18 h. The reaction mixture was diluted with CH2Cl2 (200 ml). The organic layer was washed 
with aqueous 1M NaCl (100 ml) and H2O (2 × 200ml), dried over Na2SO4, filtered, and the 
solvent was removed under reduced pressure. Flash column chromatography (SiO2, 
CH2Cl2/MeOH 1.5%) of the residue afforded 6 (340 mg, 77%) as a colourless film. 
[α]D = -0.01° (c 2.20, CH2Cl2); 
1
H NMR (600 MHz, acetone-d6) δ = 9.43 (s, 1H, Hp), 8.06 (d, 
J = 8.0 Hz, 1H, Hd), 7.87 (d, J = 8.0 Hz, 2H, Hc), 7.55 (d, J = 8.1 Hz, 2H, Hb), 7.54 (d, 
J = 8.2 Hz, 2H, Hq), 7.38 (d, J = 8.1 Hz, 2H, Hg), 7.37 – 7.30 (m, 4H, Hk + l), 7.28 (d, 
J = 8.3 Hz, 2H, Ht), 7.24 (t, J = 7.2 Hz, 1H, Hm), 7.17 (d, J = 8.3 Hz, 2H, Hr), 6.99 (d, 
J = 8.3 Hz, 2H, Hu), 6.96 (d, J = 8.1 Hz, 2H, Hh), 6.43 (d, J = 7.9 Hz, 1H, Hn), 4.94 (q, 
J = 7.7 Hz, 1H, He), 4.57 (q, J = 7.6 Hz, 1H, Hi), 3.83 (s, 1H, Ha), 3.35 (dd, J = 14.0 Hz, 
5.7 Hz, 1H, Hf), 3.26 (dd, J = 13.9 Hz, 6.0 Hz, 1H, Hj), 3.18 (dd, J = 14.7, 8.7 Hz, 1H, Hf’), 
3.15 (dd, J = 14.7 Hz, 8.9 Hz, 1H, Hj’), 1.65 (s, 6H, Hs), 1.37 (s, 9H, Ho) ; 
13
C NMR (150 
MHz, acetone-d6) δ = 171.6, 170.3, 166.8, 156.3, 150.5, 148.7, 146.5, 138.1, 138.1, 137.5, 
137.4, 136.3, 135.3, 132.7, 131.1, 130.2, 129.3, 129.2, 128.5, 127.8, 127.6, 126.2, 122.2, 
120.2, 119.4, 83.5, 81.4, 79.6, 56.8, 56.8, 56.5, 38.1, 37.8, 31.0, 28.5 ; LRESI(-)-MS: m/z 
825.36 [M+Cl]
- 
; HRESI(+)-MS: 813.3372 [M+Na]
+
, 813.3377 calc. for C47H46O6N6Na. 
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Aldehyde N-Boc-Phenylalanine Single-Barrier Rotaxane 4 
 
 
Macrocycle 7 (135 mg, 0.24 mmol, 2.00 equiv.) and Cu(MeCN)4PF6 (22 mg, 60 µmol, 0.50 
equiv.) were allowed to stir in degassed CH2Cl2 (2 ml) at room temperature for 30 minutes. 
Then a solution of alkyne 6 (95 mg, 120 µmol, 1.0 equiv.) and azide 8 (706 mg, 1.2 mmol, 
10 equiv.) in degassed CH2Cl2/tBuOH (4:1 v/v, 5 ml) was added. The reaction mixture was 
stirred at room temperature for 40 hours. The reaction mixture was diluted with CH2Cl2 (50 
ml) and the organic layer was washed with aqueous 0.01M Na4EDTA (2 × 20 ml). The 
organic layer was dried over Na2SO4, filtered, and the solvent was removed under reduced 
pressure. Flash column chromatography (SiO2, CH2Cl2/MeOH 2%) of the residue allowed 
the recovery of the excess of the azide 1 and macrocycle 2. A combined fraction of rotaxane 
4 and the corresponding uninterlocked thread was purified on preparative TLC (SiO2 
[Merck], CH2Cl2/MeOH 2%) affording 4 (87 mg, 37%) as a colourless film.  
[α]D = -1.18° (c 0.06, acetone); 
1
H NMR (600 MHz, acetone-d6) δ = 9.97 (s, 1H, HA), 9.48 
(s, 1H, Hx), 8.04 (s, 1H, Hi), 8.01 (d, J = 8.2 Hz, 1H, Hl), 7.87 (d, J = 8.1 Hz, 2H, Hj), 7.83 
(d, J = 8.1 Hz, 2H, Hk), 7.63 – 7.53 (m, 6H, Hac+B+N), 7.42 (d, J = 8.0 Hz, 2H, Ho), 
7.37 - 7.29 (m, 13H, Hb+s+t+y+C), 7.25 (t, J = 7.2 Hz, 1H, Hu), 7.20 (d, J = 8.2 Hz, 2H, Hab), 
7.13 (d, J = 8.3 Hz, 6H, Hc), 7.05 (d, J = 7.7 Hz, 2H, HM), 7.01 (d, J = 8.4 Hz, 2H, Hz), 6.98 
(d, J = 8.1 Hz, 2H, Hp), 6.95 (d, J = 8.4 Hz, 2H, Hd), 6.78 (d, J = 7.9 Hz, 4H, HI), 6.48 (d, 
J = 8.6 Hz, 2H, He), 6.47 – 6.43 (m, 5H, HH+v), 5.02 (q, J = 7.2 Hz, 1H, Hm), 4.59 (q, 
J = 7.2 Hz, 1H, Hq), 4.08 (t, J = 7.1 Hz, 2H, Hh), 3.85 – 3.74 (m, 4H, HG), 3.49 (t, J = 6.0 Hz, 
2H, Hf), 3.36 (dd, J = 14.1 Hz, 6.2 Hz, 1H, Hn), 3.27 (dd, J = 13.8 Hz, 6.0 Hz, 1H, Hr), 
3.23 - 3.13 (m, 2H, Hn’+r’), 2.79 – 2.69 (m, 4H, HD), 2.66 – 2.59 (m, 4H, HL), 2.55 – 2.51 (m, 
4H, HJ), 1.93 – 1.84 (m, 6H, Hg+K), 1.84 – 1.78 (m, 4H, HE), 1.77 – 1.72 (m, 4H, HF), 1.67 
(s, 6H, Haa), 1.38 (s, 9H, Hw), 1.32 (s, 27H, Ha); 
13
C NMR (150 MHz, acetone-d6) δ = 193.2, 
171.6, 170.4, 167.2, 162.5, 158.0, 157.2, 156.3, 150.5, 149.1, 148.7, 146.9, 146.5, 145.3, 
144.7, 140.1, 138.1, 138.1, 137.9, 137.6, 137.6, 136.4, 135.6, 135.2, 134.2, 133.9, 132.6, 
 
168 Chapter IV 
131.4, 131.2, 130.2, 130.0, 129.3, 129.2, 128.7, 127.9, 127.8, 127.6, 125.9, 125.1, 122.2, 
122.2, 120.6, 120.2, 119.4, 115.0, 114.1, 79.5, 67.9, 64.8, 63.9, 56.8, 56.5, 47.5, 42.9, 38.4, 
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Aldehyde N-Boc-Penylalanine-N-Boc-Phenylalanine-N-Boc-Leucine-N-Piv-Alanine 
Four-Barrier Rotaxane 10 
Tentagel TBTA (500 mg) resin was loaded with Cu(MeCN)4PF6 (0.12 mmol/g, 0.28 equiv.) 
in CH2Cl2 and washed with Et2O. After drying, a degassed solution of rotaxane 4 (54 mg, 
28 µmol, 2.0 equiv.) and alkyne 5 (32 mg, 14 µmol, 1.0 equiv.) in CH2Cl2/tBuOH (4:1 v/v, 
5 ml) was added. The resulting suspension was shaken at room temperature for 4 d, filtered, 
and the resin was washed with a mixture of CH2Cl2/MeOH (2:1 v/v, 6 ml). The solvent was 
removed under reduced pressure. Preparative TLC (SiO2 [Merck], CH2Cl2/MeOH 3%, 
3 elutions) of the residue afforded 10 (24 mg, 40%) as a colourless film. 
1
H NMR (600 MHz, DMSO-d6) δ = 10.30 – 10.14 (m, 4H, Hx+as+aam+aaae), 9.87 (s, 1H, HA), 
9.35 (bs, 3H, Had+ay+aay), 9.13 (bs, 1H, Haaak), 8.87 – 8.81 (m, 2H, Hl+aab), 8.77 – 8.71 (m, 2H, 
Haav+ag), 8.16 (s, 1H, Hi), 8.01 (d, J = 8.4 Hz, 6H, Haf+aaa+aau), 7.96 (d, J = 8.1 Hz, 6H, 
Hae+az+aat), 7.93 (bs, 1H, Haaac), 7.84 (d, J = 8.3 Hz, 6H, Hac+ax+aar), 7.82 (d, J = 8.4 Hz, 2H, 
Haf), 7.74 (d, J = 8.0 Hz, 2H, Hj), 7.58 – 7.48 (m, 16H, Hy+aj+at+aae+aan+aay+aaaf+B), 7.48 – 7.41 
(m, 14H, Haak+aq+ab+aw+aaq+o+N), 7.33 (s, 1H, HC), 7.31 – 7.25 (m, 8H, Hs+an+t+ao), 7.24 – 7.18 
(m, 14H, Hb+aaag+aao+z+au), 7.17 – 7.13 (m, 2H, Har), 7.11 (d, J = 8.3 Hz, 2H, CHar), 
7.08 - 7.05 (m, 2H, Hu+ap), 7.03 – 6.95 (m, 8H, Hc, Har), 6.90 (t, J = 8.1 Hz, 2H, HM), 6.73 (d, 
J = 8.7 Hz, 2H, Hd), 6.70 (d, J = 7.5 Hz, 2H, HI), 6.65 (d, J = 8.5 Hz, 2H, Har), 6.35 (dd, J = 
8.5 Hz, 3.5 Hz, 4H, HH), 6.23 (d, J = 8.5 Hz, 2H, He), 4.91 – 4.82 (m, 3H, Haaw+aac+ah), 
4.82 - 4.73 (m, 1H, Hm), 4.42 – 4.28 (m, 2H, Haaaa+q), 4.22 – 4.04 (m, 2H, Haag+al), 3.98 (t, 
J = 7.1 Hz, 2H, Hf), 3.72 – 3.56 (m, 4H, HG), 3.51 (bs, 2H, Hh), 3.21 – 3.06 (m, 6H, 
Haax+aad+ai+n+r+am), 3.05 – 2.95 (m, 6H, Haax’+aad’+ai’+n’+r’+am’), 2.60 – 2.40 (m, 12H, HD+J+L), 
1.80 – 1.70 (m, 7H, Haai+g+K), 1.69 (bs, 18H, Haap+av+aa), 1.63 – 1.54 (m, 14H, Haaah+E+F), 
1.40 (d, J = 7.3 Hz, 3H,Haaad), 1.37 -1.32 (m, 27, Hw+ar+aal), 1.23 (bs, 27H, Ha), 1.20 (s, 9H, 
Haaad), 1.09 (s, 9H, Haaal), 0.92 – 0.84 (m, 6H, Haaj); 
13
C NMR (150 MHz, DMSO-d6) 
δ = 193.1, 177.8, 176.3, 174.4, 172.0, 171.7, 171.5, 171.0, 170.4, 170.3, 166.1, 165.9, 161.0, 
156.4, 155.8, 155.7, 155.6, 155.5, 151.3, 149.1, 149.0, 148.9, 147.7, 147.6, 146.4, 145.6, 
145.5, 145.5, 145.1, 144.7, 144.0, 143.3, 138.6, 137.3, 136.9, 136.7, 136.4, 135.9, 134.3, 
134.3, 133.5, 133.4, 133.3, 133.1, 133.0, 133.0, 131.6, 131.4, 131.0, 130.3, 130.2, 130.2, 
130.0, 129.3, 129.1, 128.9, 128.3, 128.1, 128.0, 126.9, 126.8, 126.6, 126.4, 126.3, 125.0, 
124.6, 124.4, 124.2, 121.1, 121.1, 120.5, 119.9, 119.8, 119.7, 119.2, 119.1, 119.0, 114.9, 
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113.9, 113.0, 78.5, 78.4, 78.0, 69.8, 67.4, 66.8, 62.5, 56.6, 56.2, 55.8, 55.5, 55.2, 52.2, 48.2, 
47.6, 45.9, 45.9, 42.2, 41.7, 39.5, 38.1, 37.8, 37.1, 36.6, 36.3, 34.4, 34.3, 34.1, 34.0, 31.6, 
31.1, 30.5, 30.3, 28.2, 28.2, 28.1, 27.6, 27.3, 27.2, 27.2, 26.0, 25.9, 24.4, 22.8, 21.3, 16.4; 
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N-Boc-Gly-Gly-Cys(Trt)-Acyl Hydrazone Aldehyde N-Boc-Penylalanine-N-Boc-
Phenylalanine-N-Boc-Leucine-N-Piv-Alanine Four-Barrier Rotaxane 11 
 
A mixture of 10 (17 mg, 4.0 µmol), 14 (4.0 mg, 6.0 µmol) and aniline (50 µl) in 
DMSO/2-(N-morpholino)ethanesulfonic acid buffer (3:1 v/v, 1 ml, pH 6.0) was stirred at 
60 °C for 72 h. The reaction mixture was diluted with CH2Cl2 (10 ml) and the organic layer 
was washed with H2O (10 ml). The organic layer was dried over Na2SO4, filtered, and the 
solvent removed under reduced pressure. Preparative TLC (SiO2 [UNIPLATE-T], 
CH2Cl2/MeOH 5%) of the residue afforded 11 (17 mg, 90%) as a colourless solid. The title 
compound was operated without further purification. 
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NH2-Phe-Phe-OEt E1 
 
N-Boc-Phe-Phe-OEt (0.31 g, 1.00 mmol) was dissolved in EtOH (10 ml). Aqueous H2SO4 
(5%, 0.50 ml) was added and the reaction mixture was heated to reflux for 24 h. The reaction 
mixture was allowed to cool to room temperature and diluted with EtOAc (25 ml). The 
organic layer was washed with aqueous 1M NaHCO3 (10 ml) and the aqueous layer was 
extracted with EtOAc (3 × 25 ml). The combined organic layers were washed with H2O 
(25 ml), brine (25 ml), dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure to afford E1 (0.32 g, 94% yield) as amorphous white solid.  
m.p. 296 ° C; [α]D = -0.03° (c 0.43, MeOH); 
1
H NMR (600 MHz, CDCl3) δ = 7.78 (d, 
J = 8.4 Hz, 1H, Hg), 7.34 (t, J = 7.4 Hz, 2H, He), 7.30 – 7.24 (m, 4H, H f + k + l), 7.22 (d, 
J = 7.7 Hz, 2H, Hj), 7.08 (d, J = 7.3 Hz, 2H, Hd), 4.89 (q, J = 7.0 Hz, 1H, Hh), 4.24 – 4.13 
(m, 2H, Hm), 3.62 (dd, J = 9.5 Hz, 3.9 Hz, 1H, Hb), 3.18 (dd, J = 13.8 Hz, 4.0 Hz, 1H, Hc), 
3.12 (dd, J = 8.6 Hz, 6.3 Hz, 2H, Hi), 2.63 (dd, J = 13.7 Hz, 9.2 Hz, 1H, Hc’), 1.29 – 1.21 (m, 
3H, Hn); 
13
C NMR (150 MHz, CDCl3) δ = 173.8, 171.6, 137.7, 136.1, 129.4, 129.4, 128.7, 
128.5, 127.0, 126.9, 126.9, 126.9, 61.4, 56.3, 52.8, 40.8, 38.2, 14.2; HRESI(+)-MS: m/z 
363.1682 [M+Na]
+








E1 (0.17 g, 0.50 mmol, 1.00 equiv.) and E2 (0.15 g, 0.52 mmol, 1.04 equiv.) were dissolved 
in DMF (5 ml). PyBrOP (0.35 mg, 0.75 mmol, 1.50 equiv.) and N,N-diisopropylethylamine 
(0.20 ml, 1.15 mmol, 2.30 equiv.) were added and the mixture was stirred at room 
temperature for 24 h. The reaction mixture was diluted with EtOAc (20 ml) and the organic 
layer was washed with H2O (20 ml). The aqueous layer was extracted with EtOAc 
(2 × 20 ml). The combined organic layers were washed with H2O (40 ml), brine, dried over 
Na2SO4, filtered, and the solvent was removed under reduced pressure. The residue was 
purified by trituration with Et2O (5 ml) to give E3 (0.27 g, 90% yield) as a white powder.  
m.p. 232 °C; [α]D = -0.16° (c 0.16, MeOH); 
1
H NMR (600 MHz, DMSO-d6) δ = 8.45 (d, 
J = 8.1 Hz, 1H, Hj), 7.89 (d, J = 8.1 Hz, 1H, Hp), 7.62 (d, J = 8.9 Hz, 1H, Hb), 7.43 (d, 
J = 8.2 Hz, 1H, He), 7.30 – 7.13 (m, 10H, Hm+n+o+s+t+u), 4.58 – 4.50 (m, 1H, Hq), 4.43 (q, 
J = 6.9 Hz, 1H, Hk), 4.27 – 4.16 (m, 2H, Hc+f), 4.01 (q, J = 6.1 Hz, 1H, Hv), 3.04 – 2.91 (m, 
3H, Hl+l’+r), 2.76 (dd, J = 14.5 Hz, 8.5 Hz, 1H, Hr’), 1.52 – 1.42 (m, 1H, Hh), 1.30 (t, J = 6.9 
Hz, 2H, Hg), 1.16 (d, J = 6.7 Hz, 3H, Hd), 1.11 – 1.04 (m, 12H, Ha+w), 0.82 (d, J = 6.4 Hz, 
3H, Hi), 0.78 (d, J = 6.4 Hz, 3H, Hi’); 
13
C NMR (150 MHz, DMSO-d6) δ = 177.7, 172.6, 
172.0, 171.6, 171.5, 138.0, 137.4, 129.6, 129.5, 128.7, 128.4, 127.0, 126.7, 61.0, 54.2, 53.6, 
51.4, 48.6, 41.5, 38.4, 38.0, 37.2, 27.7, 24.4, 23.5, 22.1, 17.9; HRESI(+)-MS: m/z 609.3634 
[M+H]
+
, 609.3647 calc. for C34H49O6N4. 
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Piv-Ala-Leu-Phe-Phe-OH E4 
 
To a solution of E3 (0.20 g, 0.33 mmol, 1.00 equiv.) in MeOH (10 ml) was added aqueous 
1M NaOH (2.00 ml, 2.00 mmol, 6.00 equiv.) and the reaction mixture was stirred at room 
temperature for 2 h. The solvent was removed under reduced pressure. The residue was 
dissolved in EtOAc (25 ml) and the aqueous layer was washed with H2O (25 ml). The 
aqueous layer was acidified with aqueous 1M HCl to pH 3. The aqueous layer was extracted 
with EtOAc (2 × 20 ml). The combined organic layers were washed with H2O (25 ml), brine 
(25 ml), dried over Na2SO4, filtered, and the solvent was removed under reduced pressure to 
afford E4 (180 mg, 94%) as white solid.  
m.p. 123 °C; [α]D = -0.09° (c 0.17, MeOH); 
1
H NMR (600 MHz, DMSO-d6) δ 12.77 (bs, 1H, 
Hv), 8.27 (d, J = 7.7 Hz, 1H, Hp), 7.88 (d, J = 8.3 Hz, 1H, Hj), 7.64 (d, J = 8.2 Hz, 1H, He), 
7.43 (d, J = 7.5 Hz, 1H, Hb), 7.22 (m, 10H, Hm+n+o+s+t+u), 4.53 (td, J = 9.5 Hz, 4.7 Hz, 1H, 
Hk), 4.44 (q, J = 7.1 Hz, 1H, Hq), 4.22 (m, 2H, Hb+f), 3.09 – 2.97 (m, 2H, Hl+r), 2.92 (dd, 
J = 14.0 Hz, 8.6 Hz, 1H, Hr’), 2.77 (dd, J = 14.0 Hz, 9.4 Hz, 1H, Hl’), 1.52 – 1.44 (m, 1H, 
Hh), 1.31 (t, J = 7.3 Hz, 2H, Hg), 1.17 (d, J = 7.1 Hz, 3H, Hd), 1.09 (s, 9H, Ha), 0.83 (d, 
J = 6.5 Hz, 3H, Hi), 0.79 (d, J = 6.5 Hz, 3H, Hi’); 
13
C NMR (150 MHz, DMSO-d6) 
δ = 177.7, 173.1, 172.5, 171.9, 171.3, 138.0, 137.8, 129.6, 129.6, 128.7, 128.4, 126.9, 126.7, 
53.9, 53.7, 51.4, 48.6, 41.5, 38.4, 37.9, 37.1, 27.7, 24.4, 22.1, 17.9; HRESI(+)-MS: 
m/z 603.3140 [M+Na]
+
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Piv-Ala- Leu-Phe-Phe-Gly-Gly-Cys(STrt)-Macrocyclic Hydrazone E7 
 
E6 (23 mg, 20 µmol, 1.00 equiv.) and aldehyde macrocycle 7 (33 mg, 59 µmol, 3.0 equiv.) 
were dissolved in DMSO (1.5 ml). Aqueous 2-(N-morpholino)ethanesulfonic acid -buffer 
(0.5ml, pH 6.0) and aniline (50 μl) was added. The reaction mixture was stirred at 60 °C for 
72 h. The reaction mixture was allowed to cool to room temperature and then diluted with 
EtOAc (20 ml). The organic layer was washed with H2O (20 ml) and the aqueous layer 
extracted with EtOAc (2 × 20 ml). The combined organic layers were washed with H2O 
(20 ml), brine (20 ml), dried over Na2SO4, filtered, and the solvent was removed under 
reduced pressure. Flash column chromatography (SiO2, CH2Cl2/MeOH 4%) of the residue 
afforded E7 (18 mg, 56% yield) as yellowish oil.  
1:2 mixture of E (labelled 1)- and Z (labelled 2)-hydrazone. Several amide-rotamers are 
present. 
1
H NMR (600 MHz, DMSO-d6) δ = 11.51 (s, 1H, Ho1), 11.48 (s, 1H, Ho2), 
8.44 - 7.96 (m, 5H, Hv1+v2+x1+x2+z1+z2+ap1+ap2), 8.18 (s, 1H, Hs1), 7.93 (s, 1H, Hs2), 7.86– 7.63 
(m, 2H, Has1+as2+au1+au2), 7.59 (t, J = 7.6 Hz, 1H, Ha1+a2), 7.37 – 7.12 (m, 28H, 
Hj1+j2+m1+m2+j1+j2+s1+s2+t1+t2+u1+u2+ac1+ac2+ad1+ad2+ae1+ae2+ai1+ai2+aj1+aj2+ak1+ak2), 7.06 (d, J = 7.7, Hz, 
2H, Hb1+b2), 7.02 (d, J = 8.5 Hz, 2H, Hf1), 7.00 (d, J = 8.6 Hz, 2H, Hf2), 6.74 (d, J = 8.5 Hz, 
2H, Hg1), 6.68 (d, J = 8.5 Hz, 2H, Hg2), 5.41 (td, J = 8.5 Hz, 4.1 Hz, 1H, Hp2), 4.64 – 4.41 (m, 
3H, Hv1+aa1+aa2+ag1+ag2), 4.28 – 4.19 (m, 2H, Ham1+am2+ar1+ar2), 3.89 (t, J = 5.8 Hz, 4H, Hl1), 
3.79 (m, 8H, Hl2+w1+w2+y1+y2), 3.10 – 3.04 (m, 4H, Hab2+ah2), 2.88 – 2.74 (m, 4H, Hab1+ah1), 
2.70 (t, J = 7.4 Hz, 4H, Hc1+c2), 2.67 – 2.63 (m, 4H, Hk1+k2), 2.47 (q, J = 7.6 Hz, 4H, He1+e2), 
2.43 – 2.38 (m, 2H, Hq1+q2), 1.93 (p, J = 7.7 Hz, 4H, Hd1+d2), 1.77 – 1.69 (m, 4H, Hj1+j2), 1.69 
– 1.61 (m, 4H, Hi1+i2), 1.51 – 1.45 (m, 1H, Hao1+ao2), 1.32 – 1.27 (m, 2H, Han1+an2), 1.19 (dd, 
J = 7.1 Hz, 1.6 Hz, 3H, Har1), 1.14 (dd, J = 7.1 Hz, 1.5 Hz, 3H, Har1), 1.11 – 1.05 (m, 9H, 
Hau1+au2), 0.82 – 0.75 (m, 6H, Hap1), 0.72 – 0.67 (m, 6H, Hap2); 
13
C NMR (150 MHz, 
DMSO-d6) δ = 177.6, 173.0, 172.8, 172.6, 172.2, 171.5, 169.3, 169.1, 161.0, 157.2, 148.6, 
144.7, 144.6, 143.0, 138.4, 138.1, 137.1, 134.4, 134.4, 129.7, 129.7, 129.6, 129.7, 129.5, 
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128.6, 128.5, 128.4, 128.4, 128.3, 127.3, 127.1, 129.4, 125.4, 125.2, 120.6, 114.6, 114.5, 
66.5, 66.1, 54.5, 54.4, 54.4, 54.2, 54.2, 51.2, 51.1, 49.1, 48.9, 42.5, 42.3, 41.7, 41.6, 41.2, 
38.4, 38.4, 38.4, 38.3, 37.0, 37.0, 34.8, 34.7, 34.2, 34.1, 31.8, 28.3, 28.3, 28.1, 27.7, 24.5, 
24.3, 23.6, 23.5, 23.4, 23.3, 18.6, 18.6. 
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Piv-Ala- Leu-Phe-Phe-Gly-Gly-Cys(SH)-Macrocyclic Hydrazone 13 
 
E7 (15 mg, 9.4 μmol, 1.0 equiv.) was dissolved in CH2Cl2/TFA (4:1 v/v, 1 ml) and 
triisopropylsilane (5.0 μl, 24 µmol, 2.6 equiv.) was added. The mixture was stirred at room 
temperature for 90 minutes. The solvent was removed under reduced pressure and the 
residue washed with Et2O (3 × 10ml) and analysed without further purification. 
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The molecular machines capable of sequence-specific synthesis of oligopeptides presented in 
this thesis represent a significant advance in the development of novel molecular task 
performance inspired by nature. A rotaxane architecture performing highly complex tasks, 
generating an operation product that would not be possible with standard solution phase 
chemistry, therefore paves the way to the realisation for even more complicated systems. 
The ultimate goal of sequence-specific synthesis with artificial molecular machines would be 
the generation of polymers completely unrelated to the template that holds the information to 
be translated. Ideally, several reactions including C-C bond formations or a mixture of 
different co-polymers would be compatible with such a hypothetical machine. The individual 
bond forming reactions should be high yielding, fast and translate information with great 
accuracy, allowing access to very long information-rich polymer strands. Also desirable 
would be a device that–similar to the ribosome–can be reused in another translation event. 
The initial design proves that enzyme-free synthetic translation can be achieved with 
interlocked architectures, but still the level of performance of nature’s nanomachinery is out 
of reach. The system presented in this work destroys the information that is encoded in the 
track and is limited inherently to the synthesis of short oligomers. The individual bond 
forming NCL-steps are relatively slow12 h per amide bond formation eventand also the 
hypothetical extension of the systems to longer polymers would be problematic because of 
the increasing size of the transition states that are encountered as the thiolate catalyst 
advances. Furthermore, the thread component has to be synthesised in a lengthy 
protection/deprotection sequence. 
Several projects are currently ongoing in the Leigh group that address shortcomings of this 
initial design. The use of tracks which incorporate aminoacyl residues synthesised in a single 
polymerisation by sequential addition of aminoacyl succinimide derivatives would allow the 
extension of the system and easy access to longer polymer templates. A second project 
investigates the use of transacylation catalysts similar to the first generation design as 
discussed in Chapter 2 and would allow for translation without increasing the size of the 
transition states. Finally, a third project attempts the incorporation of reloadable barriers into 
a rotaxane architecture, therefore allowing the machine to be reused for a second or even 
third operation, thereby maintaining the information on the thread. These innovative new 
systems could bring us even closer towards the development of artificial ribosomes–a 
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spectively. r andM are the density and molecular
weight of water, respectively. ∆Gcycle is the molar
Gibbs free-energy change of absorbed water dur-
ing one expansion/contraction cycle. fad is the
adhesive force coefficient between PEE-PPy films
and moist substrates. Given a certain E, R, and
fad, Eqs. 1 and 2 roughly define a theoretical max-
imum and minimum limit on the required thick-
ness of the actuator to perform fast locomotion.
In practice, we found that the optimal thickness
for PEE-PPy actuators on a moist paper was
roughly 15 to 40 mm.Actuators thinner than 15 mm
tended to stick to the moist paper, whereas ac-
tuators thicker than 40 mm showed significantly
slower locomotion.
Because this PEE-PPy actuator could contin-
uously extract chemical potential energy out of
ambient water gradients to perform mechanical
work, it should be able to drive a piezoelectric
element to convert the mechanical energy into
electrical energy. A 9-mm-thick piezoelectric poly-
vinylidene difluoride (PVDF) filmwasmetallized,
wired, and insulated on both faces (Fig. 4A). A
27-mm-thick PEE-PPy actuator was attached to
one face of the PVDF element.When placed on a
moist substrate with the actuator facing down, the
actuator bent and stretched the PVDF element
repeatedly (movie S5), generating an open-circuit
voltage up to 3 V. A 10-megohm resistor was
loaded onto this generator (Fig. 4B), and the peak
output reached ~1.0 V (Fig. 4D). Analysis indi-
cated that the frequency of the alternating voltage
signal was ~0.3 Hz (fig. S12), whichmatched the
motion frequency of the generator (movie S5). The
average power outputwas 5.6 nW (fig. S13), which
corresponded to a power density of 56 mW/kg for
the 100-mg generator. In contrast, the same PVDF
element did not move on the moist substrate, and
the recording showed only noise (fig. S14), with
analysis of this background noise giving an av-
erage power output of 0.015 nW (fig. S15). The
generated alternating electrical pulses by the gen-
erator were rectified using a commercial full-wave
bridge rectifier, then stored in a 2.2 mF capacitor
(Fig. 4C).Within 7min of charging, the voltage of
the capacitor was saturated to ~0.66 V (Fig. 4E).
This was lower than the peak output voltage of the
generator, possibly due to voltage drop across
the rectifying diodes and/or current leakage of
the capacitor.
This PEE-PPy polymer composite system fea-
tures an interpenetrating network of a rigid poly-
mer with a soft, hydrolytically sensitive polymer
that can performwater-gradient–induced displace-
ment, converting the chemical potential energy in
water gradients to mechanical work. Besides me-
chanical vibration energy, the generator based
on this powerful actuator can use ubiquitous low-
temperature water gradients as its energy source,
in contrast to state-of-the-art piezoelectric energy
scavengers that rely solely onmechanical vibration
energy (26). Thus, the water-gradient–driven actu-
ator and generator demonstrated potential applica-
tions as sensors, switches, and power sources for
ultralow-power devices.
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Sequence-Specific Peptide Synthesis by
an Artificial Small-Molecule Machine
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The ribosome builds proteins by joining together amino acids in an order determined by messenger
RNA. Here, we report on the design, synthesis, and operation of an artificial small-molecule
machine that travels along a molecular strand, picking up amino acids that block its path, to
synthesize a peptide in a sequence-specific manner. The chemical structure is based on a rotaxane,
a molecular ring threaded onto a molecular axle. The ring carries a thiolate group that iteratively
removes amino acids in order from the strand and transfers them to a peptide-elongation site
through native chemical ligation. The synthesis is demonstrated with ~1018 molecular machines
acting in parallel; this process generates milligram quantities of a peptide with a single sequence
confirmed by tandem mass spectrometry.
Cells achieve the sequence-specific synthe-sis of information-rich oligomers and poly-mers through the operation of complex molecular machines that transcribe informationfrom the genetic code (1). The most extraordi-nary of these is the ribosome (2–4), a ~2.6-MD
(bacterial) to ~4.3-MD (eukaryotic) molecular
machine found in all living cells that assembles
amino acids from tRNA building blocks into a
peptide chain with an order defined by the
sequence of the mRNA strand that it moves
along. Artificial small-molecule machines (5)
have previously been used to store information
(6, 7) and do mechanical work (8–11); others
have been employed in synthesis to processive-
ly epoxidize an unsaturated polymer (12, 13),
switch “on” and “off” catalytic activity (14–17),
and change the handedness of a reaction product
(18). Large synthetic DNA molecules have been
used to guide the formation of bonds between
unnatural building blocks (19–22) and assemble
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gold nanoparticles in particular sequences (23).
Here, we report on the design, synthesis, and
operation of a rotaxane-based small-molecule
machine in which a functionalized macrocycle
operates on a thread containing building blocks
in a predetermined order to achieve sequence-
specific peptide synthesis. The design of the ar-
tificial molecular machine is based on several
elements that have analogs in either ribosomal
(2–4) or nonribosomal (24) protein synthesis:
Reactive building blocks (the role played by
tRNA-bound amino acids) are delivered in a se-
quence determined by a molecular strand (the role
played by mRNA). A macrocycle ensures pro-
cessivity during the machine’s operation (remi-
niscent of the way that subunits of the ribosome
clamp the mRNA strand) and bears a catalyst—a
tethered thiol group—that detaches the amino
acid building blocks from the strand and passes
them on to another site at which the resulting
peptide oligomer is elongated in a single specific
Fig. 2. Proton NMR spectrum of (A) the noninterlocked
thread and (B) rotaxane 1, in d6-dimethylsulfoxide
(500 MHz, 298 K). Rotaxane 1 exists in both E- and
Z-hydrazone forms. The assignments correspond to
the lettering shown in Fig. 1. C′, S-Trt-cysteine; G′,
N-Boc-glycine; F′, N-Boc-phenylalanine; L′, N-Boc-
leucine; A′, N-Piv-alanine. ppm, parts per million.
Fig. 1. Synthesis of rotaxane-basedmolecular machine 1, incorporating
a strand bearing amino acid building blocks (2), a macrocycle (3) with a
site for attachment of the reactive arm, and a terminal blocking group (5)
that prevents the threadedmacrocycle from coming off the strand until all
of the amino acid groups have been cleaved. Structure 1 is shown as the
major diastereomer; a small amount of epimerization (<5%) of some of the acyl amino units occurs during incorporation into the track. Boc, CO2C(CH3)3; Piv, COC(CH3)3;
Trt, CPh3; Ph, phenyl. Reaction conditions: (i) Cu(CH3CN)4PF6 in dichloromethane:t-butanol (2:1), room temperature, 4 days, 30%. (ii) PhNH2 (catalyst),
BocGlyGlyCys(S-Trt)NHN=CHC6H4OCH3 in 3:1 dimethylsulfoxide: aqueous 2-(N-morpholino)ethanesulfonic acid buffer (pH 6.0), 60°C, 2 days, 90%. The italicized
letters indicate key signals in the 1HNMR spectrum shown in Fig. 2B. For the full lettering scheme and assignments, see the supplementarymaterials, page S28 (26).
































sequence, through chemistry related to non-
ribosomal peptide synthesis (24).
The chemical structure of the artificial mo-
lecular machine, 1, is shown in Fig. 1. Strand 2
bears three amino acids attached to the track by
weak phenolic ester linkages (25) and separated
from each other by rigid spacers that minimize
the possibility of the reactive arm of the machine
coming into contact and reacting with a building
block out of sequence (26). Macrocycle 3 con-
tains an endotopic pyridine group that directs the
threading of strand 2 during the Cu(I)-catalyzed
cycloaddition of the terminal alkyne with the
azide-bearing stopper group 5, leading to the
assembly of rotaxane 4 in 30% yield (Fig. 1, i).
This active template (27, 28) strategy ensured
that the resulting threaded structure did not have
residual attractive intercomponent interactions
that would tend to localize the position of the
ring rather than allow it to move freely up and
down the strand between blocking groups. Once
we assembled the macrocycle-strand-stopper
conjugate 4, we used reversible hydrazone ex-
change to introduce a cysteine derivative bearing
the reactive arm [a trityl (Trt)–protected thiol
group] and the site for peptide elongation [a
tert-butoxycarbonyl carbamate (Boc)–protected
amine at the end of a glycylglycine residue]
(Fig. 1, ii). The fully assembled machine 1 is
stable in its protected form, with upfield shifts
of the HP1 triazole and nearby HS12-S14 proton
signals evident in the 1H nuclear magnetic res-
onance (NMR) spectrum on account of shielding
from the phenyl rings of the macrocycle, con-
firming that the ring is trapped in the region of
the strand between the terminal stopper and the
Boc-phenylalanine ester (Fig. 2).
We used acid-catalyzed cleavage of the Boc
and trityl protecting groups (Fig. 3, i) to activate
the molecular machine and then allowed it to oper-
ate (Fig. 3, ii) at 60°C under microwave heating
in a 3:1 acetonitrile:dimethylformamide solution in
the presence of N,N-diisopropylethylamine (a non-
nucleophilic base) and tris(2-carboxyethyl)phosphine
(a reducing agent that cleaves any disulfide bonds
formed through thiol oxidation). The design of the
machine is such that once the thiolate residue of
the cysteine group (6a) is deprotected, it is poised
to undergo a transacylation reaction with the first
amino acid phenolic ester that blocks the macro-
cycle’s path on the track (6b).We hypothesized that
the subsequently formed phenylalanine thioester
(6c) would be able to react further, transferring
the amino acid by native chemical ligation (29) to
the glycylglycine amine group by an 11-membered-
ring transition state [the dipeptide spacer between
the cysteine residue and the amine of the peptide-
elongation site was introduced because native
chemical ligation is reported to be very slow via
8-membered-ring transition states (30)]. This se-
quence simultaneously transfers the amino acid
to the end of the growing peptide (6d) and re-
generates the catalytic thiolate group, ready for
the cleavage and transfer of further building blocks.
S-N acyl transfer is a key feature of nonribosomal
peptide synthesis (24).
Once the covalent bond connecting an amino
acid to the strand is broken, the macrocycle is
able to move further along the track until its path
is blocked by the next amino acid group (6d).
The O-S acyl transfer/S-N acyl transfer/catalyst
regeneration/ring movement process continues
(6e to 6h) until the last amino acid on the track
is cleaved (6h) and the macrocycle detaches from
the strand (8) with the newly formed, full length,
peptide attached (7). The artificial molecular ma-
chine synthesizes the peptide from the C terminus
to the N terminus, the opposite direction of ribo-
somal translation (2–4).
After a 36-hour operation of 6a at 60°C, no
starting material remained, as shown by high-
performance liquid chromatography (HPLC), and
two major products were isolated from the re-
actionmixture (26).We used 1HNMRspectrosco-
py and mass spectrometry to identify one product
as the completely deacylated thread, 8. The other
product had a 1H NMR spectrum and molecular
Fig. 3. Proposed mechanism for sequence-specific peptide
synthesis by molecular machine 1. After activation of the ma-
chine by acidic cleavage of the Boc and Trt protecting groups,
under basic conditions successive native chemical ligation re-
actions transfer the amino acid building blocks to the peptide-elongation site on the macrocycle in the
order they appear on the thread. Once the final amino acid is cleaved, the macrocycle bearing the
synthesized oligopeptide 7 dethreads from the strand. The hydrazide peptide 9 is subsequently released
from the macrocycle by hydrolysis. Reaction conditions: (i) 20% CF3CO2H in dichloromethane, room tem-
perature, 2 hours, 100%. (ii) ((CH3)2CH)2NEt, (HO2CCH2CH2)3P in 3:1 acetonitrile:dimethylformamide,
60°C, 36 hours. Et, ethyl. (iii) 30% CF3CO2H in 3:1 dichloromethane:water, room temperature, 18 hours.
































weight (Fig. 4) consistent with the macrocycle
bearing the hydrazone linked to the hexapeptide
(Piv)AlaLeuPheGlyGlyCys, 7 [Piv, COC(CH3)3].
To confirm that the product of the molecular
machine’s operation had the amino acids as-
sembled in the correct order, we used tandem
mass spectrometry (MS/MS) to determine the
peptide sequence. We then validated the se-
quence by comparing it with an authentic sample
and an isomer in which the order of the Phe and
Leu residues was reversed, each prepared un-
ambiguously by conventional peptide synthesis
(26). Figure 4A shows the 1H NMR spectrum of
the molecular machine product 7, and Fig. 4B
shows the MS/MS spectrum of one isotope of a
2+ ion of 7 derivatized through the cysteine as
an S,N-acetal, a species that gave a sufficient
signal-to-noise ratio for the MS/MS experiment.
Figure 4C shows the superimposition of the
MS/MS spectra of a similar isotope and ion
from the authentic samples of the macrocycle
bearing the sequence (Piv)AlaPheLeuGlyGlyCys
(red peaks) and (Piv)AlaLeuPheGlyGlyCys
(blue peaks). The difference in the fragmenta-
tion masses of the two sequence isomers is
apparent in Fig. 4C (725.73 for the LeuGlyGlyCys-
macrocycle, 742.92 for the PheGlyGlyCys-
macrocycle), and product 7 was confirmed as
corresponding to the intended sequence isomer.
With the use of HPLC-MS analysis of the
reaction mixture from the operation of 1, we did
not detect any products corresponding to other
peptide compositions (neither different sequences
nor peptides with more or less than one Phe, Leu,
or Ala residue), indicating that the peptide syn-
thesis occurs overwhelminglywithin the confines
of the molecular machine. In contrast, a control
reaction carried out under identical conditions
but using the nonthreaded strand and macrocycle
yielded several products, including strands with
one or more amino acid groups cleaved, but there
was no evidence for the formation of 7 under
these conditions. Thus, the threaded architecture
of the molecular machine—encompassing the
catalytic site, elongation site, and the building
block strand—is essential for the sequential pep-
tide synthesis, and the mode of operation of the
molecular machine is consistent with the mech-
anism shown in Fig. 3. The peptide (9), still bear-
ing the GlyGlyCys unit at the C terminus, could
subsequently be cleaved from the macrocycle by
hydrolysis (Fig. 3, iii).
On a scale of tens of milligrams, we performed
the synthesis of the small peptide through auton-
omous multistep production by artificial small-
molecule machine 1, corresponding to parallel
synthesis by ~1018 machines. Once operation is
initiated, the synthetic tasks performed by 1 pro-
ceed automatically, requiring no further inter-
vention. As the catalytic thiolate is constrained
by the threaded architecture of the machine from
reacting with building blocks out of sequence,
the act of balancing the rate of reactions with
the speed that templates rearrange (19–22) is un-
necessary for a rotaxane-based machine.
Rotaxane 1 is a (very) primitive analog of
the ribosome. Limitations of the first-generation
artificial system include slow kinetics (1 takes
~12 hours to make each amide bond, compared
to the 15 to 20 amide bonds synthesized per sec-
ond by a ribosome) and loss of the sequence
information on the strand as it is translated into
the product. Furthermore, the size of oligopeptide
that can be produced may ultimately be restricted
by the size of the cyclic transition states involved
Fig. 4. (A) Proton NMR spectrum of molecular machine operation product
7 in d6-dimethylsulfoxide (500 MHz, 298 K). (B) Tandem mass spectrum of
a single isotope of the 2+ ion [mass/charge ratio (m/z) = 876.64] of S,N-acetal–
derivatized 7. (C) Superimposed tandem mass spectra of 2+ ions of S,N-acetal–
derivatizedmacrocycles bearing the peptide sequences (Piv)AlaPheLeuGlyGlyCys
(red; 2+ ion isotope-selectedm/z= 876.73) and (Piv)AlaLeuPheGlyGlyCys (blue;
2+ ion isotope-selected m/z = 876.92), each prepared unambiguously by con-
ventional peptide synthesis.
































in S-to-N acyl transfer [although peptide ligation
has been successfully usedwith up to 29-membered
cyclic transition states (31)]. Nevertheless, 1 dem-
onstrates that relatively small, highly modular,
artificial molecular machines can be designed
to autonomously perform iterative tasks in syn-
thesis. The principles employed in the design
and operation of 1 should be broadly applicable
to other types of monomer and chemical reac-
tions (32).
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Shape-Memory Nanopores Induced
in Coordination Frameworks by
Crystal Downsizing
Yoko Sakata,1,2 Shuhei Furukawa,1,2* Mio Kondo,1,2 Kenji Hirai,3 Nao Horike,2
Yohei Takashima,2 Hiromitsu Uehara,2 Nicolas Louvain,1,2 Mikhail Meilikhov,2
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Flexible porous coordination polymers change their structure in response to molecular
incorporation but recover their original configuration after the guest has been removed.
We demonstrated that the crystal downsizing of twofold interpenetrated frameworks of
[Cu2(dicarboxylate)2(amine)]n regulates the structural flexibility and induces a shape-memory
effect in the coordination frameworks. In addition to the two structures that contribute to the
sorption process (that is, a nonporous closed phase and a guest-included open phase), we
isolated an unusual, metastable open dried phase when downsizing the crystals to the
mesoscale, and the closed phase was recovered by thermal treatment. Crystal downsizing
suppressed the structural mobility and stabilized the open dried phase. The successful
isolation of two interconvertible empty phases, the closed phase and the open dried phase,
provided switchable sorption properties with or without gate-opening behavior.
Shape-memory materials alter their mor-phological appearance in response to anexternal stimulus (for example, mechanical
stress created bymacroscopic structural deforma-
tion), hold their new temporary shape after the
stimulus has been removed, and return to their
original morphology in the presence of another
external stimulus (1, 2). For instance, a metal alloy
can exhibit shape-memory effect if it has two
phases that can interconvert reversibly; that is,
without requiring atoms to diffuse through the
structure. Here, we describe a molecular-scale
shape-memory effect (MSME) in nanoporous
framework materials in which the application
of an adsorption stress deforms the original shape
of the nanopore into a temporary shape, which
is maintained even after desorption, and thermal
treatment then recovers the original shape.
Our design takes advantage of the flexibility
of crystalline porous coordination polymers (PCPs)
(3–8), which are assembled from organic spokes
and inorganic joints. These flexible PCPs coop-
eratively reconfigure their framework structures
in response to the incorporation of molecules into
the nanopores; this adsorption process triggers
the deformation of the pore shape. Most flexible
PCPs recover the original structure after the re-
moval of the adsorption stress (that is, the de-
sorption of the guest molecules), which leads to
the so-called framework elasticity property (9).
The MSME requires that any structural transfor-
mation during desorption should be suppressed.
We show that crystal downsizing influences the
structural mobility, because a reduction in the
number of repeating units should be sufficient to
regulate the cooperative nature of the structural
transformation and the effect of stress.
We fabricated MSME nanopores by crystal
downsizing, which regulated the flexibility of the
framework, and demonstrated the switchable sorp-
tion events based on the presence of two intercon-
vertible pore shapes (Fig. 1). Among the variety of
flexible PCPs, we chose a PCP with a twofold
interpenetrated framework (10–12)—namely,
[Cu2(bdc)2(bpy)]n (1, bdc=1,4-benzenedicarboxylate,
bpy = 4,4′-bipyridine) (13)—that exhibits a co-
operative structural transformation from the
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